var title_f12_42_12960="Structure of the TSH receptor";
var content_f12_42_12960=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F72949&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F72949&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Structure of the TSH receptor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 415px; height: 254px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hypothetical structure of the TSH receptor. Stimulating (in Graves' disease) and blocking (in Hashimoto's thyroiditis) anti-TSH receptor antibodies may bind to different regions of the extracellular",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12960=[""].join("\n");
var outline_f12_42_12960=null;
var title_f12_42_12961="Clobutinol: International drug information";
var content_f12_42_12961=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Clobutinol: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4303742\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Desketo (IT);",
"     </li>",
"     <li>",
"      Enantyum (ES, IT);",
"     </li>",
"     <li>",
"      Ketesse (CH, ES, IT, LU);",
"     </li>",
"     <li>",
"      Lomisat (DE, ES);",
"     </li>",
"     <li>",
"      mentopin Hustenstiller (DE);",
"     </li>",
"     <li>",
"      Nullatuss Clobutinol (DE);",
"     </li>",
"     <li>",
"      Quiralam (ES);",
"     </li>",
"     <li>",
"      Rofatuss (DE);",
"     </li>",
"     <li>",
"      Silomat (AR, AT, BE, BR, CZ, DE, FI, FR, IT, LU, PT);",
"     </li>",
"     <li>",
"      stas Hustenstiller N (DE);",
"     </li>",
"     <li>",
"      Sympal (DE);",
"     </li>",
"     <li>",
"      Tussamed (DE);",
"     </li>",
"     <li>",
"      Tussed (DE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1978389\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Clobutinol Hydrochloride",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1978395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antitussive",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1978398\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Symptomatic treatment of nonproductive cough",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1978392\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: 40-80 mg 3 times/day",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821189\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1978397\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Syrup: 40 mg/10 mL [sugar free; contains sodium benzoate]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justified;\">",
"     Tablet: 40 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10360 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-B2700F0D78-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12961=[""].join("\n");
var outline_f12_42_12961=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4303742\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978389\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978395\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978398\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978392\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821189\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1978397\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10360\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10360|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_42_12962="Short term tubes";
var content_f12_42_12962=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71781&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Short-term tympanostomy tubes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 353px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Short-term tympanostomy tubes are intended to remain in the eardrum for 8 to 18 months. They include Armstrong grommet tubes (A), Reuter-bobbin (R), Sheehy (S), and Paparella (P).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Isaacson G, Rosenfeld RM. Care of the child with tympanostomy tubes. A visual guide for the pediatrician. Pediatrics 1994; 93:924. Copyright &copy; 1994 by the AAP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12962=[""].join("\n");
var outline_f12_42_12962=null;
var title_f12_42_12963="Oral candidiasis - tongue";
var content_f12_42_12963=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F82214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F82214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oral candidiasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwAlh36faTkbhCwVj1J54x6cVvaFahmaPYqC5yVPOP8AdI9apwqUuHUf8e4ffhu59K2mBk1BJrBGkEY3EJwWHqBXlc2uh7nL7thNRtLh7OO3mcSxwEshC5KDHSuTNuIpDNOm2OFcZIJ5Pc/0rs7+F2uzOsxhgkXDx9NpHJ+lY+oxHULlpZgQI4sRkYIdv4cinciLtuefXE0t/ezXbxo0SlECYHzbTj8DzTb1Jbmc+YnlxyOBH8uA2MD+ldJrfhxItFW8VxC6zAvGp684P+NY99G11PDCrNGI2OD0z/gattl0uVO6IZII4ysMTQ5UBy2cc9CDmmTK9yAscWEj+RmU534PUetWH0mV7ssys8G3cxU8t9KfaRXFskkTgPHE+QAOgapctLG0Kfvcz3ZqeH5FFm1vJGisTvDtFktiraJalpHSNIwRw4YjafpVvTBapaxx3UWJFBZJY2yOegPpzTGcQM9vP+7dRuwPmDHtzS5rkuGrsU49PtNTt2t7m4CNJwrcDB9aW00s3+nPC4iDwN5c0gk2iQYwOP1zUlhHbDzY54hMrHgbsEZ/wqARCNTPbglkbDjJG9c9PqKpSuiHCzuc9b6I9tqssE0m2NANh65BPGP5V0dxpc1rYMQzXFuM45xg+4qne2DS30F35rKAhIK8ttDfMCPXvVuWOS3sSYLlXWbGeeSDx/n60edilrZXKI83MK20QWQYfcpOcdqt2tqjLJJPEZJSSGJ+7n1+tSaYFtTMhLmUKFAC5JGa0YY5fPEMI3MFOwL83X1pX0RNndla2sYbMLLuAjGSoX5gG681ZVLiWUG0YraSPndwDkdan8hba1PnRnnIlb+orUtNNxpIa1mxETkBupz6UEyaRnXNpHOscd5I7xhC53jgMPfr0qhdaZBZeV5EsloRydoyGB6EA1NqNy1tdQRzH92FIct0YdjWZd6qXLvH/DxubnCjsKHJIIwkzltf0+e2mmhQx3C3DZKsMdOT9DiuN1a0uU1CMwrJGoPyoW3bfYGu71HUjdmNFQAIDjA5yeprLuIt7wyBgCrYIP8AjQp2dkU6KtdnGgXVzNIJlOV7YqO2ikd8TJIUPQg4wa6G5IS5EhPyyfK3se1JJEXIAwSDwK0i7a2MpRls2ZMkS+aiiNyMfxNjn8KtxWiuhCnauegPB/On3AjjGGJ3f3ByTTdk7RgOAkR/hHU1pzMysiq8EagrGzcHr1/KrUEASPhfw9asQxqFjfByPyp0h2kk9Tx7VLKSsQzxqpBYYGOB6VFvZx8gJwcdcfrVzEbXANygZE6Rk8N9aayqXYou1ew9KWg7NkLJPI5aZjjuQOv40oU9E38jgVZZiEAYYXFNtgfMDj5SB8v1o1CyGrF5ThnJD9hnkVHOcsSCeR0NTToSxZj75pbSDzn3udqLx9adrivYqCMBSXwQev0qlJakHMLFc9u1bk0KtEzLjOcAY61BBZvIhEzFT0zinYm5ibJ5cqRux121qxZjs0PlscfLjbVqCzFvuBAUN6nJp5jBxsPy+tVdIfs5Sehiyh7i4SIAjYdzV1WlabLeMpjTCD7zdB+FQ2GjyXTBo49ozyxGK9H0CwNva4kCnBwAvSmFSKprzOT1LSYLOxZpQAWHBNUfC2jzyyPKhDoOMk1veMElklMZQiMetTeFI5dPszvQ+Ux3VCfvalODVLm6s1LbRrVYgJ4gznnJ7Ul34biWxf7OP3jnKknpUOta0lu0Kp8wY5wDWnpOrLcugKsoX1FaqzOOUZpXOW1Lw1NZWySFg7dDxXMaqJLG+VGh3Rlc7hXrGrTGZCFj3KDmuI1i4ty0kbpggYo0HGTe5zD3arCMK249SRVaWQlwSBkjsa0YoYrmBkBG7t61y2vi40ubnOMZoa6lp62Oz0ZzEwmYHc3TJ6VavnWVzNKA+fvZrz7S9eaVVUkqy9q2hdySj5ix/Gs3oaKClqbcKwTHO3CKT06mrL2LTFC37qMjC7jVDRZcHyyByep61oS3k0bSRsqs2PlIFNbCaeyMPVtOmsFaUfOmcZ9Kx74C3kVYhyeSfWunvL2a7j8m6Yxxkfd9aydQgjWMeYTyPlouFu567ErWpiL4KOBv3c454NXEmh01UukuTk5wUPKnPH1rNhmWSNo2clATjHXNO0+0tbpmUSOtwOVVjlX9h6GvPW56jS6ly5vLzXoS0skcLZ6sCPMPZs/pVU6Y8SJJNcuZNwyqnAIAyaZcxFH2wzhjn/VSDBNZr3Mn2yEbzlA2Qe1Vz9yHRurRLmqGK405IoYgqM435PzEDqRmobGw3wxiVSTk7WHcdjU0d3Gz7JOcLx36kZGK3XuLCYmKGQW6opyp6mr5roi3LpYq2VmZbeZA6I0aEqQOvPQVFBYSSPbxyRbJpDuHyn5lOf8A61WRdCWEeREkk2cMR8uRnr9arzNqFvdW6REvIOFA5C+2am47tBPBCuVELQyjjaDkE571Ye33CG4tjsmiA3RsvDDvUoh3IsAl3XL8yA9B3q9aSzR3L28aBpWi3kZ5xRuwlLQx5Ct3cefFEkTPwwXgemcUmno8GoyrMDEG7HP4GrMtq9rHEkKFrh2LOeoUVp3Uvn6cuzJuFQfOq8def600S5fcc7q9pPGBc2bNMYxhwBwV6GsiCAJeC1UuYnPnRKP4P7w5/OuwjxAi5TajKRIGfhvaudvLWKDcNzb0O+Ig9Vz0+g5FWuxKeuhMVELXnn27/aAwCg5wUArX0E2cEYkiYtMcBiM4Ge2KzI76G6gRjAxljYq7DPBx0NI8yxFY4IN8kv8AqxCSSp+lJ6B8SNrWwA0qunko4EgyMDGOhrnjPLJEggmUBe+48Dpms5724Lu91IwCjBBGc4rGvNUeZlAwqjjCjHepcr6m1Ok9jWvn8m6Y3sy3BUAeox61i6lMGmZA+6Mfd7ZFC3MIjIdd7levcVQlk3LzyRUK7NLJEskgCgRj5+5HTFU5j5ilGTCgYqaJ8YyMAjk0OAMn+H0NawiZTmZE9nOybQ6mM9iMkVWUTtuill2yL02jGR65rdB3p8pHBqtdW8UgCxBt/XcK2WhzSV9URR2ixp8qrnGWYdT+NJ5WMEqdx6D0qxF5kcID4kXpkHBpPNlLErC2AOcmmSRyKI4lZzhh2qrEHllYjJAOeOn0q6lvcXIHmKFT0Hf6mrcEIRsBF2nghe3vSY9DLkiJbLKNw6U/y+AWXmtj7IN25Uz2yeKlNvuGEiD49BTsDkkYTQs4BPUflTgqLCMfMfUV02l+EdUvmLRWzqjD+L5Qa6SDwFFCg+2ytvPRUGBRYzlUSPO7ZFmlMcqfw5X0NXbXTZZ5PLhif8q9S0/wfYIgIhLFe7GtlNKhgUAIFAHHFUkZOqjyRdBeML5qyCLOTtXkVTkSOSQQwsV5xjGO9euTQxBvnQHdwOKp6f4atU1X7e4X7uMECi+mhcKqjqzz+fwlcW2txWEjoxljEiuvIIIzis3UNIuNKaUXls+zoHXke1e1NZw+Yj7QQvTjkVn61YR31o8TrkMpBOORUWtsaRxbbXNseZwXP/EuSJMiX+9mvRPDQjm0mKNgrOvUg15pqVpLpVwI5gdhPyOO9avh/UZkcrCdueSQelVCo3ozor4dSgpQO01bSku42Q4Ddj6VTW2+z6eI2IYxjBx3rSs72OayEjyZboTXHa3q80d1Ibc/us46VTtHU5KcJz9zsc7cx+drm1GOwtxk/dr0nRrK0t7RSJVZ+/rXnk6CSZLh3VS3p2rZ06cPcQx2r5cHJqYNa3OjEU3JKx21zb4TKHORmvM/E0aS3Lpna3SvTbaSVoiJo8cZyOlcVqdvBNqVw74wDxTktThpuzdzlYdMl0+yaZX3gckHriuX8XXf2y1U/wAS/pXo+9HsJoiQxAIryfVyd8kZ5wauUrJIuC57tnO2WVnBX1rtNOl85AT1rjrRf31dTpJwMComzShHQ6CElDle3StTT5ppZgAuCe+KzIATjvWzprMrcIWPbHepR0uKaLF3aGR/3iDgcmsy8hV+XUFE6GunNyj2YzDtcfePrXK6pcmSYW0QGGOcCqObrY7yRBsBichgc4IxQrSRsCyBXzgsveohIsj4fKP3HY1YQOisoAZD2Jrl5U9jr9o1uNjkYyhjh+TwRmm20FpNfN5yuo2fwnODRvRmDlWU46r60pZB8ykByMHH9ajkZp7W5RaAh2EbFx94noRV9FjadxLGo/d7gSepqAqBOrHnjscflUTMzshDHOcfN/Kly2K5rlm2vjayBowCR0x2FXbLUHaVvNmdAFJUAdR1xmseNSpJbjNLMxUHBO3GeKzu0aOKkalrLKm6aTISQ5Dscfl61f064sAjzLcXIugGACjH0NYIuWms0iDjEYP3v6VBHM0cbt5uxuwA5P1q1KxLhzI3BqQS2YXKO0hO5X3Y4qaTxEn2KO0tbeOIZwZPr6mueMjzxwrcPGi5PzHn88VpoIbNY2lMMyMhUZXGPQj3pq7M5RitGOulnIQyzmSYncFjGQAabrN5NJDFEtsguIedwwS+ByOPasuFWlcjzSj4LAAkcZ7UPFbJG5aaf7aW6E7QB6+tUhNISSdYVNzbNI7PjehGAPr70yyuTHdRyR3ZhBPJC52/jVeWR4XlPDLIQWPX/Oaryudx2gbcZO7ik73LVmrWIdQkcXEqiX5QxyR0zmqgG+UbuQe5omkzuCZHXI9arhiB2/OqUblOfIiywVGZHG8dPp9KryLs69PWkabe+4DAbjOMYpDljlidtaxhY551LjTMWX92ML6mnblMQDHkcAGkdxuCBevXHapBGS4fjng89q0sZXFQcbQcH2FSyRtDbNlQXPAHpVi0jRbhTLyMHAHrjipY4pGQSCMnLbcdOam13YXNbcoWaKv7uVTu65FXYoEdyCABjdjFOLxWrSmV0WU8EdSKzWlurp38jKw+vc1Wwoxc9jQM8EcZWb5R2Qdqs2ItrhtsQ6DBbGKzLO1jkUeafn6ZNdJ4ZtIhLJbkj5uuaa1dip01GNzUs9DhYx+YrOp7k8V2OnaPbwBGSFAp77axY45bVTbxyFkYfLntV6HU5rN4IGVpdw5I6A1b5UcMoyex1e1baBem0DjtXK65q1vHdRIz9T19KuyyXN0AkjHYOgFUp9HhmT96obHTI5FZuXYIRSd5G5azWyWhkkcB8evb1FVLu6W7VPJYkKMNWDfaevkiNS2AvY0eF2WKyZC5Z95z7Cqu3oaeySjzJmkltL5wZjlewNXJIW8s7CwPtSiWIRo24cdSahvNUtrQFJiN3ajlsZ2lJ2SJo5U+zZJG7uDUc/zIUKnLDNcX4g1VJLiKS2lZY8/Njip7bxUVOxMNjoT3HpSjJHQ8JOyaK/jOzR7aMSLgq2d3pXGRzeXD5cOQxbDe4rqfEOupcQeWq5EnLAjp+Nc5M8LxooiClTyw61Et7no4WElBKSN7RHHlsqsxhPJUnjdVT7HBd3Do5aMucxg9DWcLh9phtnYxpzkCrVnmW4i3Sk4+6Md6q6dkxSpON5XKt7AmnXYSVDKpXge9V9LvpLHUUlT5Wz0au3g0i5kvFuLyJJYQMgd6yddgtr1CCohuIjkE8UOLWpiq8Ze69e519rO95aLLk4cdBWF4ltY4rWWRAAQCeK1fCN9bT2CKx+ZBtI681H4iVZIGQAHdxWklzK6PNd4TseY2N5uZ9xxXF62FF/cegbIrovFUv9n3qpbYBxzXIzu0u52OS3U1F7qx1wja8u5nwqDcGuk0lfkz71zsKYlNdVoaEw8Ck9R0la5tWUe5wAetb9tGsYSXkhT1Has3R02zZZeOAK6C2spBJs5Cv1U96EVOVim9zMwd4hmNia5i+3Qams3IOcEiuonl/s6cwGH5Byc1yfiG5WSVjEfkJ4Ap30Mt9j017ttuJoklTGAxHI96Yrq7ZjJjQ9VPIo8xkUoUDD6VX/djIXKn0Jrjuzv5EiRlRUYLIVGeR2x9KrPKQcoqsgHGDyKkKM8LAqGPUH/69Ps7S3eFpLkOXzgLGccVSkyXCJFDKAhIbeAchSOfzp0beeSCmxhzkkUzEcYwG4z3HIpnmKy4Yc9M+tVzInkZY3pIgKEFu496rSA5wQSR/KopLdVbfGdvOSAad5zhCoXdngj1/GjlVxptD4ym35s5x6UkjRtIAEO0cnrUblFAYHaf7rdBUkcwkHHyv0AJ/lT5EHtGVrp2t93OEY/dA70+MB7aOYyHCuEK5xj0NS3TGUKjqflHGRUCt5RXaMgHo3TNQ4NFKd1ZDgZJHfZgPFyp6ZFVWZ2l818N/U1aluPKuHlUbSew5pTMtxIJGUcDIXHQ1JSbI1jZbaV32/MNq4PQ9RUc4XaJPNLnHcYz7U6ScsjDkRg8LnpmsqeVmAwcoD0z0qkrkvTUr3WWYndgZ7VEGU8Lzgd6SU724zx1oTKgEdzxW8Y2RhOd2PALK3zAdjk85+lOC7hjcR/WmgbM7RmVug6k1LHG0eVZN74654FUQItuEd8crn7x705yoKqmWbsBzViFJHbB2hO4xxWpYaeseNgzmmNRbKlpDeBCxBVgAWI70W63F3KY8mPJ555NdhZWDhCWGc0230J/7Sjl2kKOaLWHFxV77mBd+G2ji83ZuZhzk5/Grmk2AggbOM47iu+SxMoCkcY9KjOjIucrnvzVLTUy+sO3Kzn9L8PxCESTqGz82OnFIdFZ77zLFSMd+ldUsEk6pGgIQccd60rKyMK521nKfRGftZK7Myy01yqtPlmxV5LGMBjszWkFAyTkD+VDypGjALuJHbtU77mV2yCOJcLhSOKivML8q8GklkmZQVOMdBS+Uz4aT7xFO6EkYd9A6sWQkHrXM6levpu0RnCsTuIH867S/HkBmcjb71wetzRTSOscZk55K80c1juwy5nrsWNV1pWs7YW0hCkfOT1zVS3eO/vY1u3ma16O6clfSp9L8O/b7pPtf7m1I7HmuisdFTTkMMbfIeQTzml70jWpVpUVaO5wM9uWumh3/KWIRn+XNZ17DLaXJU/w8cHNd14i0k3NuY0jyx6Y6g+tcPqPn6PfQxXkYJTHP94VLSW514ev7TbfsQ3kqlYyjlvUY6U+ZofIh8iUtIy/vFK42n0qveyrJcGSNcRk5wOlPhkT7XGzou09aN2dK0VzQ0HTbm4uWaNW8n+NvQVo+IbSHSRbPagidmDD5s8Vof2vbWtjKls204A2LyCa5yyvLuS8a6ktjcqFK7XXO30Iq2lFWW5wKU6k3N6JdO52GmeJkEKx3Me3cMFqrarcadJFNPKyj5CPc1kzxahqMqyz2pX5QvChRge1Yfi3TTaW6z+YSGXG00SkzB0aTkrOzZe8DXKR3skbyAIcleetdbcT+dO7OeAPk9M15JoM6/aEDtjBznNeq37ww+HDc5GfL3delbUvhOXGxtUuup5Z44s5UunncAqzdj0rjZ22oR2FdNqusy6sDGyYXNc7qsPkNs9Rmp80XdqNmVLQb2yfWu58PWbyQgLgMefwri9OTMi/Wu+0ybyEVkPK9vWkXC/KdTp1ikQB+9wM4roVZY0VwRv/AIa5a01Y7v3anaR82OlW5NVR1DLgN0FIwqRk3qO1y+gBc3QXzDxXAahHGQ5UYDNmug1C3F9GZFYmQHLA1z80JKOhOcUSZdONkehyaqwvGikVduccjBqxIyEnchBI4IrSvtAjupxIlvIXGGJT1qwttAYxFdI4cHIOMEj0rBxudMaltzn3OP8AVvj2qe3udjIZBnsR04rTudPtCwjiWUE8hs/pVI6ciyssr7cDPJpKDNHUjIpzDLklQQTnAqIhW4Xg9Kn8h3GUBPp1q7YWOoBg9rZSSswxym4U1C4nPlVzHKYXGSGqN1kwM4Vh6966u08Maxd/NLYNEcnqcCnXfhq4t1K3Kpnse4quSxKqqWiORG88yoGX1oa3+YdQPUV0a6EUIeXPHetzS9Hs7mNjIm6QHGSapRvoVK6VzgXlaLpllHrVieGFo42jbfvG7jjH412Vz4dieYxqn7vuTWLLohRjGgZRn5SRxQ00So82xzU8PGM8jjNRrmHON/sRXSnw1egbyibR6Hk1JY+Eru7kKeYkZAycmhxTFzWVzjpN7htqtz6dveqTqzFsgDHXAr0n/hBL3OPNiIPBIzUGo+CfsQX98xDckjpTUbEc6k7I85aIqOF4q5puj3N24EUZYE43HoK6mPw9Gk2J3DKOflFdTBCEsFFsgCp2xVKSvqNwdrnL6b4Huwzu00Sgrhn68elVL7R4rIrEh82Unlu1eqaSqXVmHLAZ+UjvXMa3ZmHUY1RC3OSPWqe2hNF3naRzk2jr9jj2D95jJIqfTrcIQJQw449614ZHgvTJHHmLptYVp2qQyv5s4VcdqIpM1nNxVhdPhSKKN5z8h9a27FIJd/lkEe9Y95A9wMwqdi9B61Stp7hZXQIyE8ZHQU3JPQ5fZ86udkPKSPJI6VR2G4lwuduaytOklMhilk3AngV1tpahY9ygnHtUy1RjKPs3qJaWaxBQB0qy8O0HIweDjFSFgMEdR1qtPqUUU6xzsQzjgnpUWRnZsrXeVjcqNxPYd6yLQ3JlZ7hTtHQVtSTxmHeGXHQUxMSLlQKlqzNYy5Vaw1QrxjHftU1vCjRtkqu0859KjCOCCBwT1qG5RyeODiqTZG5k+MYMWk0aSLkchvWsrwrpaLYG4QFzMMuDyAa1b20kkjY8vgZIPNZPhSZ4ZL2GPPkq2dpPQmh2vqdMb+xaizTBWCUB0GOlXpYYmYLGc8cnpg1k6kZhHJJGAx649a5vSvEswvfKnBKA4yoyRT5raMmGHlUjzR6HXsm1sEZKnisTxlpsF5o84eNWlVCykjkH2rYspPtk28NkjnHY5qe6hWRwZeFAIocU0ZRk6c01ujy6z0vUNS0W3jXToofKXG8jaZPf3rldTQ2c5t2jKyocEH1r28XUAjMaldwOMDvXCan4P1DVdQmvJCkMbvwD1AqZxdkkenh8Z7z9pojj45yI1DAj3rovDGorbShZMlW/WsvXtDu9NWNBIJQzbcBcYqGEXWkTIZo9/Gfl5wKmL5ZanTVlCtTtF7nrSTRzRKdoVWHHFcJ8RbNm01HB3eW2MY7HtTF8Yu8QVR8inKg+lWG1OPU7RmmIx0K4rdtTVkeQqU6MuZrQ8hhkeG7+UkAN19q6DWvEck+lrZwMdmMMQetY2txLFqU3l48ssazlfarAk5rOF1dHXWUZ2bQkM5TcR1Heq19I0rF261KUAHXrzVe6JyPStDmmWNKUGZK7TS7V55FjjGSTXHaXgSpxzXo3hlQpL55peY78sdDWGlyWsDGJgSV+YEVlR2zIW8zg9q6DznfoQ2eCBWTraFbhXtm525K0k7mUZtuzMW/u3hkcLlQeCB3rDlmxKcsQG9a2L4rMC6kk/wBfSsa8JICOoB9alq+5tsfWfg8xRGRZMF89TWtq9rbvHvlijK44JUVlWtsirHJv2E9Tmm6jqQeCSDcW2nrSWi1NJ0vaVLxKu22+xFHsoSsbffCjJrHvvIMgYRLs7DHStaCW08grkisW4YNIxGMLUt6HXSpK70CIQxwtlOT0rpvCt0qwFCBx0rlooWluFDAhepHtW5p08VsZDtAA6Z704PXUWJgnHlW51wmR0IJ25rmtdhRwwTll71ct7sTxkjiobu1eRQ7Mdp7VbdjzqceSV2Yctxby2jo64cDgiq7BtOtl2sGMgyD6VtR6bE8boU5NZWpQCJ4oVjLN2OaWu52QlFvlWxmG5l38scmtvS4TegCbaFXpmp10cXcKhUCzelZt+tzZyhWYqF7juadmtwco1PdjozUu7IRlthO08ECs9pfsThmIUHvmrehzteJJlssPWqut2chSRZ1IxyBT6XRnFNS5JinXybiPC4UfePY0arerqERjhGR3Pauc8qUbUK43Hg10GjW0kSbHRTz1FSm3ua1aVOmuaJXstDDAOSSc+tbAsFjt9vStizhVE2noaZqeIoj6rRynDKtKbscfbodNvpnVi0b9V9DVq5jS5dZYmPmgHGadJZtPOZGPyEflVLUVNtFtiYsx4BBq4uy1Nb80r9SDUbpY7ExCL94PvPVXRpRKwRlJxzgVFbC5unMLYOe+K6PS9HWxQSH5nPWlzXehrPlpxs9y9DLH5QxhcetZjzDzZVi+6w5wKl1SOR5P3K4GOlUVla0t5EkTLkdaGzGEFa63M68WaG4DwBgG6EV0Gj3WsoUWYqbd+Gz1qnolx50xEik7Twa6dcu4U9Ac4pBVnb3Wi4ilkzz0rF1eL7THJF0I6N3FbMsxhhwF+9xmqvlDOZThTznGaGrnPB8ruchpU84uXgunzscYJHWuygXycFuhGfwrnb6JpLlTbR7mLZAHfFadlrYuIBBLhQmSc9QaIrub1k5+8kbkMXnxuysoQevasme8VUZGxu/WoLi+/wBF3xttQZ5Heuft9TU6kqTKQsnzAk0OSTM6eHlNN9jZluSkEkiDPBBFZWjS2zXU8q5VnOCD60+/1C1dlEMgwzbcZ6/Wsm6mjzdQRMRckjaF6e/NVe5tCk3Fo6y4NuqL83LdFz1rFs9Gt0uppggRnOeRWDLqNyNQs4ZRkxsPxr0Fok8pHbjcuePWpXvGdSE6CWu5ieRJbSq0A5BzSalqZXTJw8IE5+6+a055IlQu2NnGT6Via4Y3tJEQ/MehFPZGcfeauVtHsUS0EsxzcN8xPv6CtFLt2CwORs5+Y1y2vXkmmW9qsMpDkjv1GKS2vby6CEoVjC9c8n3oTs+VGsqDkvaPZnSXKWzIOFb13CuH8Uz2j3kUKsu5c5wOlJqmp3P2aQWsu5xnOa5GO53B5JCWfqaUpJ6I1w+Fa96TDUbJLaWSSEjyjz9KqW106xTLESSV49zTL26aZmjQnYeaqzXMlpAi7cbujUlZSudklJx5WZN5IZ2CnO7PJPrVKeFoiC2drDrU94SswYdzUU0jGJwee9VE56lyEnODnAFUrqTdOqjpT55MZPpVKMl5dxqjkk7G7o6q13EH+4TzXpWlwrCPLQ4UjPWvMdLYpcR4Gea9S8ORR30bxO21iOG9KN1YU5aGhGpjRgjYbHBrDe6JLLMmJQcgjvWrfQ3ULJGdoVf4getc3cXDST56MrUWUVoTT1ZHcEDcy8K3O2sfUSDCMDlT1rXvXVzvQYzyRWVOBtY/wkcg1k2dVtD6RnupBGBk/SqrzEoeevauptvDe+FXmb5sZxWVq2ifZFDh/wAK53danpU61KUuVbmbGdy7Ihz1zQtq7RSMDyBT7WQxZbZ04pWn2QNsHL+tUmjZpp2iVrWUwyq4y2Ouanu3M7B0Vgh6nHFUZiyYHrW5pRSe0MbAGiLb0Jqrl98vaIRPH8vVa6IhPKXcwxXL6PILRpUAwc96lutTmJUxgMAcFRWsXbc8utS5pu2xsOyQndIcD+dc1e3tvJd72PzA8UupPeXUZVQFXtWRDplxPcBX4x3FEp9i6NGCTc2dRBenYCcAqODWPrclzdw7YtrgHOe9WktJ4YNhJdR1z1qtBj7aqdqrnuTBKL5oknhyJrbeZIRucggg9DUfiPULi3lU3EZ2scFgcjFbcUBGMY9ao68cWxEqbkHr2pNuKIjNSqXaMElbyDzFIVARgDrV7T3uYZk5EqZFZstxaxRrJErMWGMD1q9o18m8pcJsYjKk1Saub1E+V2R0jXRRiQwXJ6elZWr6gQSsxwrdGpL2QOQFYbexHeiVLa4g8i6+WT+8atqxxRik02Z1jdTrlQQY275qpqEMiXtu5kDI57Gob2OfS5TkmS3b7relUEu/NuIsE8HnnNZuV0dlOF3zLY9A02yhVA6xrz371otEjcYGKwW1A2ltHg5OM9aqv4jZg+AV9+1VotDj9jOeqNu8hjiG8jj0FY98sc6qIwGJPSlbUBdQJtPJqtOrRkNA4Mi8ladyoQa33JVhSO6iiAxI3OBXT20QChsDOK5CK7YzQShMzbsEV2UJYRDgZxUtpkVk1uN1IhYlxyCAeOxqi1+q20iMgJPAPoaW5YvLtPyk9M08WAaItxuB6UKT6EWSSuYN0DKyEExOBxg1z01re28guM7kJw+Oprsb603hSjYcHjikSyLqC4BHepaW50wr8iKxgEulrHEpIYDcMcisO902KND5iuGA5yT2rsN89vDIsTYRhhgR1rldcvbl4pERQJe7EdqN9xUJy5rJnHzWlw1rcXNsjPbwEeY4525PGam0e5t4nNzcTSLMrL8uOGXvz61VEd/EsuwkRvw47NTbuRLixwE8p4+GwOprJb3Pba5lyt3XkbV4Fe6tr2Fkjid2CPKcA47GtFfFf2qSCJ1IP3QwNcBLPcNamIb3hjG48Ehc8UmjTNHqcLyKCqnoDVe01Mp4OMoPm1sdpq9zcQzvbwuzJcIY8deT3xWXp0F4sc8srl0h+UkuOo9ATVjWriVLiK4imWCeEb0J5INclJdzeY0hYlmJJ57mnJ8sjOhRc6djRvbp9TuYkPKqe9d1a28ZiUhABtBAz0rjre5s7y7sVghWAxRBJAf+WjdzXZpcRqqAFQNuOv61rT11OPGprlilY828TbrLXWZQViY5GOme9c9IVaYvCeHzuzxius8XXUFzO0C4eRT6VyVvbSNKUPBzWVrS0OylrTTloT2FgJBI8pACnGO+PWq+qWe2cRB/NiYZUjsanvZ5LbfCj4PGarq4K7snIrWytYwk5X5jAuISEIfJOcVQQH51Y1qXL+beEE4wc9OtZsi+WZt3B60RRlUloYN7KTKVHY80+xTewA61UnLPMzds1o6W6r1+8a1toefe7Ox8K2aidfk8yVuAMV2smntZkuqtBMR+BrmvB0ohYXGfm7V6Lq15aXTW481WKx7mye9Q4XJlN3OSk191hMN1C2PuhscVVaya6Qy2xDOOSB1pbkRStOs4YRHJQe9UdPmubW5JgJGB0PcU2rGkHbVC3CMABIQrYyKzbnHllsdev1rTv/3g88KQSc+2fSsiSXfISSArcY9DWckbp3Pt1JIzGMNniuX8XzQmFVUnzM9KqG6micASNgd6oXExmmDOSe1YSldWOuhheSfPczip2ZXJz1FQyrujJyflPFbFrETdFFBbcODUNxpc3nk4+X61FnY9BVYqVmzImwFB5JNaemypDGhVSZO/NVJYDG5VlyepFR+awLGMcChPlZco+0jZHQKfPfZs256mtTT7C3BG7qOBXP29/HDZbySZe4o/tiZYFdGGSeAOtbXTPOnRnLSJ1Nzbwxq3TA4qrp6Rb5enWuYm1G6ZcSEhW5BqbR7iR7gKxPXk+lHOr2Rm8JKMG2zpZEGx9pFcdq8ht9RSVDgEY47V1EjEgmMkg+1YOpWDXIZyfnUZAHGaqW2hGHSi9TX03UUkCoCGbbTdbZTZswHOOnrXJWCztchYMo46k10bSfuds7bjjH0NCfMtQq0FTmmjhp3aOQ7VIQHj1rTLfaLEToSWX86q6tD5N1tU+Yrc8dc1oaafI0/eABjqp61KjqdlWXuJoLK+iaNEmzkfdrXvLV5oQyZIPSsGz08XV35+MLnIX0rYa8ntX2sGaMe1ap6anFUS5k4DhD9pszb3DcYxzXJXGnS6XehwQ6Z4z6Vp6nrHkT7lxtNMvJWuoQVOWwCAKnRs0p88NXsyOGd5B+8De1WbVWlZkkAVKNOjZp1WcELt7DvV0NGrMAGMnvRbU0craIqQz+XcqkYJOcYxWqLdZZnlBJOO3eqyWjkh4yASeTWrZOsQKtjPpQlYyqyvrEraRCH1BflIKnnIrswFUggZx2NZNlsLhypVjWvPLCqwlWA3DBz601HQ4q0nORVuIEadWZeAeKUfMSi8hehFRXTmddqYwDzilsswwuob5XOGpmbWhEYWaQlulWYlUKU4A6c9qLufYhRCGUHINQo5kUdvWhkvUi1J1W3ZlILKPWuOhe5v7oqqjyx1ciuxuIAEbzB8pFVNNt4baUmRT5OeQKhptnRSqKnF6alFrCNbUJsAbv71m3ejRvEx2gBjyAOtbty8jIFhRSu7hu+KXHkwMkwxgZyRV2VtRKpKGqZzMOgWgBCxZ3Ag+hFc9rnh9Lcm4twVKdcGuhstWijvrtHkAQNhFJ/OmX19bXMc0Lkq2Oh6Gp5YtHXCdenO+p5vHeAapG2oiSa2zhwjYYj2NbLWtmtozLa3QQp8rOvUnoc/SsbVtMltro7TuiY5Ug1taFqd5iOykuZZLdsEwnkcVjHf3j1q9nFSpmOElgiLCJ9w6HFI+qXKQhVDfIe/avQdWsTFbLkxEsPuowbb9cVydvpiXVzcRR/NsUFua15GvhOKOJjUu5o5UXJa4aWTljWvpNlJIhupF2pIDsJ71mXdvHbTTxSIRID8tWH14xWMEPRUOMY6Zpwdty66bXuIwNQaSS7l8wfNvIOKv6RpclzB5hkUIOoqlLdRSmXeMsW3KRWYdVuIkaGGRlQ9cVUWk7s56ik1ZFfUSI9SkEZ+VWIBrO1u5zCeMOVwSO9TSOS5LHPvWNq8gklVQcgdqqK1OStKyKSDI6Vbt1KYIplumRyM1q2dm0qEhWK+1Wcq0N3wu7OpVT+ddnY6e8m+SRv3ij5VPevOrR5NOnDjOz+VdtpGsLfERTyckYV84waa2HLyNGS1fyWjnARBnGeTWFESjxzMSdp2EjtWvf8AnIi+dLvxxkc8VQt4k82a2bJSRcpjuaUh011JLu2nKGONC0Mrfu2PdvQVzOqRi3vGj8mSFkwHSQ87h1P0rqZDFf2VmslxNbTWi+Uw8ppFbknIx0PNYHia6W4vwVWQJGixgyDDMAMbj9ayZtFn1PcqGChRtJHNZxj/AHbg/eHStYkSBecEDvWVcBlUkdQa5pHq0n0GQTyW8iyAjI6irw1Brh22r05xWcYy4Eh4HpSIfs8jNjO6lGTRpKnGWvUguXMk7n7jenrSWVpuePzkdYy2CcdqfHbs91ubiuntLUyWSlnyB6URjzO4qtX2SsjF1O1is1KpECh6MaoxQxSzrtTbnj2Fb96kc6F5MkLwKxbi8iS18tUxIDwQKt6GdKUpLTcuy28c0AhYYxn5hVC1V7IzNGPMQ9z2qmt3NHksxOeRinRXjBCkzfKeeKOZNl+xmk10NuDVFUrGMDI7npU06LcRnym5z2rlfs1zKFuI1JjPTJ5rW0qeVUdSjBhxg1Sn3MKtBR1iyeG2W1DPIVw3t1qHUI1jhLhsA88VYdPPQJI2MHis9LZxJIrElRxnPSrt2MEru7ZzP2pjd+YF3FCetXY1kndppD5akZC9jSeQy3T5GcdMd6tOVmKrGhjlQfxdKUdNzqqNaWIdNurgXhUoFzwOO1bZmba6yoCCPSuZlkvYb9ZGwwUgcdDXQ399DIiMsTplfmBPQ1UX3OWtH3k11KqaLbXULmRd/X8KraPYLDesiZ8scZPNXtI1GNGeO6yvox6GtK9FtAirbuHZvm+WqUU9TJ1KkbxfUjMKQTbnfbjpj0pxihluFaIhxgEHFUtQljMe2eN0GPvU3RZRDGrq5bkgZ7UXV7IpQfLzXN5bTO4lcHHSorawxcZY5749KpLq8ttqAWQCReMYPStVJ2+2KyAFG6g0aGbU47luTZb2xWUhdw+Q1zuoXoW6SINkMOBnofWtPVBLertYsFU8YrD1O2ih8ozs2edre/p+tS5FUYxvqy9aT+SnyzFrncAY+xHrW1bYNsAWJckls9KxNBs3EjFwCzjOT6VtI0cgVI+Cv3j600Z17XsiUDKAgZ+tSYAQY9OaUIUGwdCOpqTao25JAPFBzELl5cDHA9utVLi5iiDJtPPTPJpmq30lhlkB+Ws20u/7TTzXQLg7elLmV7Gsaba5nsNl1hUhWEAAl+Ki13UTFbu5cF1GCc1m+J4vJh3QDJDBsVx/iPVJLp0l6HaFZV6VMp2R3YfCKs01sWrS3Oo6oHkXbG3zqQPvVe1XSbp3WSE4UnAz2qPwfbuzRzMcDaduT1rr4plmheNTuwTwexohC8TTE15U6nu9Dzo2Ml1fraXFwkWXCmVj8q+5rI1qCTS9Ult4JxKYmwssZ4PPUVveLo57SZnjA2P7Vy1vezQ3cdwiRuyHgSLkflWU9Hax6OH5pR9otux0L+J7qbTo7SaFDPGoVJI12nb3BA6n3rNF4+n6tjcrcctG+QwIzjNUbW3ur6Z3gzuRd5IONoqCe3eG4dJAVbrzxVKTJVGmm4hql39p1B5sAA9qzLwD7+AAetS3K+TjJGD3qnPLvAUdKL3HKKSSRmOwU5UYweapuyiVmQcGp7rjeBzjk1nSyCNcntzVxVzhrSsMvJhFGWOKxgpmkZjzmluZzdS+gq3aQFmVR3NbpWPLnLnehLaRfwlc9sius0qIwWLPtXjoak0qxt7OKJrgKWfPOPu0y9wXaO2ceWxzjpzTvYzY+4mtZbd1kjXzDyfaoNQgistNSSE4fgqV71UuIZIXYMMseuDV21iE1o0ErdBx9aE77htqXtD1YT27o/ORjnrmrEKySYdOq8qa52GM2VyMfdJwa6sTvBaQyqsZdfmUkZH4iokap22LUlzJNpluLTVILPah3xeaVIbJ5OB3rlNaWV5/OuLpLpyoBkR9wPtmt+bXHikjl+z2JVwQwFutc3qly094xdIkz0WNdo/IVLVy46H1lJGz3Kq3HOOKjvbMQTFs8Yq8Itt0M9DzTNQRgrDBYE5Brns7HdGb5kZk8StaAKwye3vUMMErEI6ZKjIwKtELI6hUy/pWhaNtmKyja3ajluzV1HBEGnQqFHnxncepq0L+KOVoSAoH3fcVoDYik5XJHT1rm9bQNdh0AHHr0q37q0OeFqs7SKVzeyFrmFMeUTk57VC4ilsWbcvmqwUL3qqQTuIOSx5qa3syybtpAZuCOayTbZ6DhGC3Kt5E0BAZsv6YqhIzl8n7xGK2DYyz3hQFpGwWzUen2DzXG4jCIeankbZpGpGMbtmj4ftJDCPMdm9FI4Fbj2qKrHHzfSmWt/DaXCS3O0RfdK+nvV+6urR95ikUhslSD1rqilax41ac5TvbRnP6iPJj5X3NYkeqCKOZo/mJPINbWoJLOHCg5IrnZo/MAgjT5uhOKltx2OilCLWo22umjvPNZQQ3A9qv6qrR27S7kbd1xVG002b7WYJTlsbl296r39+spaGQMipwT70RbtqaTpqU1yalOS+KweW2eDkGiW9NxEVL4OOCagtoxNNKzI0ka+lQS28QkykxCN/D6VOpu4QvsT28szQtHMwLD9a3/Dqx7j5gbLHAzXOWUTeYFVwcnClq6OOW4giUeWNy9GFXHe5zYhq3Kjp723V7Ms6jHTnrXIymS2JCEbckGr/9uM88AnkDDowxzUOq/vHPlgDJ4xVza6GFCMou0tjPt7hhMRGAeMBmroLWe5e4gBT5kHO3uPWsN7WaG3Fxs+UnABFdHo91JIBNtVXK7MDtUxV9DWva3MjeiiDQs38JGTWFqEQSUSEkhc5GM/jWk975cAGCG7+hFZ2oXQ8syRrk9Sh7iqOGkpJlK11B7iUxW5PAOe2K19JgdPmLHJ6n1Nc1Yx/ZLpJiuPPJAPY/Suys9pjUL96pWu5pibR0jsy2JX82NnVTsGMY6ioWvYUkeKQZZu2eQKpa9qYgjSNNodBnK85zWRYz/aZRcXDYPQE0c1nYxjRvHnexs3UYu1JkIwvAyPvCmWNpFbcbBsJzjpUkd1G8RjRkYn06irCRiRGO4YUZ5PP0pta3M3JpWM/xFY200IjtyBlcbsnGf6V5f4k0ae3z5cbPEQcupzXql1AWLAHg9qydTtd6KYYyPlww9aia5jrwmJdE83sNWn0+xEDqC2QUPcVb0nxJLb3JSdd0ch5IHK+9bd/4aE65JAViHzt5z6Zq1No9pDAUWJeBxg0RjLuds8Rh2tVds5vxNq6SlSirLApBwV+97VlT3Wn62wW3tY9PmXgANiMgDoc859607wLdr9jysFpDku2Qfm7kDqe3Fc6li7MwjGGLhVXu30qZNuVzpowhGFtmthL+yn01trho5OuD1APIrNuZmkYtI5LHqT1rU1CGZZCLguXT5SH6gDtWVOqlsMealnRDVXZQu5P3bI3NZbSlA6/lmtO7UMzc4rGv1PmcHjvSRNV2WhTkfO4k4Fc5qNz5soVT8o9O5rQ1Scwx7R95qw0GWJJzXXTjpc8DFVLvlResYRJlmO0Ct/R44zeRLNgITgNWNap5aox5B610el6YL1VeFir9TmtdjmWiOt1SxWPSIxsHy8CQHOa42Znhl2g4zXQPe3sVj9juE3xryCDWHLIpIJ+9/KpkEFZCLcvFIrMd6nqDV+0Mb6sgUnyiRgGs9vmi3Mo9qfal0njbPcUimjW1aJYrlgv3GORU9iZYWMDqHyOM80uo2jnYSQwKkg1XtmmeWPJw2zgnvilJhAe9lcTJGsFvIzs5CYH3sdapeIMLOEaya2nQDdlyc8cn+vFdY0pm08SpDcmQWxtiyrmNAW+Zs+uDjFcn4hmEuoGJUljW3jWACXhyFHU+9Raxonc+xLyAELJGCfTFWlhSe09GxXN+FNdGpaWB5u2fGORnH4V0EVx5WIyQcjrjGTWa1VzSSlF8r3Rz+rB7PDJ94c8VVS7lkfdLlTjI96v6g5nnUkEqDyMcUxbYTTLKm0gcbays76HfCaUFzLUqm+KSA5JGMYPas26uJXlBGTk1u31nE0O5AN2cEVm3R82IQxxYePqQKJJmtGUd0jNhw11tBHPYV1ul2SR2ZEk4UemK562a2t4Ck8H79pAVlPYeldDcRbdPLuQExkEHrTpLqZ4qXNZLQwbiWWDUjJG21ckAqe1OtJW3zFCyrnoBmn3FoslqLiN9oHReuKr6TeSReYojLDvxRez1LavC6M7UriSa4dTnaO/Sm2d3MkijqQeBW1eqk9quItrluWrNt7CSC9Ew+ZEboOpqXF3NIzi4WaNSS4fZsKssjnqRxVcvFHbKyEG4VvmXH9asvewTzywMrIDgpnqK0Lawt1XKheRya3XkefOXIveRyF5ITdCaJ5FkBwQAaqagY2mHlAPnll75rqtSePTRh4/kzkMB0rLiktL07o1WKbOQw6mlY2hU0uloULBRMzLGvljGGwKSYQQXRhng3Z6MR2rdtIY4yC0ZBPLHpmqniC3CBZ1BOO3tVNWRHtOadugLpsYgjkiCEHkDHSr9ksc8eACWHUYrL0KYSxEPKVUnAB9KSC8MGpN5D4IPGO9F9LmM6cm3HsQa3pu1nuI1xz2FS6bGohSS7cgsmU+tX5GuJQypH5qH7wxVSxQRySJcRvgAhAR92qtqOM242ZPcSS3doqMpCoOABxU1jH9mtQFIDE5INaFkpeIFhnHpWZfXGLxQq4jz0pPR3JTcvcRYuFa4YBwVQL2pI7NJzuZ9zYxiruVkt/k6EflT7ewaF/MRs0Ec9kZUsCAgRxEvCdwz0zV2G9XZG6ZEjZ3AcAGr0wRLWSRiqMnvzn2rK0oCRMZySxYn3p3Ffmjdk8sEc8iPKAFxgZ4qSC1RoZNxCqB8oA6mppYWkG0/dB4zU8TMEIIPHakzKUnbQz4bH5iyAqwOcgc1rq0UewMMNnn3qGGXysugyx+UjPY0hjyVL/e96ETNtvUluSiMSmCCMjJzVVkkltywX5FyeOwqyI1kkRDhCx4ZjwKbdG3trqXGfKZfu9CDjpTsRoc1cTvFJ5ABZm4VR3rkvEE2o6YoEnyGVQ6qV5wehrc1+a3N1EjTmH5h868lfcVxutG5a58sXEtxAhxEzjkj6dqiUrHq4Okm02U7q3lW1FzLjzGwT6ip9UvLSdFNvL821W3BSvzY547UzU9Uub+aOZbaNRbKqlUTKnHAJrKvJFuGMkaLGzE7lHGD7VnfsejGDlZyGT3chL+azSMx5cnJqhMck/nU7DbgZx65qCZhtOKTNkktEUZzx6AHrWXfEMrEg1dndgGB6k/kKpXQ2wkk80RVznxEkjktbbMqL3xVCFSCAanvJRNdO34Cp7G2DOA/Az1rujokj52o+abZaVAFIViR2GK6TwfceXcm2lfYrjgntTYtHa2aORhuhJycDNF9aRrultyVcHKkUPQW+h1M1qZ0kWMfMB97tmuRubQq7b8hgcYrpfD1/LeqIGYLjk465qvqcaJCyyqRNuOH/vCiWquKLa0MCMhRscZ9CatFF8pZB1B5xUSQndk49iamslzE6yvglgcVF+hrbqbFv5l0TGgJ2rkDr+NV4VLOioMSRNtPuK0Ibl9Mv/MgKtHsCnjqDVKOYwag0q4CzHg46GkxK50bXlncaVDb/aorWWKFrdklJA3Fgdw9c/nXG+Jpkl1djC/mrFEkZkPWQgYLV1bPqM2kQnS1hlK5EvyIWD5PBz2xiqHiVkubS6eYWxKCJY2jCgiXHzqCOq0pFR0PQvD989hqMZDYQnBr1u3lSeJCDnpg14zIFyT0xyMV2PhrXBmKOU8qelclKVtGe1jcPzJTieiS20bQgsu0kZ61Ut7dEO1CPcirTyG6gheP7neseBroaqwRR5Z4Oa1eh5lJOUXdmgtixlLyAEZqC409IpmfzPKhAyxA6+1a8CM6sC2D6Vm63MLaxe2kQ+Y3Kv7UPQKc5Sly9zl791mkMQmMkMbZTPXFdBpkEclnGjlnj7965zETWp8th9ozyPapVv7m2jQW5xng+1ZxdtWejVpucVGLtYm1sQQXkkUDSBPyqDT7toFcoEyhz83es7UZZzdbnLMTySe9TeQ32BZVcM78Fe9Td3djX2SVNKTvc27fZeafJIpAbkn2plva7Hj2ybiRkE1j28rRRBIQyueCPWtbRY5prpraVTGyj+LjFaKVzmqU3C+uglyiy3IDRKGyADiteBVQHZzt5NV7hVWdosjeh708ZheRlAAK4IrSOhyVHzKxz3ii/Eu6Anb34rAtRJDIjsp2eoFaOu2z72lZh8x7dqdpEqyWRjJUbc5z3rK15anfC1OkuU6e3SGfT0w2XPJGOlY2tCTYrRMpEfVD3q5YT+UwiJVsrwR6Vi640sMm5tvlknGDW0nZaHDSp3qWKlhfRyPJCUA+b05FXmSINuiTEijOe9Ynnw4UgbJAchx3q3bXcLB2DN5uMDnrRGV1qdNWm73RvWVw0swgjJywzk0XyvFIFmAVScbgKgsHiNrG4SSK6UncT0NbMU6XlqVniL44ziqbucLXJK9tDGutRlhMcahIwgwQv8Y65NWY7i2vn83YsbYAKA5/GqWuxA3rCIcYyPpVfRv3SSElSrc7ccn2qE2pWOnki6fMtzo5YgLB2U47rgVe02KVlAZh+NZlpdJMhQ/IV42npW5Ytvgkk2ghF5Ga0scVS6Vmc/4mLxfKMAj0o8OWc62X2iRG8pn69hU1+6XBKyjcRxwalt764t7PyYyFjkXBU85H+NQo63NXJ+y5Eg1O7W23AMBtPOOal0S5ivE5JHzYY45+tVTpouHR5PmA7Vow26Q8qoWjW5lJw5bLcVIVUkJ/Ecmk1GU20S7gZQT95Dk57Cqc2rRWc6i4WQR5wSvapNRvotQ00WyJvjVtySj5TQmnsQqck05LQx7DWDezSxxb1mjOQB19/emrcyXl35M83zEFVz1OB0rOt7RtKv2uIXlViTllPIBqjrOrzHYIVIlU7ywXk4//AFUczS1Oz2MZTtT2IPHkLFoSsAi2qN205DH1/lVWG0k1LTp2iuYYzaQ+fvzgsRjge/NS6TqN54ixpkdvH553M0h4GOvPpWHfX8LQpAbcxTRkqxU8GobW6Z2whNJU3uiHRNTudOubhxFHKJ4zFIsi5Ug+3rWTNHslJdSFJOcnpVuXUAunpaxs+wv5koOCN3QEHr0oury1khKEMzDoaS1OzlcXzW3M2UgMWGNvoaoXEqjccipJ5ME88VmXMh5boB29alsvlsrlC7nwWPUk9BWBreoN5ZhUjcev0q9qdx5MbPgA9vrXKuxkcsx5zmt6Uep4uOrWfKiSzi82UDHA6+1dFY6bJOoKKSucZrI01djbj36/SvS9AhH9lqUhYjOdwHB9q6FY83bUq6USkD28ztuA4U98VWuodkxQg7G5Fa95DFNHvj3KwJJ9qyriZmZElP3Dw1Q33LjHqUbcPb3QMLbXJxWpcXL3Z8qYYkQ1UlVDexsuQhYcnrVvUyLfVEcD5cjP0pX0HbXUr6vH5MKIi8bcgmqRGViboetbesKVZWB3xldwxz+FUmCzW0IjABBxSe5a0RYlnGAGUBSvBp2r2TQ29vKwBEiBhg9KrNmWyJJ3OjYYDsKekks1u1vM2QiZXJpBbsa9rFbW9tHH9gS5a4tHuFkct87g8oMH0HSuZ8SAR348mFYI3hSRYgMFMjofetZDDZ6fYSiC9uXIMgkimKrG2cEDAODx+tYGqzrNfSyiOZCwBImcu2fXJqWNKx7pqWmiJdw61k20j2t5G5ztzzXXagIpSx3DB7Vg3VsRyFNcNj3KNduNpHqHh29WXSMxEsQueacb0i081VwxPWuU8DahtMls2SccD1rb1C4aHT0BTGDyK6L6XOF0UqjXmdPEf9FV1c5Yda5rX7e+nmyGZlx1q5od+LgohOBjOD61sXIy67cZptc6MYN0KmxxEdr9lZWZsu3B9q3bWwDR74gAOpzWV4hSa1uSwXAPOMVLoGsYhMdwWVx2PeohaL5WdlRTqU1Uia4tIpwqPAC68E+tLJo0JTeg2lfSptNmWeTzImyD2rTR1iimYrliOK1sjz51Jwdjlxb2kFzHvk+VhncBypoiE8d5c3EMm8yjBLjOaydTd/tbFgwUmtqzO3TYpgd0Z7gVCd2dk48sU273MWe9lS8dph8+ea6OydLm2AYDOKpNZ29yu+f5JieM/wAVWxbtaptUYHamk09TKrKEopLRmdrltGIWTblmGBzXJH91KsUiMB7da2571m1MRuhbmo7+1eaRpQoDJ0FDs9UbU701yy6lB7s28YhhVmJOA3epb0+bpzfaIt0oGB6j3qDULkFjGqbJQBg1NbubyPyXc7yMEjqarmWxThopWMdZIhbhbqPDRHj3pl00C3CTRL5R25CjvU+radJamJ49zIzFWVvWsvzGhcpKMMeme1T5M6YxU/eizoLWeea2aXOIxx9TWxoNzJBG7SowVj3rmdNmuAqwghoslsHpWq2rMlulurocck45HtVxSWpxVqbk3FIsX5WS6JEi/T2rLhXy7hmcuijlfSmap5kirKm5R2pLW9REiadGkG7DKelF7s1hBxgbMc5a23zxsB1Jz1962oLlY4AHfCMOcHpXI6neMrKVYCFudnbHpUkN1/arw28TpAXYKSTwPrQ520MpYZyXM9vyNG4aRLpmjceW2cGp7GKe4YMCREvQse9VLO0uIb17SdlcwuVJByD7iuss4FSNV27VxTjdo568+RWWpatoWjtkkIDZOPxpZuY8so574qecJDaRsmFOQeepPrVZ7uI2ksRLGRiGUjtTZwavUxdYgFxbPbxuwWTBkXHp0xUlhAllGigK0eOPSnzMOWjYBsc/Ws3WdQFgsIimW4lYZKp0BpJJanTFSmlBF66ij2H5RlhgNnqa5bU3aBJfLhJwp8x1XovfmujXUYr+wgWCI7YARPImCPrn61zusNHcRG3jmZQ5ywB6mm9VoaUIuMrSMqDybOCW5szHl12FW4JHWuOYG6uRFjEzuFX6k1001sBtjEhwDwp7+tVNf06Gz0uG8tpYln3/ADIZQWPPDAAcVk42R6tGpGMrbtmX4l0ltE1AWk0nnDaD5gBAz3Az6HisOTC5K/dzXQa/qd1r7R3d1CAYkCEoMA47n3Nc86feLN+FS0dVJvkSqPUrS7WHzHBz+dZV5OoLEjvgVpyYKfTvXLa5ciFZCCM9AKIq7sRiJqELtmNrdz5sojU57n61Qhj3tyKYSzscnJNaVrGPKA24Y45rsSsrHzU5OpNyZJbLjAHPNek+GL2aCzW1SQiBzzkdDXBW0BDDIxg12FtIy26yR9hzSuVypqxfv98UJmj2EJJhiO4rN1ZEfY6oAsi547Vox3EUqMrqMEfrVGZlWFrcqCw5U+3pUt3KUWtDFtnO/wCYkhGBwe9bGoumoW7zRqBsGSO9ZDDy7lXx8uc1ZmkEVwZIc+TIMFe1CatqNx10H2EvmWhR8koDjPcVXtz5W4sMoG/SrNk625csMhwQPaogu55Gwdu3BpPQLW3HQskUTOoZg+Q3pTbhX3xHoxXr6irHmomn+WcFZB19DUE9y0M1tIFSTyhwHGVP1FD2EtzYS88zTLKO31lLFo0KyRDeOcnk4HWuX17c96S14LxsAecCTn2554rUm11hkrY6cSQD/wAe4rE1W5a7l80xxRsQBsiXavHtUp3YWse4tcsrDdnPvTxfDGDyD61SDfMS4yamEG8biMKO1ciuew3EvaTdC0vY7ndgA1215c/a7bzlYGPAJxXmbK2dg6ZrrNCuXawkturr2NWm7WM3ZyTNWzkeJ1dDnByBW3aazDctt5Eq1zLmS2jiODyefaq7xy+ejwnaSe1Cly7Groxq6s66/wDM1aZN5GQMVm3uktbAY/iGMip9IlBmETv845Fbk7GYBJMYB3CtOVSVzkc5UZKMdjmtGF1YO/zkKO9dJb3EzfNKAQRkYpVhWQAbQc9qmK+VFsA5x0ppWMatZVHdrUwfEjQ3EUJtxiQZD5p1urppvkqwMYIYDuKhvbIIzFyfUYq2CJIEaNPTp3qXo7munIkiwrwhFMqCQsuOf4aklnBjCtnZ2OKzdTuXKJHHHtZDlie9LHO0li7Y3Adcdqq5l7N2UmEunoZUmQjI5zVO/WVXxgfMvB96bFqxa22nGUbr6iqWp3pumRIm2nOetDcbaG0ac+a0ioZ7eaGWOdczDgHuKi0+2aAPK7529AKq6nAINsit+865FWtNvgbfbMpds9aE1ezOqUWoXhszW1C6iuNHFvPsYjLJgcg1wt0d37xyRIDgA9xWtrM2254yqjkA1jStHIQw5YGk5al4elyRv3OjsmitLJGVw24Zw3NQwrndIFDPJk7fSq+kkTufNA2D17V1UKW0VukiOhbBII7VpF8xzVv3T82VLSNTYObpCH/hzVCLSIb21u7gX0cM8PIiYffHtXQaeFuoZHnYbR61WMVpNMBCEHPPNKULsxhWlG9tGcvDZ3d3H5bD5AMA10elaJb2yYYhmI79qvxWYt1LR+vQ9MU+8AYAqBuXqQapQS1FVxU5+6tEU5hHaXBZc8HNdDZXytDv2qy471g70u5RDtXce+egrQ+yNbhfLbgcEUI56qTST3Ld5cyzWvkopx654xms+ISIsIjRvMUkSHOQ6mr/APqYo2LqN3AHfFPhtXkBntyqKd2Ax9B0pWuZKXKjmtfe5SICAFl3ZOBz9M1jmzYzyJLI3l8ESdCPpXbmESbREDI5ByPSuK8ZR3FuZVtipC4JKHIP0qZK2rOzDTcnyLR9zUtrS3swkWmvN5ZwzPIMZ/4D6da5R7K4GtTy8LEJCwHbGewpINTvktDJKrD5cKc1Ut9VuJbaaWeRNyjA55PvilpodcKNSLk73JtYvVtrhVnTaxGVyPXvXPXswmLFTjA5z3pl/dXV7CsLys8MZLKOu3PWm3cJt44z5kUqyoGXYc49j6Gk5NvU66dKNNLuVvtsnlmINhM/MB0NVrp1wpBAU/rVkpiJdy/Mw4+lZd0rbeuCDikzRWb0KepyiBWct8oGcV57qV2bq4LEHGeK6fXZ9lo3zEknBzXH7STxzzW1JdTxsyqttQRNaR+Y2R2ro9FtGvJhFGpZgOijrWTZQERZA5NdL4Sle11OOVSQegIra5wJOxfm09o4vnT7nGO9XvCMiNqAtZmwkny8jNdVfCzvUMk8bxMIzkY/i7GuDmVrecSRHDIc5rOTs7lQ95WZ0uuaL/Z97MtvJ5kajcCO471kXUSxyRssgO4ZB/oa22uvtdlFPHMWmVfnXFYcyLGEkkYeVKTkD+HmiSRpBvqVLqM+UQVzg5qlas0oeEDnHSrtw/lSZjO+JuKqoTDdCZByOlTYbZN5kb2RjKYmjb9KRHDIgBw5HNKIpJ2klXACjcc1E7olxESp2Ec07EXHPOfsrW5A3KciokmCSqZYllUc+W+cH64ps20SS5JHpmo5iBtIJ6VLbuWrHQ2Vs15arN/ZWkxxlS6+bMykqDjdjPTPeub8RRNb6lJE0VvEyhcrbsSoOPU9614bnalk09rN5csT2RcEASKTxtz3BP04rJ8SOTqBh8mSHyI1hCy43naMZOPWrWxm9z26WKNpV2Dj1qWVSQFUdqlVBC6g807yzJMqIeWPWuNX2PRbvqVLC2Y3SkqWHbit4RjTo2uCDuZsnNKu2xtgUwZQelF8/wDaBWMthcc4q7GEpOTv0Lsk8N3ZqFP73qOarQ3BjOWGCBiqTWRtJ1SJizY4Oa0pij2YWbH2hRkbf4hSZ1UqsfhZVW6kaXzYsqUPzVuWWsv5yeccoQay7UwzxMqjbIPvDuak1SBbcwtERtIwRQrpXNpqE3ytHX6deB33Lgr2rWjKMxPBJ71ymkSK9h8gyyk8etLp+rzoXWUbmU9B1rTmPNnh3Jvl6HWfZIZwwfrj061gvZtZXhXd+6ft6Vr6fcmcBtwBHbuKW5QPKS+W96bszCEpQbi9jm9ctJH5jY4PpVLTo7uIXEEUpMT9iOtdZBBG5dG4IBwT9KzFBimMhjzGpz1xS5NbnTCv7vJY46dJLG8ZD0ZucjpVi6hgmMZhwXzyR3q74kDyyidYwI85BHYelQQW6osU0fPPQdQai2tjt9peKn1IjpSB0+0AgP03GnyWP2UeXHtKk5BHati/jjniQhmUqAfm71FLcWogUbirAc7j3rRJHK6s5HNapaCVJPtCszDoQKz7bSluFwECtjg+prqZbiLZGCUIbpVS7lSBS2NvHbpRZbs1jXqJWRRs7ayt3WC7do1wQ7L13Y4qAw3UVqdqswHOPWm4luJmdkyr9DjrWukUyW4K8kDHWmorcJycXrqY9vdyRW+JM4JyVNa1hILueWWC2SDfj5F6ZHcVzV20iX20ZOTyK6rTk+zxxS8EcErnipjuViIKMbrdkhjvoHcXLbYT2Jp8N0t0DHuAYDsetReJtUOoXEeVEcYA+VTjgdqbYWUDXs1xZ+YbVQMFzypPrVJu9jDlvDmloy1Z28cEpcsNx6H0rUk1QRWksTRByV27h2FYsh829itWnW3Dtt80jIB7Zqnb6u9pcXVjeoGKsUcryDjuDT5lexn7F1Nd2Z9xqd0mpNDKxVN3BPOBW4L8xKqOd5Y8jP8AKsa1SG7u3B5C8j6Vp39pbxxxPHMVcAtn3oV0bVVBtRasVNU1O6zGI1kEchxlPvVl296Vt3W4DPltqbuDitW01HzJoIY4TJIX2q2MAt61leMzGjqIHDOwy20bdr9xjtUvXU1oxXMqbjuYtxcTYkhRQ0Z6FuCtYl0Ps8pO35u+O9bCKJHBnxJlCWy5XBxxWppehLfad9suExHu2Kc1nZy0O11IUVeRyjSLDDvQDLAgilnt7IwWslrdGSRkzPGybfLbPT3FW/GGnfYXi+z/AHW/h9KxrOPcsjTcKBxzznsaet7FJqcFUiyK4uGEiluQOB9KzruYNG5PXsKsuWZSoUEDvWVdS7YmJ6DrQ2DaRyfiWX5o4wecbjWNCpdsDrVnUJvPu3PUZwKsaVADKCRkDkiumCtFI+crS9pUcjW0VI5Y2VzyvY1tw2Rt7VZI1IIbO6snT4TbX24rmNuxr0Ca2X/hHIh94tkqV4x9ap6oV7WJLa6FxbQyAhiy7CCawb203yzqMDy/zqfRj96BxncTjHUYqW9nEUpcKA5Bjcdcg1D1WpSVnYy9I1CWzlaHC7H9aLmT97IhUFWORTbq1eMmVcbVANOmjW40/wA9HAZeCvfNT5GnW5SnYqyqfunkUlyESQbMlGXGfSnxATFFlIUg4zRNEAXUvyneknoDsnqNt5Gjikjbowx1qAhp4yjDDR9CasSqpWJ0YBsZNNlO4zt/EQOB3qtiXbdFHzDNGR/GOKSOOSZREFZm6AAZJ+lRBynTgZ5FKs0kTh4mZGByGBwRSHY2Vto9T0+zM4vYXgTywY7cyI65JyMdDzWVr8vnXoHlSxCONI0Eww5CjAJ+taqzW9lY2Ynu9VWSaPzPLglAVVyRkZ+nSodZsYMTTw3N3NJEkTt9pIYuj9CD2x6GtIrQwk9T1yGYlGJ5OO9TWdxNFMJmUEAY4rJicjoTXS6U9sLc+Yg39ea5ErnfKXKiG3vAzy7uWb1rR06RVt/nXJ+lYE3zXbMvA3cYrY02N3OxW/eHsKQ5JWuTuswIdl2sx478UXdqYVWa4LqxGVINayotqEadlkk6bfSsrXbwXJWNTwOgFVstTODbehWj1AW8yuyq/v0rQiuP7QTpkg8+1Yz2zC3y43A9x2qXSpHgYPFk7T82fSludHtLanRaFceU7wfxZFdfDYwqfPjC7iMnArgRcC0uI7sDcGYq2O2a6/RNSgkt0RGO/oc04WejIxUH8cdmbUSIMFVAJPJqO9ldCuNrAYqwFGzIOKrgCYDgbgeuau1jhi9bshEyyRkYIcHpUrmCTTrjzOJFXPH8X4U6EwqxSUlT6iorsItvMqgll5Rx1qugbuyOXE4nQxpG3Bw2eaZLalTuUlR0x7+tS6bqFs+oy/a1ECKOcDHPQU28ufODBQCpPykVmnc9BqUZWtYR0uIItzNvUjBzzWTPZK0485iqsNw5rRN1J5XlyxOcdweopihLm3xMBlD174p2uVHmhqzG1C2a3IQMCWPyk9MVNYws0Esd3g/3TmpNcjjWJfIkYketN0R43naKcnpxnkUktbFybdPmFWYq4RExEvBapQtxPcbonHlD0HWtSO3t1VipUjPOKgM9vFceWhAb2qlpuc/Nd6IyXW2afbNDiQnJYdaUNKp+QARDggCrWoGKIiVzg/zqqdVhaHYo57GndGqTkk0rlPV43nRPKBG3uah0O7aC7jtriUwxyOFdz0UdzVefUQZWickBuOKqTszyEc4I4NZt31R2wpNw5JbG94lxaanJBDcJcRLgiRTnIqiLm3kdSiHP8ZHeqSKgjCNJuPep4be3/wBaj4XByB0ppk+zUI2fQ1LO1Q3XmWc8jho8kOu0g9wB3qRI5Jbq1KhpeCGQMMkd+vesP+05dPuRJaEqSpC7hu6+npU9lYXt9paXEOCHuPKBL4O739M+tHMloROk/ik9HoXnuLeG3eVZUBTrGCd2c+nr7is3WdH1KKCW9uY2TdGkqA8lwx9qy9WiktLoQSb/ADduJFZdpRu456/Wt+31+7ltW023iluLfYNiTLmSPGCefTPap5ubQt05U7Tp63/I554kjKrPBPI8iMCobAU9iP6g1s6PG1tJDaiQMZGC/M2FyfU1k399JHG05+Vs4IFQStL/AGX/AGil3Er7jH5BbLtnqcenvVaJl1IyqRUXpf8AMi8T3UrX8ttOgEkLlWGc81gXl0PLCwADGC3FX5bKZoXun3Ef7R5rGbAJyCT2qbs1pwhGKS6EAuDvZzwDXMeJb9Y1a3j+85yeelbksoRZWYYRQSfauAu5TPdySMc5Y4rSnG7PPx9bkXLHdkaKSQOa2LNGt5E3YIPcVSs498qjbn2rXtrYsCCDtB/I1ueTFHbT6dD/AGLA0WN5G7PtWj4dkWTTzFI3Tse1UtIl/wCJX5b429OeoqO0lS3vpY05Rhx9aTetyox0aGsFs9ZTHTPBHFLqiOLs5UEgZYetM1ViWiYjMing1LqDhgjRnLvwRU9zRdClxJAgTODw2Twaz4j5d35ZOI3ar86fZJDC2CGHPsapSxIU3McOOBSuFrCvGo83GSEORmq5lVZDkfI4wCe1WhxHKsh2Pjoe9Ubhh5EaDjaaA9Se4UI8aAggDJqvclmcvkAjt7U5gTEsrH5x0FRTsXbIHGMGk2KxWaPdl1PAHSmEgjrQ5K8dqiAAzk8VSVxSdkdDaXCWdhajULmPbIpeGNrUTFFz1ySMAkHiqurz3UMssM9wk6TlZ/MCY80Y+X6ADt2qC11KH7NFDfWcd0IQVjfeUYLnO046jmna0skl2rzmJd0KNGkfCohHyqPoK2toczd2erLHzuU8A1qklrMlVwfWotTtzbqCq4BqbTG863aPODjP1rjsd/NdXKsStMqfMc56Cu50W1gsrJ5iw8wjv1FclYIUus8YUZrSbWUWNxgucdKSsKV5aIt30vkbpnJYt0qnb2+f3zcsTnFUb26ludhZcBe1a9irpbozR5Liptdlv3Ig+w4Gzr/Om3csNnYPxiarr4i8sgbn9PSsnxbbiIIwbLOMkelPzJhaUkijb6xHDG6sQy5ztPNdFY3mwL9lOAy7l46j0rzxIjLdIignnmupsb5Uu44GGxFIAP8AdNTF63O3lUVbc7O01+V4MEgstNh1t9shjwx9BWFJ8krvGo8s8ZHSqkJKSu0R47j0qnJjjh6bu0dPa66ZLkCdCD2I7fWugtr1J2SLIUN1Y9BXM6JJbxsXnUMw55qD7QbvUhbxzpbrIT8zngVXNZamFShGbfKrWNDUksrG/uoz+84wpYeveozeWhsljjceZjp71lq720oN/CZ1R/mXPDfjTfs/2i4/0SIDkuiE42gc9TU3NlSVvee3U0tMtWntZJbjcdufyqhG6i6IhQ7CcZ9fxq/Jd291aWyQGVJSMSKwwCfUetXYdGwqsjkqPm5PGfWnvsZOajdz6mTqsCeQCUw4Hp1quiWwiUx4DY+Zehre1IlLF+Fd8HAHWub0qGWZm+0QnDH5SaezHB80Lt2SH2nnQNIud0WeT3qG8sv9LWYMSp+YYrSXS5I5SxLKDyPQirctqRGpZsqKdrk+1UZXizD1JPMtsSnjqCaw7kwwQHYWxjpW7q1z+8SERDae9YN3p9wHMgcGM9vaok+x24ZKy5mZ0Mi3ExK9QO9TXAdkLI3QfdPWo412NkIVINVbyScXJIIGfSpT0O9R5noTopa3P8LngnPWtFmS4+zQWVsYj5YVwDncw/i/Gs4MwAXIBHpWloV8sd1GrDc/Y46U42MqyaV+xZuBcXNja2M8SiOB22ShcEZ6jNYjJNE8kCF9gOTg9cGu61ydItPi2wFQ+QX9T/8AWrlNVmtbW4Q2dwbhW6h0Ksv1/XpVNJHJhqspq1iKfVbu4mtRcXTSCBgULqGZe34/SodUm1KzLw3TSQfasS4K/fHY5pl9qFnLp0cEFkYr1ZCzTh87l/u4rGnuXlf/AEi4kfaMKGbO0egrO5106V7O1kaM9tI2kpIQphkywbcD09fT8axCjm4iZMsoPIqf7Wq2zxgHa/VfWs8yyhiYx8pHAJ6VVy1GSujd1HUVezSIgBccgVzVy67yH+6RxTJZWdQrE5zzUMh3sWYfKo6GqcuZmKpqmtDE8SzeRZOoOC/GK41FyQeprY8Q3X2q92g5VOOPWoLK1aU5VTx7VtDRWPCxU/a1L9ixp0G2WIH7zV21tZ/ZrfbNGFimH3j2NZlnYPHPatMAUHSuo1dy0QUOCmMgDtWlzn1urFbSVVLeUMQQcg+3oapyqqXSbvXBPtWhpmx9Pm3ghQ/LevtVC+AFuHPUnjPXFQ9UbQ0epe1q1hRIntZ/OUAbsjkVTt4vNilediogGRjuaiSRmhKg8kdM1NKwg0Z4pBid3zk9SKla6lO6VipcxNNAsu/LMfyqNjFJHEoyJgfmzRaDeGEnKLyaih3/AGoMgyOuD6U7dQb6BqL+bcu5ycADNVrqJdsWwls4z7VYuZBJJkcKe9Vo2CyjePkpPe5I66cLIij7oHNV2OXb0POKSVgZPm5GeKdKwHPT0qW7sOhUmwfwogaESI1xEZIgfnVG2kj2NJIdgbJzmm6bbyXt7DbxkBnbGT0Hv+Vb01oYVJGn5+iBeNNvMf8AXyP8Kq61dQ3cySW8bRRLEsQVm3EBRjrV0xaNuObi+bBwWWJdp9wM5xVDVrZbS48tWWWN0WSNwMblYZHHatNzE+gJ3F3ZbSgGOeKybZvImYAVfRzGp5FQ7BM+4jDVw3PR5bXIpLgxszDHzDrUduFYMX+8x4FRzRlWCgE0+H5GCscY6VD3N4aRNa4tgnkEn5COa6fw75c8SrM3yjgCuUUtNYOzuPkbii2vXgibY5DDpWidjCpTckddq7QWl4sMGGLDO6uS8RSFIZDcuRLn5M1u6JeJIGmulEkgGK5Hxdei/ujt7fKoom9BYePv8pFo6FYWu5FAABC+5pVV55C56k0loriyEMhx7CtnTIogyo7BT1yazSvY6pz5W2WtM1DMLWM8QVyMq54yajT91Kw24buDVDXR+8BhYkrzuWprDUYrxfLusrdbcKw/iNNpmlGorepqwyKwOxiKnS0EhjZF3nPzZrPtMxyskilSQRz71dZ57K1WWNtysxUj0p+po97RZq35UzoCiqAvQ96h1W4sZLOIQxmG5jJMjLnBBqhO4uLcPNI+T+lQ213dWtrOIMGKZdr7lznHTrRJkxpaJ31RZtr9n8iKYCdIjhVIxgfWux8O7nYhokYcZDnoPUVydsl1c2Ul/IsDKZlVlUAMT0yBWq1z9q/dQQm2aNT5h5OQPUdqcGznxUFNcq0C+gLXlyvlMpQ5KfxBfWsqC5lidgAGQZAB60+3nlS6WazuT5mdhRuSBjrn0qSa1uvM89VaYqwDqq80076jUVD3ZFg6jLNtQr93k5FMkvFRmJ2lcc45xWlElpeG3hjkbzWyZiV+aIDsw/rXN6np0UOqwW41CNoJmw8i/wDLPnvTcrLQimoTlyvQy766b7RjJ2k5ArMvp7hXXLMEPQetbl7pTQG42P8AaEhl2CVOhHY5rOEcc1w6tIIgBlcjO4+lZO7PTpSgkmtSraJHLkXLFImOCwXJX8Kz7tFik2wyb1BzzWxq2l3OmyutwFDbVc7DkYIyKxriMsTjhscYFJ7WOmlJSfNF6MoiWQzfOuAP5V1WgaQ3n2cl9NHZpOw2M552Ho47YzxWDDaz3LiOFGkkAPyoMk4pGv55oEt2mZo4shEb+H1x6Uk7PUdeLqLlg7dzv9Vubq4jS3kWC5W2UgGE5woOC2B645rk9burSWxhijt9s6uxMg6Mp7fhVbw/qsen3shvLYzRvGyLh9pVj3qG9nEkEcZjUCM8SLwSCckH1+tW3dHHSw3sp2eyMmZtwwo+YEnjuKrzEMOEVWzg5p8+chxgKD0XvUNxIZFDlQoBqT0dtiKclSAFXiqU74fcvWrRUOdqdPbrVOVSQMngHFBE5dxhCmIiQnfnrWB4i1ZYYza2xy/8Rp+v6wIsQ2uN+ME9cVzUcLSy7myzE85raEerPHxeIv7kRLS2eWRcr949fWu10fSjAqSyxkqDhl9BUGm6c5iWRgNq45A6V2tlazCwJDLIrL071umeW7lK+sgljHIvIPzCm3awPZK6E79ueOmasNcH7G1qVy0Z+U1BpahTHJcgeUpOAe9S2XGNldlWyk8u0ljbgFsgHp9az7k+bGg6EHHB61eu5wbu4OBsPA4qiYm2Bj8oPIJ6Ggduo/T7d5L0QpywG7k9QKNTmd2KuBvGMGoFkeGeN1Pz9M+1MuWbdyxO481L02KJZCbaIDIPnLk+1RWzCKB5X++cqvtSyx+fcxwq2Rgc+lR3K+VO8RbO04HvTuTYht1MhcgZQDJNRTKHc46KM1M0nkwlOjNyaqCTAZfWhghj4K9OelEwAUVGrggj3olYhDtGTRGN2TOViK4KP93KnH507TVmjvYTbb/PDApsGWz9KgIyBzyD0qRMsU8ot5+4bdvXPt71vscrZ0Mxv1fePDsTyHq/2Vxk/QcVz2sPdveO+oo0c5A+Rl2bR2AHYVtXllrV5ceZKBFKVG5BcBSxA67c8E1zmoRzxXMkd3vEy8MJM5FUhH0JN8yHGQw6VHAzZ+bPFXL6Dy3wOMmqeQrH9K81aHrPVDpZkZCMYYc5rOn3O2Rk1dkUEnHUiqaZGQeRQxwdh0TOEKgkVMisyqWztJ5qKMbpCuMYq0HEfyuPl60kavbQ2r26gstLjW3I8xxg1zy2TFfPlXqcg1ejs3uDHJICIicKPWt/WY4f7OENqgPlrljird3uc6ag7LdmBZW3nSKdw461pf2WjscMRk9fSqOkDa4djgEcCumhhMZDuTtI5z6URRNSTT0MS7t0t18pV3t6jkmuWuGMc3C7WFd1AkUjzPkYB4PeuP1JMzSuRn5iAfahl0ZXeptaHrMd1CbTUB83/LOUDnPpWzcAQxokhyjDOe2a8+bciq6HDDketdDofiFbj/QtQ2hjwrt0PtTubWtsaly4dAC4G04AAp39rYgW2eMYHcCoFgfEisn7snIcc1Pa2kXkAsyl15/Clq2dHNBL3iK2cJKBlwM9Aa0xb3KxtLDcSAsCHPfB65qshSCXLpgnlW9KgfUbrEqo5COeTjrTtbcmV5u6Rq2NsbZI5baSCRsHKlsMvua1fDOoXNxqE4aAyOkTKGUYx3G6uElkl3hjIFJ44NLY3s8cjJb3ciZ5+UkfgaSlZ2CphPaRd2rnpFhrenySSxXKxfbFUsr4ALsRyCfWuLubRrWG11SdRc20spDoQRjB6E1lvugMgDZcd1Oetbmh+Ko7PTk03UrIXVqX3EnnAP8AWlJ33IWGlQvKkrp7ry8i7qN9aTWZ+zbra8WENtjbMcyj19SBXIW5uHvFvIt6QQOpMm3IQnkcVZ1CTT5r6V7d5Le3RG8v+IluwPpmsvTb65S1uo7MO8UkZEykZGPU+mPWpcmdVCj7Om+X8fMvvLf6nPdXcommSMZlZV4A9/Qe1Zd5fGKGUQ7djgZwOpHStfw/rN1p2lXdgrq0E+d+5c9awbyIBhtZQf7tDva5tTVpuMlotipa3M0UiSo7RS5yCDgimMqAuwJLMcsfepdg4L53Cq00jBWx19Kn1Oq6b0HSNwDjPbmoFmkkfHO0cY7Uok8xMMAMU/aFXfkAd8VS1IcuXRjHKiN0IG3696oOWceWBkVZniLuu04B71Xl8uxbEm4uw4A700mZSqRir3K5UxK7M21QOABzXLatqMs0jW9kpJxgsOa6+e2ub2HdKGhgYfKccn2rOsNCktbuEuu1JDgkito0zy62L5rxicxY6BLKpmuNwQ/rWgtijupRcMowQK9BtoFVJbJghTBCsRWPptqUu54hGpOK0dloeem3dsvaBZJPp7JjaoUjPqaghnexlEUxyjelaFgTaQMH4iJ4I9fesrV9u8MvJbp7GlIIWu0w1GYeaGQAj2qxfyJ/Y1vFEiqy/OSTyTWXbtuuEjcnIOSPWpLyUOu8ADDEYoTuW48rSKMrJJGzKfm9Kr3M8k0Ua4wijtUjRkoWVcZPNNSJ5QqRL8zcYpJsJLqLZwxyySSShtqKdv1qKSNHt/OZxnoFHWp3kZbRbZ9q7GJOOpNUFBKuMd+lNkj0uiHV8AbVx6VTuXwyueGJ65q0VEKfMPm7g1SukWZFxnOc8Ghdg80ObDOS/JAqspJlPFSyEB1APHrTNp3EihEtjTGQC+OPQVEvmMW2jr2q1JHI8QKgYPpTo22fKcBx39a2irI5pO5nqwyAy521Jp9wbTUobrYXEb7sZxmifCMT368VNo9zDBqttLcAeSrgtkZx7471aJJLi00pX3yX15Fv+bbJa/P+ecH61R1+Zbm8V0SRI0iSNPN++ygcMfrWnJqDSXM9jrNwt3bOcrcI28xN1DKfT1FUvEZRtRiEU0cyrbRJvjOQcLimI+kdTtfNXzFzWAYz5+G4rrIZPMjKHHpWTqVmQ4IA+tedJX1PQo1NLMySu9+OSKq3Y8v5lBwauuPJQkYqK5kzEqkDJpGyWtynZnlt38Qq7ap58hBblB09aqMFBO04PpSKWjO9PzpGvoajai6SRxpwqHoaffXcxRudqydRWYmfP3ueTU9zI0u0HgUNthypM1NAhjba8zYUcdK1L64WS0KxyfKpxmsGO68m2KLjOMYpR532L/VkKTkmnzWVjP2fM+Zm5pFr9smZFbaAMfWqWq6ZFFN5JBJDc/SrehubdBJwRjk5qyY/tEonf5gxq46mMm1LQ56fSLfrGSBjvVO6020LBZXG49xxXRW8MD3M4mbCqOOapS6bHI0rRgMqjp3qrEqbT1Zk2usy6TO0CEzxY4z6Vs29/BeRb4o96N94J95DXFsxt9RLOhKjjFQpdTQXnn2rNGQc8dKg6ovlO3ubmQQhJSRtHDEc496qwu7rtdxjqDSaf4n+0hFvrdGJG1j2IqxNHas4lsMBf+ebn+VJrW50U6ytZqxnzPyCq5GealRVicsGALDvU09g8S+aqFoWPUdqrLBINpx8p5DE8VKudftItaMkkTgncdzeoqrPEyg5O4H8KlmlEvG7kcEAc1RJYuAMke1DKpsjfAzgZweMGrehF0uZQkpjdkKN6Mp7GqcsTxvgIy59ajTzI3ABfdUre5rO04ONzS1W3NvHvR8rnkVkSMJZN2STjippYbuXO9Sy44BNFpp8gVzJIsQAzyelDV2RGUYR96WpUeVm+ViOeM1LHZSckkBjzjOaR/sMRDKzzyHqAKs2k13I5Nvbr5Y7Hk01G+5hVxVl7osGmLIpJYq3cAcGqz2KRNieYBM8DPJqeWWaa9jj37I2XnHAzWZqFp5F2Crs+DkHNa8qRxSxc31GyGVrkRRLj0wM8fWq1/YTxzpLMpAzuXPtXT2LJ9h3BVMhP4im6ztkgRZMkIOMVpZW0ON15zl7xNLEv9n2ymRWQ4Jx2qrrwSSESIFGwjIA6VWsJXFs4bkAAEelWbuUS2uxxwVxuAocrozjBxkUJ22xIyNlW+bjtVNle3Ek4xvBz07elT2NwBAY3GdmQRinTRbYFabKgjI+lLoaW5XYrCcyW7BiVVvmqnePlVAxkdaRZhFMyjDKeRzUF3KM7u5HalfSw+VJ6DEQOZnBwyCmKB5Rd8nnp2p9kdmZZPudMe9U5JyJDzwT0p7FPUSSVnZicBc9BU1k7Wm4sOXBK+1MijM0wAGFHJpk8gW4GMFRxin5kaPQjuNu9nUn156k0xY2h2Tnbk9jQFZZclSy5zgHtUd3OZZQ2eOmBQJjJm80uSRuJzVPoOO1SO53ZAwaCC3zYAFCTJckhjR7wvanQ+WzMjttOKlDRyAgkqe2KrouG5H41slZHPKVxyMIldd26oJGBIYE0+6I2jPeqsj+naqSuZiSMGPNRW0RluUiQF2kYKAO5NNfJf5TxUulzLb6hFJKSqAlWYfwggjP4Zz+FWtBFibT7SK4MP2yQykE5SAtGAOp3ZyR7gYqlPA9pOY5gN69cHIPoQe4IroVtpPt9tebbppIUVVWNMxNtGOJM4CHGTn1NYmrSo9wkcTK4hiWIuvRiOuPbsPpQ2NH0nbuwdcHrVy5AeA7qKK4HsdMPiRztyMxsD2NU5CTs/Ciis0dq2K8qgPnvmnRj9waKKDRbDYzlwDyM1PC7CcHPPIoopLYcuotvzd5PY1pTXMjxOCRj0AoopMb3RPasRYqRWzAT9kUdsE0UVpDc46vX1MO3JbUSCeMmtSVFVdy8FutFFaQ2M5mRcWkMkTF0BOetYmoWsULFY1wMUUUPYUW7EMEaqMgc121hawvp8JZASVooqGVUdjMvryezvBFBJiMjlSM1JaX0hmEO2PYy5I296KKaNYv3S3buJQ0jRpvXOCBjP1rPuRHM2WgiDf3lBBooptaGtOT5ty7AQ0K7kVsDuKrXBVY1kEabiPSiihLQlSfMczrepXAbykZUX/ZHJqlYM04mErswHIBNFFR1N5u1PQdGoS+AUcVv27FEwpxnrRRWsTz56mPcfJflR096uahBH9nc452Bs+9FFT3NexTtGYRRgE4NWm+adQxJHvRRTiQ9yooxqMyj7rZyKrxSsQyk5AzRRSRZVB+cn3ps8jOzKzEgCiigb3Rk3HyygjrxRff6sHvRRTRTH3caxWsIQY3Lk+9UZVDKxI5AzRRQyEJbTOYn568GoCM7yeo6UUVS2F1G7iICcnJHNUVY5f2GaKKHuSwi+dRu7jNOufkRdvpRRWkNzCoQ9FB9akY4Xjiiire5iU7piynPas5XYryaKKtCE3H1pQc9aKKbAa7MI9oZgp6gHinxoCm45zRRUjP/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    White plaques are present on the tongue.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12963=[""].join("\n");
var outline_f12_42_12963=null;
var title_f12_42_12964="Grade III liver laceration and hematoma on ultrasound and CT";
var content_f12_42_12964=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F86846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F86846&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 621px\">",
"   <div class=\"ttl\">",
"    Grade III liver laceration and hematoma on ultrasound and CT",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 601px; height: 273px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The ultrasound&nbsp;(A) shows an almost isoechoic intraparenchymal hematoma in the liver (yellow arrow) that mesasures 4.4 cm (+---+).&nbsp;The CT scan,&nbsp;reformatted in the coronal plane (B),&nbsp;shows a 4 cm laceration (dashed yellow arrow) with a subcapsular hematoma (yellow arrowhead) that was estimated to occupy more than 10 percent of the surface of the liver. The depth of the laceration &gt;3 cm characterizes this as a grade III injury.",
"    <div class=\"footnotes\">",
"     CT: computed tomography.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12964=[""].join("\n");
var outline_f12_42_12964=null;
var title_f12_42_12965="Mebendazole: Drug information";
var content_f12_42_12965=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Mebendazole: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?1/29/1492?source=see_link\">",
"    see \"Mebendazole: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/53/11091?source=see_link\">",
"    see \"Mebendazole: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F191554\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Vermox&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F191598\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anthelmintic",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F191557\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Canadian manufacturer labeling:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Ancylostoma duodenale",
"      </i>",
"      (hookworm),",
"      <i>",
"       Necator americanus",
"      </i>",
"      (hookworm),",
"      <i>",
"       Ascaris lumbricoides",
"      </i>",
"      (roundworm),",
"      <i>",
"       Strongyloides stercoralis",
"      </i>",
"      (roundworm),",
"      <i>",
"       Taenia solium",
"      </i>",
"      (tapeworms),",
"      <i>",
"       Trichuris trichiura",
"      </i>",
"      (whipworm), mixed infection:",
"     </b>",
"     Oral: 100 mg twice daily for 3 days; repeat in 3 weeks if not cured with initial treatment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Enterobius vermicularis",
"      </i>",
"      (pinworm):",
"     </b>",
"     Oral: 100 mg as a single dose; repeat in 2 or 4 weeks (manufacturer&rsquo;s labeling); treatment should include family members in close contact with patient (",
"     <i>",
"      Med Lett",
"     </i>",
"     , 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Unlabeled dosing:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Ancylostoma duodenale",
"      </i>",
"      (hookworm),",
"      <i>",
"       Ascaris lumbricoides",
"      </i>",
"      (roundworm),",
"      <i>",
"       Necator americanus",
"      </i>",
"      (hookworm),",
"      <i>",
"       Trichuris trichiura",
"      </i>",
"      (whipworm):",
"     </b>",
"     500 mg as a single dose (",
"     <i>",
"      Med Lett",
"     </i>",
"     , 2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Unlabeled uses:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Ancylostoma caninum (eosinophilic enterocolitis):",
"      </i>",
"     </b>",
"     Oral: 100 mg twice daily for 3 days (",
"     <i>",
"      Med Lett,",
"     </i>",
"     2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Capillaria philippinensis",
"      </i>",
"      (capillariasis):",
"     </b>",
"     Oral: 200 mg twice daily for 20 days (",
"     <i>",
"      Med Lett,",
"     </i>",
"     2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Giardia duodenalis",
"      </i>",
"      (giardiasis):",
"     </b>",
"     Oral: 200 mg 3 times daily for 5 days (Canete, 2006; Chandy, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Mansonella perstans",
"      </i>",
"      (filariasis):",
"     </b>",
"     Oral: 100 mg twice daily for 30 days (",
"     <i>",
"      Med Lett,",
"     </i>",
"     2007)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Visceral larva migrans (toxocariasis):",
"     </b>",
"     Oral: 100-200 mg twice daily for 5 days (",
"     <i>",
"      Med Lett,",
"     </i>",
"     2007)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F191577\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/53/11091?source=see_link\">",
"      see \"Mebendazole: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &ge;2 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F191558\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F13906823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13906824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling; however, undergoes extensive hepatic metabolism; use with caution as systemic exposure may be increased.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F191533\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, chewable, oral: 100 mg [DSC]",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F13880659\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Vermox&reg; 100 mg [scored]",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F803167\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tablets may be chewed, swallowed whole, or crushed and mixed with food. Tablets may be administered with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F191534\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of",
"     <i>",
"      Ancylostoma duodenale",
"     </i>",
"     or",
"     <i>",
"      Necator amiericanus",
"     </i>",
"     (hookworms),",
"     <i>",
"      Ascaris lumbricoides",
"     </i>",
"     (roundworms),",
"     <i>",
"      Enterobius vermicularis",
"     </i>",
"     (pinworms),",
"     <i>",
"      Strongyloides stercoralis",
"     </i>",
"     (roundworm),",
"     <i>",
"      Taenia solium",
"     </i>",
"     (tapeworms),",
"     <i>",
"      Trichuris trichiura",
"     </i>",
"     (whipworms),",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F11232833\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of",
"     <i>",
"      Ancylostoma caninum",
"     </i>",
"     (eosinophilic enterocolitis),",
"     <i>",
"      Capillaria philippinensis",
"     </i>",
"     (capillariasis),",
"     <i>",
"      Giardia duodenalis",
"     </i>",
"     (giardiasis),",
"     <i>",
"      Mansonella perstans",
"     </i>",
"     (filariasis), visceral larva migrans (toxocariasis)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9500697\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Mebendazole may be confused with metroNIDAZOLE",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F191596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, drowsiness, headache, seizure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia, angioedema, exanthema, itching, rash, Stevens-Johnson syndrome, toxic epidermal necrolysis, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, diarrhea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Agranulocytosis, eosinophilia, hemoglobin decreased, leukopenia, neutropenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased, ALT increased, AST increased, GGT increased, hepatitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: BUN increased, cylindruria, glomerulonephritis, hematuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Hypersensitivity reactions (anaphylactic, anaphylactoid)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F191537\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to mebendazole or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F191523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bone marrow suppression: Neutropenia and agranulocytosis have been reported with high doses and prolonged use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution; systemic exposure may be increased with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hydatid disease: Not effective for hydatid disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Metronidazole: Concomitant use with metronidazole should be avoided; may increase the risk of adverse events including Stevens-Johnson syndrome and toxic epidermal necrolysis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Experience with use in children &lt;2 years of age is limited; convulsions in infants &lt;1 year have been reported (rare) postmarketing.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F191528\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoquinolines (Antimalarial): May decrease the serum concentration of Anthelmintics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May decrease the serum concentration of Mebendazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May increase the serum concentration of Mebendazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May decrease the serum concentration of Mebendazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MetroNIDAZOLE (Systemic): Mebendazole may enhance the adverse/toxic effect of MetroNIDAZOLE (Systemic). Particularly the risk for Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis may be increased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MetroNIDAZOLE (Topical): Mebendazole may enhance the adverse/toxic effect of MetroNIDAZOLE (Topical). Particularly the risk for Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis may be increased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May decrease the serum concentration of Mebendazole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F191549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: Mebendazole serum levels may be increased if taken with food.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F191529\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13386518\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in animal reproduction studies; adverse pregnancy outcomes have not been observed following use in pregnancy (Diav-Citrin, 2003; Gyorkos, 2006).  Treatment of pinworm in pregnancy may be considered; however, the CDC suggests postponing therapy until the third trimester when possible (CDC, 2010).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F191564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F191540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Since only 2% to 10% of mebendazole is absorbed, it is unlikely that it is excreted in breast milk in significant quantities (CDC, 2010)",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F191531\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Periodic hematologic, hepatic, and renal function; check  for helminth ova in feces within 3-4 weeks following the initial therapy",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F191542\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Adec (TW);",
"     </li>",
"     <li>",
"      Anelmin (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);",
"     </li>",
"     <li>",
"      Antiox (PH);",
"     </li>",
"     <li>",
"      Benda (TH);",
"     </li>",
"     <li>",
"      Bendrax (BR);",
"     </li>",
"     <li>",
"      Big-Ben (TH);",
"     </li>",
"     <li>",
"      Combantrin-1 (NZ);",
"     </li>",
"     <li>",
"      Combantrin-1 with mebendazole (AU);",
"     </li>",
"     <li>",
"      Conquer (TW);",
"     </li>",
"     <li>",
"      D-Worm (ZA);",
"     </li>",
"     <li>",
"      Diacor (CN);",
"     </li>",
"     <li>",
"      Fugacar (TH);",
"     </li>",
"     <li>",
"      Hitolin (TW);",
"     </li>",
"     <li>",
"      L-Ombrix (MX);",
"     </li>",
"     <li>",
"      Lomper (ES);",
"     </li>",
"     <li>",
"      Mebedal (MX);",
"     </li>",
"     <li>",
"      Mebendazol (MX);",
"     </li>",
"     <li>",
"      Mebensole (MX);",
"     </li>",
"     <li>",
"      Mebex (IN);",
"     </li>",
"     <li>",
"      Mebezol (TW);",
"     </li>",
"     <li>",
"      Nemasole (AR);",
"     </li>",
"     <li>",
"      Pantelmin (AT, CO, EC, PE, PT, PY, UY, VE);",
"     </li>",
"     <li>",
"      Quemox (MY, TH);",
"     </li>",
"     <li>",
"      Revapol (MX);",
"     </li>",
"     <li>",
"      Ridworm (AU);",
"     </li>",
"     <li>",
"      Surfont (DE);",
"     </li>",
"     <li>",
"      Toloxim (PT);",
"     </li>",
"     <li>",
"      Vermazol (TR);",
"     </li>",
"     <li>",
"      Vermin-Dazol (MX);",
"     </li>",
"     <li>",
"      Vermox (AE, AU, BB, BE, BF, BG, BH, BJ, BM, BS, BZ, CH, CI, CL, CY, CZ, DE, DK, EE, EG, GB, GH, GM, GN, GR, GY, HK, HN, HR, HU, ID, IE, IL, IQ, IR, IT, JM, JO, KE, KW, LB, LR, LU, LY, MA, ML, MR, MU, MW, MX, NE, NG, NL, NO, NZ, OM, PK, PL, PR, QA, RU, SA, SC, SD, SE, SL, SN, SR, SY, TN, TT, TZ, UG, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Vertizole (MX);",
"     </li>",
"     <li>",
"      Warca (TH);",
"     </li>",
"     <li>",
"      Wormgo (ZA);",
"     </li>",
"     <li>",
"      Wormin (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, IN, IQ, IR, JO, KE, KW, LB, LR, LY, MA, ML, MR, MU, MW, NE, NG, OM, QA, SA, SC, SD, SL, SN, SY, TN, TZ, UG, YE, ZM, ZW);",
"     </li>",
"     <li>",
"      Zadomen (MY)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F191522\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits the formation of helminth microtubules; selectively and irreversibly blocks glucose uptake and other nutrients in susceptible adult intestine-dwelling helminths",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F191536\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 1-2 L/kg; to liver, fat, muscle, plasma, and hepatic cysts",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 90% to 95%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively hepatic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: ~20%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: 3-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Primarily feces; urine (~2%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Canete R, Escobedo AA, Gonzalez ME, et al, \"Randomized Clinical Study of Five Days Apostrophe Therapy With Mebendazole Compared to Quinacrine in the Treatment of Symptomatic Giardiasis in Children,\"",
"      <i>",
"       World J Gastroenterol",
"      </i>",
"      , 2006, 12(39):6366-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/42/12965/abstract-text/17072963/pubmed\" id=\"17072963\" target=\"_blank\">",
"        17072963",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Parasites - Enterobiasis (also known as Pinworm Infection),\" 2010. Available at",
"      <a href=\"file://www.cdc.gov/parasites/pinworm/health_professionals/index.html\" target=\"_blank\">",
"       file://www.cdc.gov/parasites/pinworm/health_professionals/index.html",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chandy E and McCarthy J, \"Evidence Behind the WHO Guidelines: Hospital Care for Children: What Is the Most Appropriate Treatment for Giardiasis?\"",
"      <i>",
"       J Trop Pediatr",
"      </i>",
"      , 2009, 55(1):5-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/42/12965/abstract-text/18786986/pubmed\" id=\"18786986\" target=\"_blank\">",
"        18786986",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      de Silva N, Guyatt H, and Bundy D, &ldquo;Anthelmintics. A Comparative Review of Their Clinical Pharmacology,&rdquo;",
"      <i>",
"       Drugs",
"      </i>",
"      , 1997, 53(5):769-88.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/42/12965/abstract-text/9129865/pubmed\" id=\"9129865\" target=\"_blank\">",
"        9129865",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Diav-Citrin O, Shechtman S, Arnon J, et al, \"Pregnancy Outcome After Gestational Exposure to Mebendazole: A Prospective Controlled Cohort Study,\"",
"      <i>",
"       Am J Obstet Gynecol",
"      </i>",
"      , 2003, 188(1):282-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/42/12965/abstract-text/12548230/pubmed\" id=\"12548230\" target=\"_blank\">",
"        12548230",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Drugs for Parasitic Infections,&rdquo;",
"      <i>",
"       Med Lett Drugs Ther",
"      </i>",
"      , 2007, 5(suppl):e1-14.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gyorkos TW, Larocque R, Casapia M, et al, \"Lack of Risk of Adverse Birth Outcomes After Deworming in Pregnant Women,\"",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2006, 25(9):791-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/42/12965/abstract-text/16940835/pubmed\" id=\"16940835\" target=\"_blank\">",
"        16940835",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hotez PJ, &ldquo;Hookworm Disease in Children,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 1989, 8(8):516-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/42/12965/abstract-text/2671907/pubmed\" id=\"2671907\" target=\"_blank\">",
"        2671907",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9594 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-77399545CD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12965=[""].join("\n");
var outline_f12_42_12965=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191554\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191598\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191557\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191577\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191558\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13906823\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13906824\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191533\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13880659\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F803167\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191534\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11232833\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9500697\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191596\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191537\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191523\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299650\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191528\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191549\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191529\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13386518\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191564\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191540\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191531\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191542\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191522\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191536\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9594\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9594|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?1/29/1492?source=related_link\">",
"      Mebendazole: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/53/11091?source=related_link\">",
"      Mebendazole: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_42_12966="Lateral canthal rhytides botulinum toxin injection sites";
var content_f12_42_12966=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54110&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Botulinum toxin injection sites for lateral canthal rhytides",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 512px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Examples of sites for botulinum toxin injection of the orbicularis oculi muscle for the treatment of lateral canthal rhytides.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12966=[""].join("\n");
var outline_f12_42_12966=null;
var title_f12_42_12967="Verruca vulgaris - finger";
var content_f12_42_12967=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F58825%7EDERM%2F70615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F58825%7EDERM%2F70615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Verruca vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A well-defined keratotic papule is present on the dorsal finger in this patient with verruca vulgaris (common wart).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Verruca vulgaris",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A keratotic papule with peripheral hyperpigmentation is present on the hand of this patient with verruca vulgaris (common wart).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12967=[""].join("\n");
var outline_f12_42_12967=null;
var title_f12_42_12968="Cogan’s syndrome";
var content_f12_42_12968=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cogan&rsquo;s syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/42/12968/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/42/12968/contributors\">",
"     E William St Clair, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/42/12968/contributors\">",
"     Rex McCallum, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/42/12968/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/42/12968/contributors\">",
"     John H Stone, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/42/12968/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/42/12968/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/42/12968/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cogan&rsquo;s syndrome (CS) is a chronic inflammatory disorder that most commonly affects young adults. Clinical hallmarks are interstitial keratitis (IK) and vestibuloauditory dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/1\">",
"     1",
"    </a>",
"    ]. Associations between CS and systemic vasculitis, as well as aortitis, also exist [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/2-4\">",
"     2-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pathology, pathogenesis, clinical manifestations, and treatment of Cogan&rsquo;s syndrome will be presented here.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Limited autopsy data derived from temporal bone specimens of patients with CS reveal a range of findings, including [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Lymphocyte and plasma cell infiltration of the spiral ligament",
"     </li>",
"     <li>",
"      Endolymphatic hydrops",
"     </li>",
"     <li>",
"      Degenerative changes in the organ of Corti",
"     </li>",
"     <li>",
"      Extensive new bone formation in the inner ear",
"     </li>",
"     <li>",
"      Demyelination and atrophy of the vestibular and cochlear branches of the eighth cranial nerve",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Histopathologic examination of corneal tissue from patients with IK reveals lymphocytic and plasma cell infiltration in the deeper layers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite an association with systemic vasculitis, eye and inner ear specimens of those with CS do not reveal any evidence of vasculitis. In cases with systemic vasculitis, affected vessel walls outside the eye and inner ear show typical histopathologic changes of acute and chronic inflammation depending upon the nature of involvement (Takayasu-like or polyangiitis-like) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/2,5,9-12\">",
"     2,5,9-12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/19/13624?source=see_link\">",
"     \"Clinical features and diagnosis of Takayasu arteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional pathologic findings are relatively nonspecific and are compatible with a chronic inflammatory process. As an example, damaged aortic valves in cases of aortitis grossly manifest cusp detachments and outpouchings, fenestrations, thinning, thickening, and retraction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/9,10,12,13\">",
"     9,10,12,13",
"    </a>",
"    ]. Microscopic examination of affected valvular tissue shows lymphoid cell infiltration, fibrinoid necrosis, and myxomatous degeneration [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/9,10,12-14\">",
"     9,10,12-14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanisms responsible for the eye and inner ear disease in CS are unknown. Some evidence suggests that the disease is a result of inner ear autoimmunity. A few patients display reactivity against antigens expressed in the inner ear [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/15\">",
"     15",
"    </a>",
"    ]. These antigens share sequence homology with",
"    <span class=\"nowrap\">",
"     Ro/SSA",
"    </span>",
"    autoantigen and the reovirus III major core protein lambda 1.",
"   </p>",
"   <p>",
"    In animals, passive transfer of the autoantibodies reproduced features of CS; this supports a hypothesis that infection, perhaps from reovirus type III, may be involved in triggering this autoimmune disease through molecular mimicry [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/15\">",
"     15",
"    </a>",
"    ]. This is further supported by the observations that one-quarter to one-third of patients with CS have an antecedent viral-like illness [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/2,16,17\">",
"     2,16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An additional trigger may be cigarette smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The peak incidence of CS occurs in the third decade of life. In the two largest series, the median age of onset was 22 years (range 5 to 63 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. CS may also occur in children and in older adults [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/18-20\">",
"     18-20",
"    </a>",
"    ]. There is no known gender or racial predominance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A definite diagnosis of CS is based upon characteristic involvement of both the eye and the inner ear. Both organs are nearly equally likely to be the cause of presenting symptoms.",
"   </p>",
"   <p>",
"    Less than 5 percent of patients initially present with systemic manifestations. In these cases, the diagnosis of CS can only be established after the development of eye or inner ear disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/2,3,17\">",
"     2,3,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Ocular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The predominant ocular feature of CS is interstitial keratitis (IK), which typically causes eye redness, pain, photophobia, and blurred vision. Slit-lamp examination commonly demonstrates a patchy, deep, granular corneal infiltrate (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52648 \" href=\"UTD.htm?33/17/34079\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Cases of early IK may produce a faint peripheral, anterior stromal, subepithelial keratitis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/21\">",
"     21",
"    </a>",
"    ]; these manifestations may be confused with a viral or chlamydial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/21\">",
"     21",
"    </a>",
"    ]. Rarely, uncontrolled corneal inflammation may lead to neovascularization and corneal clouding, resulting in permanent visual loss [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/17,22\">",
"     17,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although IK is the classic eye finding, it is not essential for the diagnosis. Ocular inflammation may involve other parts of the eye and may lead to iridocyclitis, conjunctivitis, episcleritis, anterior or posterior scleritis, or retinal vasculitis (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77595 \" href=\"UTD.htm?23/48/24320\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/3,17,18,23,24\">",
"     3,17,18,23,24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Retinal vasculitis and posterior scleritis are serious conditions that frequently cause visual impairment; when present, they demand urgent treatment intervention. (See below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Inner ear disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The inner ear manifestations of CS are Meniere-like attacks consisting of vertigo, ataxia, nausea, vomiting, tinnitus, and hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/25\">",
"     25",
"    </a>",
"    ]. Vestibular dysfunction may also cause oscillopsia, which is the perception of objects jiggling back and forth after abruptly turning the head to one side or the other. Caloric testing often reveals absent vestibular function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32057?source=see_link\">",
"     \"Approach to the patient with vertigo\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Recurrent episodes of inner ear disease frequently result in profound hearing loss. In a retrospective series of 60 patients from one center, hearing loss was typically sudden, bilateral, fluctuating, and progressive, resulting in complete hearing loss in 73 of 120 ears [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/17\">",
"     17",
"    </a>",
"    ]. Hearing loss in both ears was noted at some point in all patients. Two smaller studies both found bilateral deafness in approximately two-thirds of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Recurrent episodes of inner disease may also result in cochlear hydrops [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/2\">",
"     2",
"    </a>",
"    ]; this condition may be associated with down-fluctuations in hearing because of changes in the cochlear pressure independent of inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/26\">",
"     26",
"    </a>",
"    ]. Such noninflammatory down-fluctuations are difficult to distinguish from those of inflammatory origin, after several episodes of active CS.",
"   </p>",
"   <p>",
"    Down-fluctuation in hearing associated with an upper respiratory infection or menses may be monitored without change in therapy to observe if it will resolve in three to five days, since a noninflammatory down-fluctuation frequently abates within this time frame. If hearing loss is associated with eye inflammation or other features of active CS, then a down-fluctuation in hearing is most likely due to inflammation.",
"   </p>",
"   <p>",
"    Typically, audiometry testing demonstrates a sensorineural hearing loss, preferentially involving the low and high range frequencies; poor speech discrimination is also observed (",
"    <a class=\"graphic graphic_figure graphicRef67321 graphicRef81989 \" href=\"UTD.htm?39/2/39969\">",
"     figure 1A-B",
"    </a>",
"    ). In one preliminary study, at least 30 percent of patients had a pure-tone audiometry threshold of greater than or equal to 60 dB, a threshold value indicative of moderately severe hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Systemic vasculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;When present, the systemic vasculitis associated with CS is a large- or medium- to small-sized vessel vasculitis or an aortitis. The pattern of vessel involvement may be overlapping.",
"   </p>",
"   <p>",
"    Aortitis, which may develop within weeks to years of disease onset, has been described in approximately 10 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/2,3,25\">",
"     2,3,25",
"    </a>",
"    ]. It may cause proximal aorta dilation, aortic valvular regurgitation, ostial coronary artery disease, and thoracoabdominal aortic aneurysms [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/9,10,25,27-29\">",
"     9,10,25,27-29",
"    </a>",
"    ]. A coronary arteritis has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/3,11,26\">",
"     3,11,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The large-vessel vasculitis associated with CS may also resemble Takayasu arteritis, causing an occlusion of the aortic arch vessels with resultant upper",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    lower limb claudication or renal artery stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/9,11,30,31\">",
"     9,11,30,31",
"    </a>",
"    ]. A small- or medium-sized vessel arteritis has been described in some cases [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/19/13624?source=see_link\">",
"     \"Clinical features and diagnosis of Takayasu arteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonspecific systemic manifestations of CS include fever, fatigue, weight loss, lymphadenopathy, hepatomegaly, hepatitis, splenomegaly, pulmonary nodules, pericarditis, abdominal pain, arthralgia, arthritis, myalgia, and urticaria [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/4,17,24,25\">",
"     4,17,24,25",
"    </a>",
"    ]. The disorder has also been described in patients with inflammatory bowel disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/33,34\">",
"     33,34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of the patient with possible Cogan&rsquo;s syndrome requires the following steps:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ophthalmologic examination to establish the presence of interstitial keratitis, scleritis, or episcleritis and to exclude other diseases and ocular pathology",
"     </li>",
"     <li>",
"      Neurologic and otologic examination to establish the presence of vestibuloauditory abnormalities",
"     </li>",
"     <li>",
"      Rheumatologic examination to seek evidence of systemic vasculitis",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of CS is based upon the presence of characteristic inflammatory eye disease and vestibuloauditory dysfunction. The previously used modifying terms &ldquo;typical&rdquo; and &ldquo;atypical&rdquo; CS have been abandoned because this distinction no longer appears to carry prognostic significance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of CS includes diverse conditions that cause similar eye and inner ear manifestations (",
"    <a class=\"graphic graphic_table graphicRef81562 \" href=\"UTD.htm?22/16/22796\">",
"     table 1",
"    </a>",
"    ), such as sarcoidosis, polyarteritis nodosa, granulomatosis with polyangiitis (Wegener&rsquo;s), and rheumatoid arthritis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=see_link\">",
"     \"Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=see_link\">",
"     \"Clinical manifestations and diagnosis of sarcoidosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other diagnostic possibilities are the infectious causes of interstitial keratitis, such as congenital syphilis, tuberculosis, chlamydial infection, and viral infection. Infectious agents can be differentiated from CS by serologic testing (eg, FTA-abs for syphilis), skin tests (eg, tuberculin skin testing), cultures, therapeutic trials of antimicrobial treatment (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    for chlamydia), and characteristic clinical signs (eg, dendritic pattern in herpetic corneal infections). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/17/20760?source=see_link&amp;anchor=H10#H10\">",
"     \"Conjunctivitis\", section on 'Chlamydial infections'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17607?source=see_link&amp;anchor=H12#H12\">",
"     \"Evaluation of the red eye\", section on 'Viral keratitis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/31/17914?source=see_link&amp;anchor=H28809349#H28809349\">",
"     \"Congenital syphilis: Clinical features and diagnosis\", section on 'Late congenital syphilis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/40/5767?source=see_link\">",
"     \"Tuberculosis and the eye\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cogan&rsquo;s syndrome also must be distinguished from a syndrome of subacute encephalopathy, sensorineural hearing loss, and retinal arteriolar occlusions in young adults that is due to an occlusive nonvasculitic vasculopathy. The major findings in this disorder, which differ from those in Cogan&rsquo;s syndrome, include the presence of retinal and neuropsychiatric findings and the absence of interstitial keratitis or other inflammation of the anterior segment of the eye.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapeutic options for the treatment of CS include the use of topical agents for limited ocular disease and immunosuppressive therapy for more extensive ocular disease, inner ear involvement,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    systemic vasculitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Systemic vasculitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic vasculitis associated with CS is treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    . This agent is administered at 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day given in divided doses to produce a short period of intense immunosuppression; this may result in more rapid disease control with subsequent consolidation to once per day dosing with clinical improvement. The glucocorticoid taper is approached in a manner similar to that generally utilized for systemic vasculitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28119?source=see_link\">",
"     \"Treatment and prognosis of polyarteritis nodosa\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional immunosuppressive therapy may be required depending upon the severity of disease and upon the nature of organ system involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/26,35\">",
"     26,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For the treatment of large-vessel vasculitis,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"       cyclosporine",
"      </a>",
"      (4",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day or less) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      (starting at 2 to 3",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day by mouth) is recommended. Therapeutic failure has been reported among some patients given cyclophosphamide [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/11\">",
"       11",
"      </a>",
"      ]. Cyclosporine is usually continued for one year after clinical and laboratory parameters of the vasculitis have become inactive, with a subsequent taper over three months. An alternative therapeutic agent is",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      (15 to 25",
"      <span class=\"nowrap\">",
"       mg/week).",
"      </span>",
"     </li>",
"     <li>",
"      For medium-sized vessel vasculitis,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      (starting at 2 to 3",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day by mouth) is recommended [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/11,26,35\">",
"       11,26,35",
"      </a>",
"      ]. Tapering of cyclophosphamide is performed in a regimen similar to that used for polyarteritis nodosa. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28119?source=see_link\">",
"       \"Treatment and prognosis of polyarteritis nodosa\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Surgical bypass grafting or aortic valve replacement may be required in some patients with severe ischemic symptoms or heart failure. If possible, such procedures should be avoided during periods of increased disease activity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/26,35\">",
"     26,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Ocular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In those with CS, anterior ocular inflammation and posterior ocular inflammation are treated quite differently. Anterior disease usually responds to topical glucocorticoids, while posterior involvement requires systemic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Anterior ocular inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anterior ocular inflammation, such as IK and anterior uveitis, should initially be treated with topical ocular glucocorticoids.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/48/33536?source=see_link\">",
"     Prednisolone",
"    </a>",
"    acetate at 1 percent (lower potency formulations are also frequently adequate) and mydriatics are administered to decrease ocular inflammation and photophobia, to prevent synechiae, and to relieve ocular discomfort [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/26,35\">",
"     26,35",
"    </a>",
"    ]. The symptoms and signs of IK and anterior uveitis usually improve within three to seven days with topical glucocorticoid therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with IK who fail to respond to the above regimen should be evaluated and treated for other potential causes of corneal inflammation, particularly chlamydia. A trial of oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/41/2714?source=see_link\">",
"     doxycycline",
"    </a>",
"    (200 mg daily for two to three weeks) should be considered in such cases [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/26,35,36\">",
"     26,35,36",
"    </a>",
"    ]. Rarely, treatment of IK or anterior uveitis may require systemic glucocorticoid therapy if the above treatments are ineffective after 2 to 2.5 weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/37\">",
"     37",
"    </a>",
"    ]. Topical glucocorticoids do not exacerbate a chlamydial infection as long as the patient is receiving oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    therapy.",
"   </p>",
"   <p>",
"    Other forms of anterior ocular inflammation, including conjunctivitis, scleritis, and episcleritis, should also be treated with topical glucocorticoid therapy. Topical or systemic nonsteroidal antiinflammatory drug (NSAID) therapy may benefit some patients with episcleritis and scleritis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/35\">",
"     35",
"    </a>",
"    ]. Nodular scleritis or scleritis unresponsive to topical glucocorticoids and oral NSAIDs may require treatment with systemic glucocorticoids [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Posterior ocular inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posterior ocular inflammation requires treatment with systemic glucocorticoids beginning at a dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    of 1",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day. Failure to respond within two to three weeks to high-dose glucocorticoids, inability to taper the glucocorticoids to a dose equivalent to 10 mg of",
"    <span class=\"nowrap\">",
"     prednisone/day",
"    </span>",
"    or less, or the development of significant glucocorticoid-induced toxicity are indications for the use of other immunosuppressive drugs, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    (15 to 25",
"    <span class=\"nowrap\">",
"     mg/week),",
"    </span>",
"    oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    (2 to 3",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day), or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/39/32368?source=see_link\">",
"     cyclosporine",
"    </a>",
"    (5",
"    <span class=\"nowrap\">",
"     mg/kg/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/11,35,38\">",
"     11,35,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Since",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    is probably the safest option, it is frequently chosen first. When used together with another immunosuppressive agent, the glucocorticoid dose should be tapered to the lowest possible dose or should be discontinued, as tolerated, over the next three to four months. If the patient remains free of active disease for six to nine months, consideration should be given to tapering the additional agent over the next three to four months [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Progressive corneal opacification may require corneal transplantation. Cataracts that develop in this setting may require extraction to correct the loss of visual acuity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/22,35\">",
"     22,35",
"    </a>",
"    ]. The threshold for such procedures may be lower in hearing-impaired patients with CS than in other individuals because they may rely upon lip reading or sign language for communication [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/26,35\">",
"     26,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Inner ear disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compromised auditory acuity and vestibular dysfunction in a patient with newly diagnosed CS are indications for a therapeutic trial of systemic glucocorticoids. The degree of hearing loss should be quantified by audiometry. For initial therapy, we recommend",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (1 to 2",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day) administered in divided doses to produce a short period of intense immunosuppression [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/3,4,16,35,39\">",
"     3,4,16,35,39",
"    </a>",
"    ]. With clinical improvement, the dose may be consolidated to a single morning administration [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/26,35\">",
"     26,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subjective hearing improvement and decreased hearing thresholds after two to three weeks of high-dose therapy warrant further tapering of the dose to an every-other-day regimen for the next four to eight weeks. However, reductions in the glucocorticoid dose are contingent upon stable auditory acuity and vestibular function [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Worsening hearing loss judged to be inflammatory in nature should be documented by audiometry and should be treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (0.5 to 2.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day); the dose chosen depends upon the severity of the change and upon the dose of prednisone at which the hearing loss occurred. Some patients may require long-term glucocorticoid therapy because of recurrent hearing loss during attempts to taper the prednisone dose (",
"    <a class=\"graphic graphic_figure graphicRef67321 graphicRef81989 \" href=\"UTD.htm?39/2/39969\">",
"     figure 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intratympanic glucocorticoids may be effective in some patients with idiopathic sensorineural hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/40\">",
"     40",
"    </a>",
"    ]. This approach can be considered, although it is uncertain whether intratympanic glucocorticoids will benefit patients with CS [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When hearing loss is not believed to be caused by inflammation, auditory acuity should be monitored without change in the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    dose. Since these patients may have hearing loss due to cochlear hydrops, a course of diuretic therapy should be considered [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/26\">",
"     26",
"    </a>",
"    ]. Both",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/4/8263?source=see_link\">",
"     hydrochlorothiazide",
"    </a>",
"    at 25",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/52/28488?source=see_link\">",
"     furosemide",
"    </a>",
"    at 10 to 20",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    have been used. Failure to improve after four to seven days of diuretic therapy, along with the absence of any other explanation for the hearing loss (such as an upper respiratory tract infection), justifies a trial of an increased dose of prednisone [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of glucocorticoid-sparing immunosuppressive therapy should be considered in patients for whom excessive glucocorticoid doses either are required to control hearing loss or result in toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/26,35\">",
"     26,35",
"    </a>",
"    ]. In this setting,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19015?source=see_link\">",
"     leflunomide",
"    </a>",
"    , and tumor necrosis factor (TNF)-alpha therapies have been successfully utilized as adjunctive immunosuppressive therapy, but their efficacies remain uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/16,26,41-45\">",
"     16,26,41-45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Our first preference is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    (15 to 25",
"    <span class=\"nowrap\">",
"     mg/week),",
"    </span>",
"    while our second option is",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"     azathioprine",
"    </a>",
"    (1.5 to 2.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per day). Any of the medications above may be tried if these two agents are ineffective. The duration of therapy depends upon the response. If the glucocorticoid-sparing therapy stabilizes the hearing loss and allows tapering of the glucocorticoids, we continue such therapy for six to nine months after tapering off the glucocorticoids, if possible. Some patients may require chronic glucocorticoid-sparing therapy.",
"   </p>",
"   <p>",
"    Cochlear implants have been beneficial in patients who fail to respond to pharmacologic therapy, resulting in severe hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/17,46,47\">",
"     17,46,47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Vestibular dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute vestibular dysfunction is treated using antihistamines (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/17/37141?source=see_link\">",
"     meclizine",
"    </a>",
"    hydrochloride 25 to 50 mg every four hours) or benzodiazepines (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    2 to 10 mg four times per day), as well as bedrest. Recurrent vestibular dysfunction is virtually always accompanied by hearing loss and should be treated as described above, using glucocorticoids and, if needed, glucocorticoid-sparing therapy.",
"   </p>",
"   <p>",
"    Significant recurrent vestibular dysfunction without concomitant hearing loss is very unusual and should be treated with antihistamines or benzodiazepines, as discussed above. A trial of glucocorticoids should be considered if this treatment fails. Long-term glucocorticoid therapy has generally not been required to control recurrent vestibular dysfunction.",
"   </p>",
"   <p>",
"    Chronic vestibular dysfunction occurs in a few patients with CS and can be treated with antihistamines, benzodiazepines, and vestibular therapy, which includes exercise activities aimed at maximizing central nervous system compensation for vestibular dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12968/abstract/2,16,17,48\">",
"     2,16,17,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24863832\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cogan&rsquo;s syndrome (CS) is a chronic inflammatory disorder that most commonly affects young adults. Clinical hallmarks are interstitial keratitis (IK) and vestibuloauditory dysfunction, and associations between CS and systemic vasculitis, as well as aortitis, also exist. There are a range of pathologic findings, most of which reflect immune-mediated injury of the affected tissues; however, despite an association with systemic vasculitis, eye and inner ear specimens of those with CS do not reveal any evidence of vasculitis. The underlying mechanisms responsible for the eye and inner ear disease in CS are unknown. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathogenesis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The predominant ocular feature of CS is interstitial keratitis (IK), which typically causes eye redness, pain, photophobia, and blurred vision. Slit-lamp examination commonly demonstrates a patchy, deep, granular corneal infiltrate. IK is not essential for the diagnosis; ocular inflammation may involve other parts of the eye and may lead to iridocyclitis, conjunctivitis, episcleritis, anterior or posterior scleritis, or retinal vasculitis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Ocular disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The inner ear manifestations of CS are Meniere-like attacks consisting of vertigo, ataxia, nausea, vomiting, tinnitus, and hearing loss. Vestibular dysfunction may also cause oscillopsia, and caloric testing often reveals absent vestibular function. Recurrent episodes of inner ear disease frequently result in profound sensorineural hearing loss. Noninflammatory down-fluctuations in hearing may be difficult to distinguish from those of inflammatory origin. If hearing loss is associated with eye inflammation or other features of active CS or does not resolve within three to five days, an inflammatory origin is more likely. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Inner ear disease'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When present, the systemic vasculitis associated with CS is a large- or medium- to small-sized vessel vasculitis or an aortitis. The pattern of vessel involvement may be overlapping. Other systemic manifestations of CS include fever, fatigue, weight loss, lymphadenopathy, hepatomegaly, hepatitis, splenomegaly, pulmonary nodules, pericarditis, abdominal pain, arthralgia, arthritis, myalgia, and urticaria. An association with inflammatory bowel disease has also been observed. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Systemic vasculitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H9\">",
"       'Other findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Evaluation of the patient with possible Cogan&rsquo;s syndrome requires ophthalmologic examination to establish the presence of interstitial keratitis, scleritis, or episcleritis and to exclude other diseases and ocular pathology; neurologic and otologic examination to establish the presence of vestibuloauditory abnormalities; and rheumatologic examination to seek evidence of systemic vasculitis. We diagnose CS based upon the presence of characteristic inflammatory eye disease and vestibuloauditory dysfunction. The eye and inner ear are nearly equally likely to be the cause of presenting symptoms, while less than 5 percent of patients initially present with systemic manifestations. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical features'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Evaluation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of CS includes diverse conditions that cause similar eye and inner ear manifestations, such as sarcoidosis, polyarteritis nodosa, granulomatosis with polyangiitis (Wegener&rsquo;s), and rheumatoid arthritis. Other diagnostic possibilities include the infectious causes of interstitial keratitis and a syndrome of subacute encephalopathy, sensorineural hearing loss, and retinal arteriolar occlusions in young adults that is due to an occlusive nonvasculitic vasculopathy. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Therapeutic options for the treatment of CS include the use of topical agents for limited (usually anterior) ocular disease and systemic immunosuppressive therapy for more extensive (usually posterior) ocular disease, inner ear involvement,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      systemic vasculitis. Immunosuppressive therapy typically includes glucocorticoids, and additional immunosuppressive therapy, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      , may be required depending upon the severity of disease and upon the nature of organ system involvement. Surgical bypass grafting or aortic valve replacement may be required in some patients. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Systemic vasculitis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Ocular disease'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H16\">",
"       'Anterior ocular inflammation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Posterior ocular inflammation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In a newly diagnosed patient with CS, we treat compromised auditory acuity or vestibular dysfunction with a therapeutic trial of systemic glucocorticoids. Glucocorticoid-sparing immunosuppressive therapy, such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"       methotrexate",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/3/38967?source=see_link\">",
"       azathioprine",
"      </a>",
"      , may also be required. We generally treat acute vestibular dysfunction using antihistamines (such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/17/37141?source=see_link\">",
"       meclizine",
"      </a>",
"      hydrochloride) or benzodiazepines, as well as bedrest. Recurrent vestibular dysfunction is virtually always accompanied by hearing loss and should be treated using glucocorticoids and, if needed, glucocorticoid-sparing therapy. Chronic vestibular dysfunction should be treated with antihistamines, benzodiazepines, and vestibular therapy. Cochlear implants have been beneficial in patients with severe hearing loss who have not responded to pharmacologic therapy. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Inner ear disease'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H19\">",
"       'Vestibular dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/1\">",
"      Cogan DS. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol 1945; 33:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/2\">",
"      Haynes BF, Kaiser-Kupfer MI, Mason P, Fauci AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) 1980; 59:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/3\">",
"      Vollertsen RS, McDonald TJ, Younge BR, et al. Cogan's syndrome: 18 cases and a review of the literature. Mayo Clin Proc 1986; 61:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/4\">",
"      St Clair EW, McCallum RM. Cogan's syndrome. Curr Opin Rheumatol 1999; 11:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/5\">",
"      FISHER ER, HELLSTROM HR. Cogan's syndrome and systemic vascular disease. Analysis of pathologic features with reference to its relationship to thromboangiitis obliterans (Buerger). Arch Pathol 1961; 72:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/6\">",
"      Rarey KE, Bicknell JM, Davis LE. Intralabyrinthine osteogenesis in Cogan's syndrome. Am J Otolaryngol 1986; 7:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/7\">",
"      Schuknecht HF, Nadol JB Jr. Temporal bone pathology in a case of Cogan's syndrome. Laryngoscope 1994; 104:1135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/8\">",
"      Negroni L, Tiberio G. [Cogan's syndrome]. Riv Otoneurooftalmol 1969; 44:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/9\">",
"      Cochrane AD, Tatoulis J. Cogan's syndrome with aortitis, aortic regurgitation, and aortic arch vessel stenoses. Ann Thorac Surg 1991; 52:1166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/10\">",
"      Livingston JZ, Casale AS, Hutchins GM, Shapiro EP. Coronary involvement in Cogan's syndrome. Am Heart J 1992; 123:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/11\">",
"      Allen NB, Cox CC, Cobo M, et al. Use of immunosuppressive agents in the treatment of severe ocular and vascular manifestations of Cogan's syndrome. Am J Med 1990; 88:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/12\">",
"      Gelfand ML, Kantor T, Gorstein F. Cogan's syndrome with cardiovascular involvement: aortic insufficiency. Bull N Y Acad Med 1972; 48:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/13\">",
"      EISENSTEIN B, TAUBENHAUS M. Nonsyphilitic interstitial keratitis and bilateral deafness (Cogan's syndrome) associated with cardiovascular disease. N Engl J Med 1958; 258:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/14\">",
"      Pinals RS. Cogan's syndrome with arthritis and aortic insufficiency. J Rheumatol 1978; 5:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/15\">",
"      Lunardi C, Bason C, Leandri M, et al. Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome. Lancet 2002; 360:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/16\">",
"      McCallum RM, Allen NB, Cobo LM, et al. Cogan's syndrome: Clinical features and outcomes (abstract). Arthritis Rheum 1992; 35(Suppl):S51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/17\">",
"      Gluth MB, Baratz KH, Matteson EL, Driscoll CL. Cogan syndrome: a retrospective review of 60 patients throughout a half century. Mayo Clin Proc 2006; 81:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/18\">",
"      Podder S, Shepherd RC. Cogan's syndrome: a rare systemic vasculitis. Arch Dis Child 1994; 71:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/19\">",
"      Fidler H, Jones NS. Late onset Cogan's syndrome. J Laryngol Otol 1989; 103:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/20\">",
"      Kasap&ccedil;opur O, Ashraf M, Caliskan S, et al. Cogan's syndrome: a rare vasculitis in childhood. J Rheumatol 2000; 27:1824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/21\">",
"      Cobo LM, Haynes BF. Early corneal findings in Cogan's syndrome. Ophthalmology 1984; 91:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/22\">",
"      Cogan DG, Kuwabara T. Late corneal opacities in the syndrome of interstitial keratitis and vestibulo-auditory symptoms. Acta Ophthalmol Suppl 1989; 192:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/23\">",
"      Shah P, Luqmani RA, Murray PI, et al. Posterior scleritis--an unusual manifestation of Cogan's syndrome. Br J Rheumatol 1994; 33:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/24\">",
"      Mazlumzadeh M, Matteson EL. Cogan's syndrome: an audiovestibular, ocular, and systemic autoimmune disease. Rheum Dis Clin North Am 2007; 33:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/25\">",
"      Grasland A, Pouchot J, Hachulla E, et al. Typical and atypical Cogan's syndrome: 32 cases and review of the literature. Rheumatology (Oxford) 2004; 43:1007.",
"     </a>",
"    </li>",
"    <li>",
"     McCallum RM, Haynes BF. Cogan's syndrome. In: Ocular Infection &amp; Immunity, 1st, Pepose JS, Holland GN, Wilhelmus KR (Eds), Mosby, St. Louis 1996. p.446.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/27\">",
"      Hammer M, Witte T, M&uuml;gge A, et al. Complicated Cogan's syndrome with aortic insufficiency and coronary stenosis. J Rheumatol 1994; 21:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/28\">",
"      Cremer J, Laas J, Heublein B. A case of coronary stenosis developing after successful aortic valve repair in Cogan's syndrome. Thorac Cardiovasc Surg 1993; 41:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/29\">",
"      Tseng JF, Cambria RP, Aretz HT, Brewster DC. Thoracoabdominal aortic aneurysm in Cogan's syndrome. J Vasc Surg 1999; 30:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/30\">",
"      Raza K, Karokis D, Kitas GD. Cogan's syndrome with Takayasu's arteritis. Br J Rheumatol 1998; 37:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/31\">",
"      Vella JP, O'Callaghan J, Hickey D, Walshe JJ. Renal artery stenosis complicating Cogan's syndrome. Clin Nephrol 1997; 47:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/32\">",
"      Vollertsen RS. Vasculitis and Cogan's syndrome. Rheum Dis Clin North Am 1990; 16:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/33\">",
"      Jacob A, Ledingham JG, Kerr AI, Ford MJ. Ulcerative colitis and giant cell arteritis associated with sensorineural deafness. J Laryngol Otol 1990; 104:889.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/34\">",
"      Thomas HG. Case report: clinical and radiological features of Cogan's syndrome--non-syphilitic interstitial keratitis, audiovestibular symptoms and systemic manifestations. Clin Radiol 1992; 45:418.",
"     </a>",
"    </li>",
"    <li>",
"     McCallum RM. Cogan's syndrome. In: Current Ocular Therapy, 4th, Franunfelder FT, Hampton R (Eds), WB Saunders, Philadelphia 1993. p.410.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/36\">",
"      Darougar S, John AC, Viswalingam M, et al. Isolation of Chlamydia psittaci from a patient with interstitial keratitis and uveitis associated with otological and cardiovascular lesions. Br J Ophthalmol 1978; 62:709.",
"     </a>",
"    </li>",
"    <li>",
"     Chandler RD. Inclusion conjunctivitis (paratrachoma, chlamydia). In: Current Ocular Therapy, 4th, Fraunfelder FT, Roy FH, Grove J (Eds), WB Saunders, Philadelphia 1995. p.59.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/38\">",
"      Dev S, McCallum RM, Jaffe GJ. Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology 1999; 106:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/39\">",
"      Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am J Med 1977; 63:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/40\">",
"      Haynes DS, O'Malley M, Cohen S, et al. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2007; 117:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/41\">",
"      Riente L, Taglione E, Berrettini S. Efficacy of methotrexate in Cogan's syndrome. J Rheumatol 1996; 23:1830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/42\">",
"      Pouchot J, Vinceneux P, Bouccara D, et al. Methotrexate as a steroid-sparing agent in Cogan's syndrome: comment on the concise communication by Richardson. Arthritis Rheum 1995; 38:1348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/43\">",
"      Roat MI, Thoft RA, Thomson AW, et al. Treatment of Cogan's syndrome with FK 506: a case report. Transplant Proc 1991; 23:3347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/44\">",
"      Matteson EL, Tirzaman O, Facer GW, et al. Use of methotrexate for autoimmune hearing loss. Ann Otol Rhinol Laryngol 2000; 109:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/45\">",
"      Xie L, Cai Y, Bao X, Cao L. Leflunomide for the successful management of juvenile Cogan's syndrome. Clin Rheumatol 2009; 28:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/46\">",
"      Peters BR, Wyss J, Manrique M. Worldwide trends in bilateral cochlear implantation. Laryngoscope 2010; 120 Suppl 2:S17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/47\">",
"      Wang JR, Yuen HW, Shipp DB, et al. Cochlear implantation in patients with autoimmune inner ear disease including cogan syndrome: a comparison with age- and sex-matched controls. Laryngoscope 2010; 120:2478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12968/abstract/48\">",
"      Coelho DH, Lalwani AK. Medical management of M&eacute;ni&egrave;re's disease. Laryngoscope 2008; 118:1099.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8227 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-61.234.146.186-F0BCE44B44-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12968=[""].join("\n");
var outline_f12_42_12968=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24863832\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Ocular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Inner ear disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Systemic vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other findings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Systemic vasculitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Ocular disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Anterior ocular inflammation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Posterior ocular inflammation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Inner ear disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Vestibular dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24863832\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/8227\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8227|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?33/17/34079\" title=\"diagnostic image 1\">",
"      Interstitial keratitis Cogans",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/48/24320\" title=\"diagnostic image 2\">",
"      Posterior scleritis in Cogans",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8227|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/10/41134\" title=\"figure 1A\">",
"      Audiograms in Cogans I",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/53/12127\" title=\"figure 1B\">",
"      Audiograms in Cogans II",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8227|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/16/22796\" title=\"table 1\">",
"      Differential diagnosis Cogans",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32057?source=related_link\">",
"      Approach to the patient with vertigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/19/13624?source=related_link\">",
"      Clinical features and diagnosis of Takayasu arteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/62/17386?source=related_link\">",
"      Clinical manifestations and diagnosis of granulomatosis with polyangiitis (Wegener's) and microscopic polyangiitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/25/21914?source=related_link\">",
"      Clinical manifestations and diagnosis of sarcoidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/31/17914?source=related_link\">",
"      Congenital syphilis: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/17/20760?source=related_link\">",
"      Conjunctivitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/12/17607?source=related_link\">",
"      Evaluation of the red eye",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/29/28119?source=related_link\">",
"      Treatment and prognosis of polyarteritis nodosa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/40/5767?source=related_link\">",
"      Tuberculosis and the eye",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_42_12969="Cutaneous arteriovenous malformation";
var content_f12_42_12969=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83553%7EDERM%2F83576%7EDERM%2F83577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83553%7EDERM%2F83576%7EDERM%2F83577&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Cutaneous arteriovenous malformation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Arteriovenous malformation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Arteriovenous malformation of the hand",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12969=[""].join("\n");
var outline_f12_42_12969=null;
var title_f12_42_12970="Pneumococcal meningitis in children";
var content_f12_42_12970=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pneumococcal meningitis in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/42/12970/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/42/12970/contributors\">",
"     Elaine I Tuomanen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/42/12970/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/42/12970/contributors\">",
"     Sheldon L Kaplan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/42/12970/contributors\">",
"     Douglas R Nordli, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/42/12970/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/42/12970/contributors\">",
"     Mary M Torchia, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/42/12970/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 25, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meningitis is an inflammatory disease of the leptomeninges, the tissues surrounding the brain and spinal cord. The meninges consist of three parts: the pia, arachnoid, and dura mater. Meningitis reflects inflammation of the arachnoid mater and the cerebrospinal fluid (CSF) in both the subarachnoid space and in the cerebral ventricles.",
"   </p>",
"   <p>",
"    Suspected bacterial meningitis is a medical emergency, and immediate diagnostic steps must be taken to establish the specific cause so that appropriate antimicrobial therapy can be initiated. The mortality rate of untreated bacterial meningitis approaches 100 percent, and even with optimal therapy, morbidity and mortality may occur. Neurologic sequelae are common among survivors.",
"    <em>",
"     Streptococcus pneumoniae",
"    </em>",
"    is one of the most common causes of acute bacterial meningitis.",
"   </p>",
"   <p>",
"    This topic will review meningitis caused by",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    (pneumococcal meningitis). The pathogenesis, epidemiology, clinical features, complications, diagnosis, and treatment of bacterial meningitis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/41/38549?source=see_link\">",
"     \"Pathogenesis and pathophysiology of bacterial meningitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Bacterial meningitis in infants younger than one month of age and bacterial meningitis in adults also are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=see_link\">",
"     \"Clinical features and diagnosis of bacterial meningitis in the neonate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/47/16121?source=see_link\">",
"     \"Treatment and outcome of bacterial meningitis in the neonate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=see_link\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=see_link\">",
"     \"Initial therapy and prognosis of bacterial meningitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=see_link\">",
"     \"Treatment of bacterial meningitis caused by specific pathogens in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    is the most common cause of bacterial meningitis in infants and children older than one month of age. Despite prompt and appropriate care, it remains an important cause of childhood morbidity and mortality. (See",
"    <a class=\"local\" href=\"#H31\">",
"     'Outcome'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The incidence of pneumococcal meningitis declined significantly after the pneumococcal conjugate vaccine was added to the universal infant immunization schedule in the United States and other developed countries [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/1-7\">",
"     1-7",
"    </a>",
"    ]. Population-based surveillance data from the United States indicate that the greatest decline occurred in children younger than two years (from 10.2 to 3.7 cases per 100,000 between 1998-1999 and 2004-2005, a decline of 64 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After the introduction of the heptavalent pneumococcal conjugate vaccine (PCV7), there was an increase in the proportion of cases of pneumococcal meningitis caused by serotypes not contained in the vaccine, particularly among children younger than two years [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. In population-based surveillance (1998-2007), serotypes 19A, 7F, 10A, and 22F were the most common non-PCV7 serotypes isolated from children with pneumococcal meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/7\">",
"     7",
"    </a>",
"    ]. Approximately 60 percent of cases were caused by serotypes contained in PCV13 (",
"    <a class=\"graphic graphic_table graphicRef77274 \" href=\"UTD.htm?14/59/15293\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The impact of the pneumococcal conjugate vaccine on invasive pneumococcal disease, antibiotic resistance, and nasopharyngeal carriage of pneumococcus is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/37/601?source=see_link\">",
"     \"Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain children are at increased risk for invasive pneumococcal disease, including meningitis (",
"    <a class=\"graphic graphic_table graphicRef68655 \" href=\"UTD.htm?6/13/6364\">",
"     table 2",
"    </a>",
"    ). Approximately 10 to 20 percent of children who develop pneumococcal meningitis have an underlying condition [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/4,8\">",
"     4,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In children younger than six months of age, low birth weight and exposure to siblings or other children at day care is associated with increased risk of invasive pneumococcal disease [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/9\">",
"     9",
"    </a>",
"    ]. In children between 6 and 23 months, the risk of invasive pneumococcal disease is increased during the first two months after enrollment in day care, but declines after attendance for at least six months.",
"   </p>",
"   <p>",
"    The risk of meningitis among cochlear implant recipients is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35913?source=see_link&amp;anchor=H4#H4\">",
"     \"Cochlear implant infections\", section on 'Risk of meningitis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of bacterial meningitis and of",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    infection are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/41/38549?source=see_link\">",
"     \"Pathogenesis and pathophysiology of bacterial meningitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23143?source=see_link\">",
"     \"Microbiology and pathogenesis of Streptococcus pneumoniae\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Summarized briefly, bacterial meningitis usually arises in the context of sustained bacteremia that permits bacterial localization to and transit across the blood-brain barrier (BBB) into the subarachnoid space. The central pathologic event in meningitis is breakdown of the BBB.",
"   </p>",
"   <p>",
"    Bacteria penetrate from the blood across the tight junctions of the cerebral vessels and multiply upon entry into the cerebrospinal fluid (CSF), a site sequestered from host defenses. Once in the CSF space, multiplication of bacteria results in release of cell wall components and toxins (pneumolysin and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?40/41/41617?source=see_link\">",
"     hydrogen peroxide",
"    </a>",
"    ). Bacterial surface fragments, including cell wall, incite direct host-cell toxicity and the release of a broad range of cytokines that serve to increase inflammation, alter vascular permeability, and induce influx of leukocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Over a period of hours, gaps are opened between endothelial cells, pinocytotic activity increases, leukocytes are recruited to the CSF, and cytochemical parameters in CSF change [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Injury to the cerebral microvasculature promotes brain edema that in turn leads to intracranial hypertension. In addition, oxygen and nitrogen intermediates released by the inflammatory process cause loss of autoregulation of cerebral vascular perfusion pressure with resultant ischemia [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/13\">",
"     13",
"    </a>",
"    ]. The precise events that lead to neuronal damage remain unclear, but both direct toxicity and injury from host-derived inflammation are involved [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Bacterial labyrinthitis can lead to sensorineural hearing loss, one of the most common sequelae of pneumococcal meningitis. Labyrinthitis can occur as bacteria reach the cochlea via the cochlear aqueduct from the subarachnoid space. Alternatively, bacteria may travel with the eighth cranial nerve in the internal auditory canal. The subsequent infection and inflammation lead to loss of hair cells, calcification of the perilymphatic channels,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    damage to the auditory nerve, which can result in varying degrees of hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/15\">",
"     15",
"    </a>",
"    ]. A mouse model of pneumococcal meningitis suggested a role for the Toll-like receptor-associated adapter molecule MyD88 in the development of cochlear inflammation and hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=see_link&amp;anchor=H10#H10\">",
"     \"Neurologic complications of bacterial meningitis in children\", section on 'Hearing loss'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical features of pneumococcal meningitis are similar to those of other types of bacterial meningitis, which are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Symptoms and signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with bacterial meningitis present with fever and symptoms and signs of meningeal inflammation, often preceded by symptoms of upper respiratory tract infection. Symptoms and signs of meningeal inflammation include nausea, vomiting, irritability, anorexia, headache, confusion, back pain, and nuchal rigidity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations of bacterial meningitis are variable and nonspecific; no single sign is pathognomonic [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. The symptoms and signs depend, to some extent, upon the duration of illness, the host response to infection, and the age of the child [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In infants, the clinical manifestations may include fever, hypothermia, lethargy, respiratory distress, jaundice, poor feeding, vomiting, diarrhea, seizures, restlessness, irritability,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bulging fontanel [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. In older children, clinical manifestations may include fever, headache, photophobia, nausea, vomiting, confusion, lethargy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    irritability [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 20 percent of children have a seizure before diagnosis; seizures before diagnosis are typically generalized (76 percent of preadmission seizures in one series) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/8\">",
"     8",
"    </a>",
"    ]. Advanced illness is characterized by lethargy, dehydration, or signs of septic shock.",
"   </p>",
"   <p>",
"    Examination findings may include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nuchal rigidity.",
"     </li>",
"     <li>",
"      Kernig sign. Kernig sign is present if the patient, in the supine position with the hip and knee flexed at 90&ordm;, cannot extend the knee more than 135&ordm;",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      there is flexion of the opposite knee.",
"     </li>",
"     <li>",
"      Brudzinksi sign. Brudzinski sign is present if the patient, while in the supine position, flexes the lower extremities during attempted passive flexion of the neck.",
"     </li>",
"     <li>",
"      Altered mental state (eg, irritability, lethargy, obtundation, coma); in the multicenter pneumococcal meningitis surveillance study, 11 percent of patients were comatose at the time of admission [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Shock or disseminated intravascular coagulation (present in 16 and 11 percent of patients in the multicenter pneumococcal meningitis surveillance study, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Focal neurologic signs (eg, hemiparesis, quadriparesis, facial palsy, visual field defects).",
"     </li>",
"     <li>",
"      Signs of increased intracranial pressure (eg, bulging or tense fontanel, sixth cranial nerve [abducens] palsy) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/19\">",
"       19",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=see_link\">",
"       \"Elevated intracranial pressure in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Petechial or purpuric rash (such a rash is more characteristic of meningococcal disease, but may occur in children with pneumococcal meningitis).",
"     </li>",
"     <li>",
"      Another focus of infection (eg, otitis media, pneumonia, mastoiditis,",
"      <span class=\"nowrap\">",
"       pericarditis/endocarditis).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Compared with children with other causes of bacterial meningitis, those with pneumococcal meningitis are more likely to have focal neurologic findings and to be semicomatose or comatose at the time of presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations of bacterial meningitis are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Clinical features'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Laboratory features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain laboratory findings are characteristic of bacterial meningitis and are present in most cases. These include (",
"    <a class=\"graphic graphic_table graphicRef76324 \" href=\"UTD.htm?13/55/14204\">",
"     table 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CSF pleocytosis with a predominance of neutrophils; the normal CSF WBC count is usually &lt;6",
"      <span class=\"nowrap\">",
"       WBC/microL",
"      </span>",
"      in children older than three months of age",
"     </li>",
"     <li>",
"      Elevated CSF protein; the normal CSF protein is &lt;50",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"     </li>",
"     <li>",
"      Decreased CSF glucose, or ratio of CSF to blood glucose",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the specific case of pneumococcal meningitis, the diagnosis is established by:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Isolation of",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      from the CSF culture or with rapid diagnostic techniques.",
"     </li>",
"     <li>",
"      The presence of gram-positive diplococci on CSF Gram stain (",
"      <a class=\"graphic graphic_picture graphicRef72926 \" href=\"UTD.htm?10/49/11039\">",
"       picture 1",
"      </a>",
"      ). The Gram stain is positive in approximately 90 percent of children with pneumococcal meningitis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications that can occur during therapy for bacterial meningitis include seizures, increased ICP, cerebral edema, ischemia, hearing loss, and subdural effusion. Hearing loss in children is two to three times more common with pneumococcal meningitis than other forms of bacterial meningitis. These complications are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, pneumococcal pneumonia has been associated with atypical hemolytic uremic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/52/43849?source=see_link&amp;anchor=H5#H5\">",
"     \"Atypical hemolytic uremic syndrome in children\", section on 'Streptococcus pneumoniae'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The laboratory evaluation of children with suspected bacterial meningitis is discussed separately (",
"    <a class=\"graphic graphic_algorithm graphicRef74865 \" href=\"UTD.htm?34/44/35521\">",
"     algorithm 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H16#H16\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Laboratory evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Summarized briefly, the laboratory evaluation of a child with suspected bacterial meningitis should include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cerebrospinal fluid (CSF) examination (cell count and differential, glucose and protein concentration, Gram stain, and culture). Analysis of the CSF is critical to the diagnosis of meningitis and the differentiation of bacterial from other etiologies (",
"      <a class=\"graphic graphic_table graphicRef76324 \" href=\"UTD.htm?13/55/14204\">",
"       table 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/22\">",
"       22",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Contraindications to lumbar puncture (LP) and the need for imaging before LP are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/1/25625?source=see_link&amp;anchor=H6#H6\">",
"       \"Lumbar puncture: Indications, contraindications, technique, and complications in children\", section on 'Contraindications'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H28#H28\">",
"       \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Imaging'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Two aerobic blood cultures of appropriate volume. In one prospective study, blood cultures were positive in 52 percent of children with pneumococcal meningitis overall, and in 80 percent of children with pneumococcal meningitis who had not received antibiotics before blood cultures were obtained [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Blood chemistries and glucose (to assess the ratio of CSF glucose to blood glucose and to help in decisions regarding fluid management). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H11#H11\">",
"       \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Fluid management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Complete blood count (CBC) with differential and platelet count; evaluation of clotting function (prothrombin time, partial thromboplastin time) is especially indicated if petechiae or purpuric lesions are noted.",
"     </li>",
"     <li>",
"      Rapid diagnostic tests should be reserved for cases in which the initial CSF Gram stain is negative and culture is negative at 48 hours of incubation [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/24\">",
"       24",
"      </a>",
"      ]. In the multicenter pneumococcal meningitis surveillance study, latex agglutination was positive in 66 percent of 74 CSF samples that grew",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      and in four CSF samples that were culture negative [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/8\">",
"       8",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      A rapid immunochromatographic test (ICT) for",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      was evaluated in 450 children with suspected bacterial meningitis, 346 with eventual diagnosis of pyogenic meningitis and 122 with eventual diagnosis of pneumococcal meningitis [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/25\">",
"       25",
"      </a>",
"      ]. Compared with CSF culture, latex agglutination,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      polymerase chain reaction, ICT was 100 percent sensitive and specific for the diagnosis of pneumococcal meningitis. If these results are replicated in other studies, ICT may be helpful in guiding the appropriate selection of antibiotics in resource-poor communities.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of pneumococcal meningitis requires growth of",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    in cerebrospinal fluid (CSF) culture; or identification of",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    on Gram stain (",
"    <a class=\"graphic graphic_picture graphicRef72926 \" href=\"UTD.htm?10/49/11039\">",
"     picture 1",
"    </a>",
"    ) or with rapid diagnostic techniques; or a positive blood culture in a patient with CSF pleocytosis.",
"   </p>",
"   <p>",
"    The CSF culture may be negative in children who received antibiotic therapy before CSF examination. In such children, increased CSF white blood cell (WBC) count and elevated CSF protein concentration usually are sufficient to establish the diagnosis of meningitis; blood cultures",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    rapid diagnostic tests may help to identify pneumococcus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Serotype of isolate",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children younger than five years who develop pneumococcal meningitis despite having received at least one dose of pneumococcal conjugate vaccine, the pneumococcal isolate should be serotyped if possible [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26\">",
"     26",
"    </a>",
"    ]. Most cases of pneumococcal meningitis that have occurred in such children have been caused by serotypes that are not included in the vaccine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     REPORTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumococcal meningitis in children younger than five years should be reported according to state standards [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26\">",
"     26",
"    </a>",
"    ]. In addition, children who develop pneumococcal meningitis despite having received at least one dose of pneumococcal conjugate vaccine should be reported to the Centers for Disease Control and Prevention through the state health department.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     OVERVIEW OF TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;General aspects of the treatment of bacterial meningitis in children are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Supportive care",
"    </span>",
"    &nbsp;&mdash;&nbsp;Supportive care for children with bacterial meningitis, including fluid management and monitoring, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Supportive care'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Isolation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children admitted to the hospital with suspected pneumococcal meningitis should be placed on standard precautions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link&amp;anchor=H2#H2\">",
"     \"General principles of infection control\", section on 'Standard precautions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Dexamethasone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to neurologic sequelae after bacterial meningitis and the possible role of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    therapy to minimize these complications are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=see_link\">",
"     \"Neurologic complications of bacterial meningitis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/21/4442?source=see_link&amp;anchor=H3#H3\">",
"     \"Dexamethasone and other measures to prevent neurologic complications of bacterial meningitis in children\", section on 'Dexamethasone'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    in children with pneumococcal meningitis (or suspected pneumococcal meningitis) is controversial.",
"   </p>",
"   <p>",
"    We suggest that decisions regarding the use of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    in children with pneumococcal meningitis, or in those in whom bacterial meningitis is suspected but the etiology unknown, be individualized based on careful analysis of the potential risks and benefits. The author of this topic review uses dexamethasone for all patients with possible pneumococcal meningitis (eg, those &ge;6 weeks and &le;5 years of age with community-acquired meningitis, even if they have been vaccinated; those with sickle cell disease or hyposplenism). In the same patients, other experts may choose not to use dexamethasone. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/21/4442?source=see_link&amp;anchor=H3#H3\">",
"     \"Dexamethasone and other measures to prevent neurologic complications of bacterial meningitis in children\", section on 'Dexamethasone'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The American Academy of Pediatrics (AAP) Committee on Infectious Diseases suggests that",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    therapy be considered for infants and children older than six weeks with pneumococcal meningitis after weighing the potential risks and benefits [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ANTIBIOTIC THERAPY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Antibiotic resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Penicillin-resistant",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    meningitis was first reported in 1974, but the emergence of widespread resistance worldwide has been increasingly recognized, including resistance to multiple antibiotics. The increasing prevalence of antibiotic-resistant",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    has important implications for the treatment of pneumococcal meningitis, as discussed below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/5/81?source=see_link\">",
"     \"Resistance of Streptococcus pneumoniae to beta-lactam antibiotics\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23143?source=see_link\">",
"     \"Microbiology and pathogenesis of Streptococcus pneumoniae\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Empiric therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Empiric antimicrobial therapy should be initiated immediately after the results of the lumbar puncture (LP) have been obtained, or immediately after LP alone if the clinical suspicion is high. For patients who require neuroimaging before LP, blood cultures should be obtained and empiric antibiotic therapy administered before the imaging study (",
"    <a class=\"graphic graphic_algorithm graphicRef74865 \" href=\"UTD.htm?34/44/35521\">",
"     algorithm 1",
"    </a>",
"    ). If",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    is to be administered, it should be given before or at the time of the first dose of empiric antimicrobial therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H28#H28\">",
"     \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Imaging'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H16\">",
"     'Dexamethasone'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Coverage for",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    should be included in the empiric antibiotic regimen for infants and children older than one month with suspected bacterial meningitis, since",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    is the most common cause of bacterial meningitis for this age group. This is true even for children who have completed immunization with the pneumococcal conjugate vaccine [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of the increasing prevalence of antibiotic-resistant strains of pneumococcus, the empiric regimen should include",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    until culture results are available and the isolated pathogen is confirmed to be susceptible to penicillin,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     cefotaxime",
"    </a>",
"    , or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    &nbsp;(",
"    <a class=\"graphic graphic_table graphicRef63881 \" href=\"UTD.htm?16/13/16605\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26,28,29\">",
"     26,28,29",
"    </a>",
"    ]. No pneumococcal isolates resistant to vancomycin have been reported; however, approximately 3 percent of isolates are tolerant to vancomycin [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/30\">",
"     30",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Vancomycin'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Empiric therapy for suspected bacterial meningitis in infants and children older than one month includes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26,31\">",
"     26,31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       Cefotaxime",
"      </a>",
"      300",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day intravenously (IV) (maximum dose 12",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      in 3 divided doses,",
"      <strong>",
"       or",
"      </strong>",
"      &nbsp;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      100",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV (maximum dose 4",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      in 1 or 2 divided doses,",
"      <strong>",
"       plus",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       Vancomycin",
"      </a>",
"      60",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV (maximum dose 4",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      in 4 divided doses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Concerns have been raised regarding the early administration of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    and adverse effects [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/32\">",
"     32",
"    </a>",
"    ]. We typically administer the third-generation cephalosporin first, followed immediately by vancomycin.",
"   </p>",
"   <p>",
"    Some experts would add",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"     rifampin",
"    </a>",
"    to the above regimen if",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    is administered [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/33\">",
"     33",
"    </a>",
"    ]. The addition of rifampin is reasonable in areas with pneumococcal isolates resistant to penicillin and cephalosporins, even if the frequency of such isolates is low.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Specific therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Empiric therapy can be altered when pneumococci are isolated from cerebrospinal fluid (CSF) culture and the antimicrobial susceptibility pattern is known (",
"    <a class=\"graphic graphic_table graphicRef63881 \" href=\"UTD.htm?16/13/16605\">",
"     table 4",
"    </a>",
"    ). The therapeutic options for pneumococcal meningitis are outlined in the table (",
"    <a class=\"graphic graphic_table graphicRef79959 \" href=\"UTD.htm?32/0/32780\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Penicillin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Penicillin therapy may be used for penicillin-susceptible isolates (MIC &le;0.06",
"    <span class=\"nowrap\">",
"     microgram/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?13/46/14054?source=see_link\">",
"       Penicillin G",
"      </a>",
"      300,000",
"      <span class=\"nowrap\">",
"       units/kg",
"      </span>",
"      per day IV in 4 to 6 divided doses",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Cephalosporins",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     Cefotaxime",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    can be used alone if the MIC for these drugs is &lt;0.5",
"    <span class=\"nowrap\">",
"     microgram/mL.",
"    </span>",
"    Although some retrospective studies have advocated cephalosporin therapy for MICs up to 1.0",
"    <span class=\"nowrap\">",
"     microgram/mL",
"    </span>",
"    for cefotaxime, some authors advise a lower breakpoint [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/34\">",
"     34",
"    </a>",
"    ]. Cefotaxime and ceftriaxone can attain levels of only 3 to 8",
"    <span class=\"nowrap\">",
"     microgram/mL",
"    </span>",
"    in the CSF and achieve reliable bactericidal activity only if the MIC is &le;0.5",
"    <span class=\"nowrap\">",
"     microgram/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/35\">",
"     35",
"    </a>",
"    ]. The doses for these agents are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       Cefotaxime",
"      </a>",
"      300",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day (maximum dose 12",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      in 3 or 4 divided doses",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"       Ceftriaxone",
"      </a>",
"      100",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day (maximum dose 4",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      in 1 or 2 divided doses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pneumococci with MICs &le;0.5",
"    <span class=\"nowrap\">",
"     microgram/mL",
"    </span>",
"    are considered susceptible to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     cefotaxime",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    &nbsp;(",
"    <a class=\"graphic graphic_table graphicRef63881 \" href=\"UTD.htm?16/13/16605\">",
"     table 4",
"    </a>",
"    ), and meningitis caused by such strains can be treated with either of these agents (",
"    <a class=\"graphic graphic_table graphicRef79959 \" href=\"UTD.htm?32/0/32780\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. Isolates with MICs &ge;2.0",
"    <span class=\"nowrap\">",
"     microgram/mL",
"    </span>",
"    to these antibiotics are considered resistant when associated with CNS infections (",
"    <a class=\"graphic graphic_table graphicRef63881 \" href=\"UTD.htm?16/13/16605\">",
"     table 4",
"    </a>",
"    ). Meningitis caused by isolates with intermediate susceptibility to cefotaxime or ceftriaxone (MIC = 1.0",
"    <span class=\"nowrap\">",
"     microgram/mL)",
"    </span>",
"    may not be treated optimally with extended-spectrum cephalosporins alone [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Vancomycin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     Vancomycin",
"    </a>",
"    achieves a mean concentration of 3.3",
"    <span class=\"nowrap\">",
"     microgram/mL",
"    </span>",
"    in the CSF of children with bacterial meningitis with or without concurrent",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    administration [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/38\">",
"     38",
"    </a>",
"    ]. Vancomycin should be included in the empiric antimicrobial regimen for children with suspected bacterial meningitis and continued (along with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     cefotaxime",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    ) for patients with isolates with MICs &gt;0.06",
"    <span class=\"nowrap\">",
"     microgram/mL",
"    </span>",
"    to penicillin and MICs &gt;0.5",
"    <span class=\"nowrap\">",
"     microgram/mL",
"    </span>",
"    to cefotaxime or ceftriaxone (",
"    <a class=\"graphic graphic_table graphicRef79959 \" href=\"UTD.htm?32/0/32780\">",
"     table 5",
"    </a>",
"    ). In a rabbit model of pneumococcal meningitis using an isolate resistant to ceftriaxone, the combination of vancomycin and ceftriaxone was superior to vancomycin alone [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 3 percent of pneumococcal isolates may be tolerant to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/30\">",
"     30",
"    </a>",
"    ]. Vancomycin-tolerant pneumococcus has been associated with treatment failure in at least one patient [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    is given,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"     rifampin",
"    </a>",
"    may be added as a third agent because it may increase the efficacy of the other two drugs [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/38\">",
"     38",
"    </a>",
"    ].",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     Vancomycin",
"    </a>",
"    and rifampin are dosed as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       Vancomycin",
"      </a>",
"      60",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV (maximum dose 4",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      in 4 divided doses",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"       Rifampin",
"      </a>",
"      20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV in 2 divided doses",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Rifampin",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"     Rifampin",
"    </a>",
"    also may be added to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    in selected patients if the isolate is susceptible to rifampin (",
"    <a class=\"graphic graphic_table graphicRef79959 \" href=\"UTD.htm?32/0/32780\">",
"     table 5",
"    </a>",
"    ); the addition of rifampin may be indicated in patients who have a particularly high MIC for the cephalosporins (&ge;4",
"    <span class=\"nowrap\">",
"     microgram/ML),",
"    </span>",
"    appear to be failing vancomycin, or continue to have organisms present at repeat LP [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H30\">",
"     'Treatment failure'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"       Rifampin",
"      </a>",
"      20",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV in 2 divided doses",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Other drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The role of other antibiotics in the treatment of meningitis caused by pneumococcal isolates resistant to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     cefotaxime",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    is unclear.",
"   </p>",
"   <p>",
"    The in vitro activity of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?2/24/2439?source=see_link\">",
"     meropenem",
"    </a>",
"    against pneumococcal isolates that are nonsusceptible to extended-spectrum cephalosporins has not been studied adequately [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/41\">",
"     41",
"    </a>",
"    ]. In a study from Memphis, pneumococcal isolates not susceptible or resistant to",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     cefotaxime",
"    </a>",
"    were likely to be nonsusceptible or resistant to meropenem [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/42\">",
"     42",
"    </a>",
"    ]. In two comparative trials of meropenem versus cefotaxime, only two patients received meropenem for pneumococcal meningitis caused by isolates with decreased susceptibility to cefotaxime [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. Furthermore, in one of the studies, more of the children in the meropenem group tended to have neurologic or audiologic abnormalities, although these differences did not achieve statistical significance.",
"   </p>",
"   <p>",
"    Newer-generation quinolones, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/51/33584?source=see_link\">",
"     moxifloxacin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/60/12231?source=see_link\">",
"     gemifloxacin",
"    </a>",
"    , with enhanced activity against pneumococci, are effective in animal models of antibiotic-resistant pneumococcal meningitis and may prove to be alternative agents for treating this infection in humans [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/45\">",
"     45",
"    </a>",
"    ]. Fluoroquinolones are not routinely recommended for use in children younger than the age of 18 years because of effects on growing cartilage in experimental animals. However, for serious infections such as meningitis, these drugs may be indicated if other agents cannot be used [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?4/35/4664?source=see_link\">",
"     Chloramphenicol",
"    </a>",
"    also has been used for patients with an allergy to penicillin and cephalosporin. Unfortunately, many penicillin-resistant strains are somewhat resistant to chloramphenicol killing (despite in vitro tests that show inhibition), and treatment failures of meningitis caused by penicillin-resistant",
"    <em>",
"     S. pneumoniae",
"    </em>",
"    have occurred when chloramphenicol was used [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/47\">",
"     47",
"    </a>",
"    ]. One series evaluated 25 children with pneumococcal meningitis treated with chloramphenicol whose isolates were sensitive to the drug in vitro; 20 (80 percent) had an adverse outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Duration",
"    </span>",
"    &nbsp;&mdash;&nbsp;In uncomplicated pneumococcal meningitis, parenteral antibiotics generally are administered for 10 to 14 days, and at least five afebrile days.",
"   </p>",
"   <p>",
"    The possibility of receiving a portion of the parenteral treatment course as an outpatient is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H34#H34\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Outpatient therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Response to therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The response to therapy is monitored clinically (eg, fever curve, resolution of symptoms and signs). Repeat examination of the spinal fluid or neuroimaging may be necessary in some patients. In bacteremic infants, a blood culture should be performed to document sterility of the blood stream. The follow-up blood culture is usually obtained when it is known that the initial blood culture is positive.",
"   </p>",
"   <p>",
"    In the multicenter study surveillance of pneumococcal meningitis, among 180 children with pneumococcal meningitis, the median duration of fever was three days (range 0 to 23 days) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/8\">",
"     8",
"    </a>",
"    ]. Secondary fevers (recurrence of fever after at least 24 hours without fever) developed in 34 patients overall, 52 percent of patients treated with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    , and 24 percent of those not treated with dexamethasone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Repeat LP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Repeat CSF analysis is not routinely indicated for patients with bacterial meningitis who have responded appropriately to antimicrobial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/33\">",
"     33",
"    </a>",
"    ]. However, repeat LP should be performed in any patient who is not improving as expected after 48 hours of antimicrobial therapy, particularly if he or she has a pneumococcal isolate with an MIC &ge;2",
"    <span class=\"nowrap\">",
"     microgram/mL",
"    </span>",
"    for penicillin,",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"     cefotaxime",
"    </a>",
"    , or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/33\">",
"     33",
"    </a>",
"    ]. In addition, the American Academy of Pediatrics Committee on Infectious Diseases suggests that repeat LP be considered in children who have received",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"     dexamethasone",
"    </a>",
"    therapy, as dexamethasone may interfere with the ability to interpret the clinical response [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neuroimaging (with CT or MRI) may be indicated during the course of treatment in the following circumstances [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/20\">",
"     20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Focal neurologic signs; increasing head circumference; or prolonged obtundation, irritability, or seizures (&gt;72 hours after the start of treatment)",
"     </li>",
"     <li>",
"      Persistently positive CSF cultures despite appropriate antibiotic therapy",
"     </li>",
"     <li>",
"      Persistent elevation of CSF neutrophils at the completion of standard duration of therapy (more than 30 to 40 percent)",
"     </li>",
"     <li>",
"      Recurrent meningitis (to evaluate the possibility of a communication between the nasal passage or ear and the meninges; sectional [2 mm] coronal cranial CT is a relatively easy, noninvasive means of delineating anatomic abnormalities in children with recurrent meningitis) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/49\">",
"       49",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Treatment failure",
"    </span>",
"    &nbsp;&mdash;&nbsp;If viable organisms are still present on repeat LP, the antimicrobial regimen should be changed as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26\">",
"     26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       Vancomycin",
"      </a>",
"      should be added to the regimen of patients who were being treated with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       cefotaxime",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"       ceftriaxone",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/52/17225?source=see_link\">",
"       Rifampin",
"      </a>",
"      should be added for patients who were being treated with",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       cefotaxime",
"      </a>",
"      or",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      (provided that the isolate is susceptible to rifampin) (",
"      <a class=\"graphic graphic_table graphicRef79959 \" href=\"UTD.htm?32/0/32780\">",
"       table 5",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pneumococcal meningitis is associated with increased rates of mortality and neurologic sequelae compared with",
"    <em>",
"     Haemophilus influenzae",
"    </em>",
"    or",
"    <em>",
"     Neisseria meningitidis",
"    </em>",
"    meningitis. Several case series have suggested that the outcome (mortality, length of hospital stay, and neurologic sequelae) is unrelated to the antibiotic susceptibility pattern of the isolate [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/8,50,51\">",
"     8,50,51",
"    </a>",
"    ]. However, the power of these studies is limited by the small numbers of patients with nonsusceptible strains and initial treatment with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"     vancomycin",
"    </a>",
"    in a majority of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;The case-fatality rate for pneumococcal meningitis is greater than that for meningococcal or",
"    <em>",
"     H. influenzae",
"    </em>",
"    meningitis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/7\">",
"     7",
"    </a>",
"    ]. The mortality rate for pneumococcal meningitis in children in developed countries is approximately 8 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/4,7,8,52\">",
"     4,7,8,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mortality is increased in children who are comatose or in shock at the time of admission and in those who require mechanical ventilation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/8,53,54\">",
"     8,53,54",
"    </a>",
"    ] In population-based surveillance in the United States (1998-2007), mortality was similar among children with meningitis caused by PCV7 (10.7 percent) and nonPCV7 (7.6 percent) serogroups [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Neurologic sequelae",
"    </span>",
"    &nbsp;&mdash;&nbsp;In approximately one-half of survivors, pneumococcal meningitis is associated with a broad spectrum of long-term neurologic sequelae, including motor handicaps, seizures, intellectual disability (mental retardation), impairment of hearing, and loss of cognitive functions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/52,55-57\">",
"     52,55-57",
"    </a>",
"    ]. In one large series of children, for example, 32 percent had moderate to severe unilateral or bilateral hearing loss at discharge, and 25 percent developed motor deficits [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the multicenter study of surveillance of pneumococcal meningitis, the rate of neurologic sequelae was greater among children who had seizures more than 72 hours after hospital admission than for those with no seizures or none beyond 72 hours (44 versus 7 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/8\">",
"     8",
"    </a>",
"    ]. In a single-institution case series, the rate of neurologic sequelae was similar in children with meningitis caused by vaccine and vaccine serogroups [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The poor outcome of pneumococcal meningitis may result in part from the persistence of potent biologic activity in the debris of killed bacteria [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/59\">",
"     59",
"    </a>",
"    ]. The vast amount of debris produced abruptly by antibiotics greatly stimulates the host inflammatory response, which contributes to continuing tissue damage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children who have been treated for pneumococcal meningitis should undergo hearing evaluation at the time of, or shortly after, discharge. They should also be followed closely for other neurologic sequelae, including gross motor and cognitive impairment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H44#H44\">",
"     \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children who develop pneumococcal meningitis with a vaccine serotype despite having received at least one dose of pneumococcal conjugate vaccine may have an underlying immunodeficiency. However, pneumococcal meningitis is rarely the sole manifestation of the underlying problem. The American Academy of Pediatrics Committee on Infectious Diseases suggests that evaluation of the immunologic and HIV status of such children may be warranted [",
"    <a class=\"abstract\" href=\"UTD.htm?12/42/12970/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of pneumococcal meningitis in children can be reduced through universal immunization of infants with the pneumococcal conjugate vaccine and the immunization of unimmunized high-risk patients (",
"    <a class=\"graphic graphic_table graphicRef68655 \" href=\"UTD.htm?6/13/6364\">",
"     table 2",
"    </a>",
"    ) with the pneumococcal conjugate or polysaccharide vaccine as appropriate. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=see_link\">",
"     \"Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13926?source=see_link\">",
"     \"Pneumococcal (Streptococcus pneumoniae) polysaccharide vaccines in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chemoprophylaxis of contacts is not necessary to prevent the spread of pneumococcal meningitis. However, chemoprophylaxis is an important aspect of prevention of invasive pneumococcal infections in children with functional or anatomic asplenia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1177?source=see_link&amp;anchor=H11#H11\">",
"     \"Prevention of sepsis in the asplenic patient\", section on 'Antibiotic prophylaxis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/0/39946?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of the management of sickle cell disease\", section on 'Infection control and prophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <em>",
"       Streptococcus pneumoniae",
"      </em>",
"      is the most common cause of bacterial meningitis in children. Certain children are at increased risk for pneumococcal meningitis (",
"      <a class=\"graphic graphic_table graphicRef68655 \" href=\"UTD.htm?6/13/6364\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical features of pneumococcal meningitis are similar to those of other types of bacterial meningitis, which are discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=see_link&amp;anchor=H5#H5\">",
"       \"Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age\", section on 'Clinical features'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Most patients present with fever and symptoms and signs of meningeal inflammation, but no single sign is pathognomonic. Manifestations in infants may include fever, hypothermia, lethargy, respiratory distress, poor feeding, seizures, irritability,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bulging fontanel. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Symptoms and signs'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory features of pneumococcal meningitis include cerebrospinal fluid (CSF) pleocytosis with predominance of neutrophils, elevated CSF protein, decreased CSF glucose, isolation of",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      from the CSF by culture, and the presence of gram-positive diplococci on CSF Gram stain (",
"      <a class=\"graphic graphic_picture graphicRef72926 \" href=\"UTD.htm?10/49/11039\">",
"       picture 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Laboratory features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The pretreatment evaluation of children with suspected pneumococcal meningitis should include CSF examination, complete blood count with differential and platelet count, two aerobic blood cultures, and measurement of blood chemistries and glucose; evaluation of clotting function (prothrombin time, partial thromboplastin time) is especially indicated if petechiae or purpuric lesions are noted (",
"      <a class=\"graphic graphic_algorithm graphicRef74865 \" href=\"UTD.htm?34/44/35521\">",
"       algorithm 1",
"      </a>",
"      ). Rapid diagnostic tests of CSF should be reserved for cases in which the initial CSF Gram stain is negative and CSF culture is negative at 48 hours. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of pneumococcal meningitis requires growth of",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      in CSF culture or identification of",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      on Gram stain (",
"      <a class=\"graphic graphic_picture graphicRef72926 \" href=\"UTD.htm?10/49/11039\">",
"       picture 1",
"      </a>",
"      ) or with rapid diagnostic techniques, or a positive blood culture in a patient with CSF pleocytosis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In children who received antibiotics before CSF examination, increased CSF white blood cell count and elevated CSF protein concentration usually are sufficient to establish the diagnosis, particularly if the blood culture or rapid diagnostic test is positive. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      General aspects of the treatment of bacterial meningitis in children are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H10#H10\">",
"       \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Supportive care'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The use of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/33/35344?source=see_link\">",
"       dexamethasone",
"      </a>",
"      in children with pneumococcal meningitis (or suspected pneumococcal meningitis) is controversial. The author of this topic review uses dexamethasone for all patients with possible pneumococcal meningitis (eg, those &gt;6 weeks and &le;5 years of age with community-acquired meningitis, those with sickle cell disease or hyposplenism). In the same patients, other experts may choose not to use dexamethasone. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Dexamethasone'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H16#H16\">",
"       \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Use of dexamethasone'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We recommend that empiric therapy for bacterial meningitis in infants and children older than one month of age include coverage for",
"      <em>",
"       S. pneumoniae",
"      </em>",
"      (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Given the high rate of nonsusceptibility to penicillin and third-generation cephalosporins, empiric therapy should include",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       vancomycin",
"      </a>",
"      in addition to a third-generation cephalosporin. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Empiric therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?39/23/40310?source=see_link\">",
"       Cefotaxime",
"      </a>",
"      300",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day intravenously (IV) (maximum dose 12",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      in 3 divided doses,",
"      <strong>",
"       or",
"      </strong>",
"      &nbsp;",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?0/19/312?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      100",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV (maximum dose 4",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      in 1 or 2 divided doses,",
"      <strong>",
"       plus",
"      </strong>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/58/23465?source=see_link\">",
"       Vancomycin",
"      </a>",
"      60",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      per day IV (maximum dose 4",
"      <span class=\"nowrap\">",
"       g/day)",
"      </span>",
"      in 4 divided doses",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Empiric therapy can be altered when pneumococci are isolated from CSF culture and the antimicrobial susceptibility pattern is known (",
"      <a class=\"graphic graphic_table graphicRef63881 \" href=\"UTD.htm?16/13/16605\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef79959 \" href=\"UTD.htm?32/0/32780\">",
"       table 5",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Specific therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The response to therapy is monitored clinically. Repeat CSF examination is indicated in children who are not improving as expected (",
"      <a class=\"graphic graphic_table graphicRef63881 \" href=\"UTD.htm?16/13/16605\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Repeat LP'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The mortality rate for pneumococcal meningitis is approximately 8 percent; approximately one-half of survivors have long-term neurologic sequelae. (See",
"      <a class=\"local\" href=\"#H31\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Children who have been treated for pneumococcal meningitis should undergo hearing evaluation at the time of or shortly after discharge. They also should be followed closely for other neurologic sequelae, including gross motor and cognitive impairment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=see_link&amp;anchor=H44#H44\">",
"       \"Treatment and prognosis of acute bacterial meningitis in children older than one month of age\", section on 'Follow-up'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/1\">",
"      Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004; 113:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/2\">",
"      Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348:1737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/3\">",
"      Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 2008; 46:1664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/4\">",
"      Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009; 360:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/5\">",
"      Dubos F, Marechal I, Husson MO, et al. Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France. Arch Dis Child 2007; 92:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/6\">",
"      Casado-Flores J, Rodrigo C, Ar&iacute;stegui J, et al. Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2008; 27:1020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/7\">",
"      Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011; 364:2016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/8\">",
"      Arditi M, Mason EO Jr, Bradley JS, et al. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 1998; 102:1087.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/9\">",
"      Hjuler T, Wohlfahrt J, Simonsen J, et al. Perinatal and crowding-related risk factors for invasive pneumococcal disease in infants and young children: a population-based case-control study. Clin Infect Dis 2007; 44:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/10\">",
"      van Furth AM, Roord JJ, van Furth R. Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun 1996; 64:4883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/11\">",
"      Freyer D, Manz R, Ziegenhorn A, et al. Cerebral endothelial cells release TNF-alpha after stimulation with cell walls of Streptococcus pneumoniae and regulate inducible nitric oxide synthase and ICAM-1 expression via autocrine loops. J Immunol 1999; 163:4308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/12\">",
"      Tuomanen E, Liu H, Hengstler B, et al. The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis 1985; 151:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/13\">",
"      Pfister HW, Fontana A, T&auml;uber MG, et al. Mechanisms of brain injury in bacterial meningitis: workshop summary. Clin Infect Dis 1994; 19:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/14\">",
"      T&auml;uber MG, Sachdeva M, Kennedy SL, et al. Toxicity in neuronal cells caused by cerebrospinal fluid from pneumococcal and gram-negative meningitis. J Infect Dis 1992; 166:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/15\">",
"      Igarashi M, Saito R, Alford BR, et al. Temporal bone findings in pneumococcal meningitis. Arch Otolaryngol 1974; 99:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/16\">",
"      Klein M, Schmidt C, Kastenbauer S, et al. MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis. J Infect Dis 2007; 195:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/17\">",
"      Klein JO, Feigin RD, McCracken GH Jr. Report of the Task Force on Diagnosis and Management of Meningitis. Pediatrics 1986; 78:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/18\">",
"      Feigin RD, McCracken GH Jr, Klein JO. Diagnosis and management of meningitis. Pediatr Infect Dis J 1992; 11:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/19\">",
"      Kaplan SL. Clinical presentations, diagnosis, and prognostic factors of bacterial meningitis. Infect Dis Clin North Am 1999; 13:579.",
"     </a>",
"    </li>",
"    <li>",
"     Feigin  RD, Cutrer W. Bacterial meningitis beyond the neonatal period. In: Textbook of Pediatric Infectious Diseases, 6th, Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL (Eds), Saunders, Philadelphia 2009. p.439.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/21\">",
"      Waters AM, Kerecuk L, Luk D, et al. Hemolytic uremic syndrome associated with invasive pneumococcal disease: the United kingdom experience. J Pediatr 2007; 151:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/22\">",
"      Marton KI, Gean AD. The spinal tap: a new look at an old test. Ann Intern Med 1986; 104:840.",
"     </a>",
"    </li>",
"    <li>",
"     Feigin RD and Dodge PR. Personal experience: Unpublished data for prospective studies of bacterial meningitis, 1974-1979.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/24\">",
"      Maxson S, Lewno MJ, Schutze GE. Clinical usefulness of cerebrospinal fluid bacterial antigen studies. J Pediatr 1994; 125:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/25\">",
"      Saha SK, Darmstadt GL, Yamanaka N, et al. Rapid diagnosis of pneumococcal meningitis: implications for treatment and measuring disease burden. Pediatr Infect Dis J 2005; 24:1093.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Pediatrics. Pneumococcal infections. In: Red Book: 2012 Report of the Committee on Infectious Diseases, 29th Ed, Pickering LK, Baker CJ, Kimberlin DW, Long SS (Eds), American Academy of Pediatrics, Elk Grove Village, IL 2012. p.571.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/27\">",
"      Kaplan SL. Management of pneumococcal meningitis. Pediatr Infect Dis J 2002; 21:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/28\">",
"      Centers for Disease Control and Prevention (CDC). Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006. MMWR Morb Mortal Wkly Rep 2007; 56:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/29\">",
"      Pelton SI, Huot H, Finkelstein JA, et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J 2007; 26:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/30\">",
"      Henriques Normark B, Novak R, Ortqvist A, et al. Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin. Clin Infect Dis 2001; 32:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/31\">",
"      Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med 1997; 336:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/32\">",
"      Buckingham SC, McCullers JA, Luj&aacute;n-Zilbermann J, et al. Early vancomycin therapy and adverse outcomes in children with pneumococcal meningitis. Pediatrics 2006; 117:1688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/33\">",
"      Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/34\">",
"      John CC. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis 1994; 18:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/35\">",
"      Tan TQ, Schutze GE, Mason EO Jr, Kaplan SL. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1994; 38:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/36\">",
"      Cherubin CE, Eng RH, Norrby R, et al. Penetration of newer cephalosporins into cerebrospinal fluid. Rev Infect Dis 1989; 11:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/37\">",
"      Par&iacute;s MM, Ramilo O, McCracken GH Jr. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother 1995; 39:2171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/38\">",
"      Klugman KP, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995; 39:1988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/39\">",
"      Friedland IR, Paris M, Ehrett S, et al. Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1993; 37:1630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/40\">",
"      McCullers JA, English BK, Novak R. Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis. J Infect Dis 2000; 181:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/41\">",
"      Fitoussi F, Doit C, Benali K, et al. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis. Antimicrob Agents Chemother 1998; 42:942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/42\">",
"      Buckingham SC, Davis Y, English BK. Pneumococcal susceptibility to meropenem in a mid-south children's hospital. South Med J 2002; 95:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/43\">",
"      Klugman KP, Dagan R. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study Group. Antimicrob Agents Chemother 1995; 39:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/44\">",
"      Odio CM, Puig JR, Feris JM, et al. Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group. Pediatr Infect Dis J 1999; 18:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/45\">",
"      Lutsar I, Friedland IR, Wubbel L, et al. Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother 1998; 42:2650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/46\">",
"      Bradley JS, Jackson MA, Committee on Infectious Diseases, American Academy of Pediatrics. The use of systemic and topical fluoroquinolones. Pediatrics 2011; 128:e1034.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/47\">",
"      Klugman KP, Walsh AL, Phiri A, Molyneux EM. Mortality in penicillin-resistant pneumococcal meningitis. Pediatr Infect Dis J 2008; 27:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/48\">",
"      Friedland IR, Klugman KP. Failure of chloramphenicol therapy in penicillin-resistant pneumococcal meningitis. Lancet 1992; 339:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/49\">",
"      Steele RW, McConnell JR, Jacobs RF, Mawk JR. Recurrent bacterial meningitis: coronal thin-section cranial computed tomography to delineate anatomic defects. Pediatrics 1985; 76:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/50\">",
"      Fiore AE, Moroney JF, Farley MM, et al. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance. Clin Infect Dis 2000; 30:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/51\">",
"      Buckingham SC, McCullers JA, Luj&aacute;n-Zilbermann J, et al. Pneumococcal meningitis in children: relationship of antibiotic resistance to clinical characteristics and outcomes. Pediatr Infect Dis J 2001; 20:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/52\">",
"      Casado-Flores J, Aristegui J, de Liria CR, et al. Clinical data and factors associated with poor outcome in pneumococcal meningitis. Eur J Pediatr 2006; 165:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/53\">",
"      Kornelisse RF, Westerbeek CM, Spoor AB, et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis 1995; 21:1390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/54\">",
"      Bohr V, Rasmussen N, Hansen B, et al. Pneumococcal meningitis: an evaluation of prognostic factors in 164 cases based on mortality and on a study of lasting sequelae. J Infect 1985; 10:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/55\">",
"      Jiang ZD, Liu XY, Wu YY, et al. Long-term impairments of brain and auditory functions of children recovered from purulent meningitis. Dev Med Child Neurol 1990; 32:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/56\">",
"      Pfister HW, Feiden W, Einh&auml;upl KM. Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol 1993; 50:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/57\">",
"      Christie D, Viner RM, Knox K, et al. Long-term outcomes of pneumococcal meningitis in childhood and adolescence. Eur J Pediatr 2011; 170:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/58\">",
"      Rajasingham CR, Bonsu BK, Chapman JI, et al. Serious neurologic sequelae in cases of meningitis arising from infection by conjugate vaccine-related and nonvaccine-related serogroups of Streptococcus pneumoniae. Pediatr Infect Dis J 2008; 27:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/42/12970/abstract/59\">",
"      Tuomanen E, Hengstler B, Rich R, et al. Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J Infect Dis 1987; 155:985.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6052 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-41.78.124.10-C1F21EE0D5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12970=[""].join("\n");
var outline_f12_42_12970=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H36\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Symptoms and signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Laboratory features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Serotype of isolate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      REPORTING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      OVERVIEW OF TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Supportive care",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Isolation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Dexamethasone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ANTIBIOTIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Antibiotic resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Empiric therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Specific therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Penicillin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Cephalosporins",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Vancomycin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Rifampin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Other drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Duration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Response to therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Repeat LP",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Treatment failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Neurologic sequelae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6052\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6052|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?34/44/35521\" title=\"algorithm 1\">",
"      Management of suspected meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6052|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/49/11039\" title=\"picture 1\">",
"      S pneumoniae in CSF",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6052|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/59/15293\" title=\"table 1\">",
"      Pneumococcal vaccines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/13/6364\" title=\"table 2\">",
"      High risk conditions for invasive pneumococcal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?13/55/14204\" title=\"table 3\">",
"      CSF analysis in CNS infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/13/16605\" title=\"table 4\">",
"      Susceptibility of pneumococci",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/0/32780\" title=\"table 5\">",
"      Drugs pneumococcal meningitis children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/52/43849?source=related_link\">",
"      Atypical hemolytic uremic syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/8/28810?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/47/7928?source=related_link\">",
"      Clinical features and diagnosis of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/4/35913?source=related_link\">",
"      Cochlear implant infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/21/4442?source=related_link\">",
"      Dexamethasone and other measures to prevent neurologic complications of bacterial meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/37/44633?source=related_link\">",
"      Elevated intracranial pressure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=related_link\">",
"      General principles of infection control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/37/601?source=related_link\">",
"      Impact of universal infant immunization with pneumococcal (Streptococcus pneumoniae) conjugate vaccines in the United States",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/17/22810?source=related_link\">",
"      Initial therapy and prognosis of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/1/25625?source=related_link\">",
"      Lumbar puncture: Indications, contraindications, technique, and complications in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23143?source=related_link\">",
"      Microbiology and pathogenesis of Streptococcus pneumoniae",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/58/31656?source=related_link\">",
"      Neurologic complications of bacterial meningitis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/0/39946?source=related_link\">",
"      Overview of the management of sickle cell disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/41/38549?source=related_link\">",
"      Pathogenesis and pathophysiology of bacterial meningitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/14/7402?source=related_link\">",
"      Pneumococcal (Streptococcus pneumoniae) conjugate vaccines in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/38/13926?source=related_link\">",
"      Pneumococcal (Streptococcus pneumoniae) polysaccharide vaccines in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/9/1177?source=related_link\">",
"      Prevention of sepsis in the asplenic patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/5/81?source=related_link\">",
"      Resistance of Streptococcus pneumoniae to beta-lactam antibiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/47/16121?source=related_link\">",
"      Treatment and outcome of bacterial meningitis in the neonate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/35/38458?source=related_link\">",
"      Treatment and prognosis of acute bacterial meningitis in children older than one month of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/60/15306?source=related_link\">",
"      Treatment of bacterial meningitis caused by specific pathogens in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_42_12971="Risk factors for dystocia";
var content_f12_42_12971=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F66586&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F66586&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=13\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Risk factors for abnormal labor",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Older maternal age",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregnancy complications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nonreassuring fetal heart rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epidural anesthesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrosomia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pelvic contraction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Occiput posterior position",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nulliparity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Short stature (less than 150 cm)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        High station at full dilatation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chorioamnionitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Postterm pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obesity",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Dystocia and augmentation of labor. ACOG Practice Bulletin #49. Obstet Gynecol 2003; 102:1445.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12971=[""].join("\n");
var outline_f12_42_12971=null;
var title_f12_42_12972="Pseudoall drug rxn";
var content_f12_42_12972=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F79967&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F79967&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Common examples of pseudoallergic drug reactions",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Drug",
"      </td>",
"      <td class=\"subtitle1\">",
"       Clinical reaction(s)",
"      </td>",
"      <td class=\"subtitle1\">",
"       Presumed mechanism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Aspirin and other NSAIDs",
"      </td>",
"      <td>",
"       <p>",
"        Exacerbations of rhinitis, asthma (in patients with aspirin-exacerbated respiratory disease)",
"       </p>",
"       <p>",
"        Urticaria/angioedema (NOTE: urticaria may also result from a Type I, IgE-mediated allergic reaction)",
"       </p>",
"      </td>",
"      <td>",
"       Inhibited prostaglandin production and enhanced leukotriene production",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Opiates",
"      </td>",
"      <td>",
"       Pruritus, urticaria",
"      </td>",
"      <td>",
"       Direct stimulation of mast cells and/or basophils causing release of mediators",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Vancomycin",
"      </td>",
"      <td>",
"       Flushing during infusion",
"      </td>",
"      <td>",
"       Direct stimulation of mast cells and/or basophils causing release of mediators",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Radiocontrast media",
"      </td>",
"      <td>",
"       Anaphylaxis, shock (NOTE: some may be Type I, IgE-mediated allergic reactions)",
"      </td>",
"      <td>",
"       unknown mechanism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ciprofloxacin",
"      </td>",
"      <td>",
"       Urticaria (most reactions)",
"      </td>",
"      <td>",
"       Direct stimulation of mast cells and/or basophils causing release of mediators",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Local anesthetics",
"      </td>",
"      <td>",
"       Syncope",
"      </td>",
"      <td>",
"       vaso-vagal reflex",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Protamine",
"      </td>",
"      <td>",
"       Hypotension, pulmonary hypertension",
"      </td>",
"      <td>",
"       unknown mechanism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Choline",
"      </td>",
"      <td>",
"       Pruritus, urticaria",
"      </td>",
"      <td>",
"       unknown mechanism",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Isoniazid",
"      </td>",
"      <td>",
"       Hepatitis",
"      </td>",
"      <td>",
"       unknown mechanism",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     NSAIDs: non-steriodal antiinflammatory drugs.",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Celik, G, Pichler, WJ, Adkinson, NF Jr. Drug Allergy. In: Middleton's Allergy Principles &amp; Practice, 7th ed, Adkinson, NF, et al (Ed), Mosby Elsevier, Philadelphia 2009. p. 1205-1226. Illustration used with permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12972=[""].join("\n");
var outline_f12_42_12972=null;
var title_f12_42_12973="Diagnostic criteria SM variants";
var content_f12_42_12973=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F82828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F82828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic criteria of variant forms of systemic mastocytosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Indolent systemic mastocytosis (ISM)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meets criteria for SM. No \"C\" findings (see below). No evidence of an associated non-mast cell lineage clonal haematological malignancy/disorder (AHNMD). In this variant, the mast cell burden is low and skin lesions are almost invariably present.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Bone marrow mastocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        As above (ISM) with bone marrow involvement, but no skin lesions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Smouldering systemic mastocytosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        As above (ISM), but with 2 or more \"B\" findings but no \"C\" findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Systemic mastocytosis with associated clonal haematological non-mast cell lineage disease (SM-AHNMD)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meets criteria for SM and criteria for an associated, clonal haematological non-mast cell lineage disorder, AHNMD (MDS, MPN, AML, lymphoma, or other haematological neoplasm that meets the criteria for a distinct entity in the WHO classification)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Aggressive systemic mastocytosis (ASM)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meets criteria for SM. One or more \"C\" findings. No evidence of mast cell leukaemia. Usually without skin lesions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Lymphadenopathic mastocytosis with eosinophilia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Progressive lymphadenopathy with peripheral blood eosinophilia, often with extensive bone involvement, and hepatosplenomegaly, but usually without skin lesions. Cases with rearrangement of",
"        <em>",
"         PDGFRA",
"        </em>",
"        are excluded.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Mast cell leukaemia (MCL)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meets criteria for SM. Bone marrow biopsy shows a diffuse infiltration, usually compact, by atypical, immature mast cells. Bone marrow aspirate smears show 20 percent or more mast cells. In typical MCL, mast cells account for 10 percent or more of peripheral blood white cells. Rare variant: aleukaemic mast cell leukaemia - as above, but &lt;10 percent of white blood cells are mast cells. Usually without skin lesions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Mast cell sarcoma (MCS)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unifocal mast cell tumour. No evidence of SM. Destructive growth pattern. High-grade cytology.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Extracutaneous mastocytoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unifocal mast cell tumour. No evidence of SM. No skin lesions. Non-destructive growth pattern. Low-grade cytology.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        \"B\" findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ol>",
"         <li>",
"          Bone marrow biopsy showing &gt;30 percent infiltration by mast cells (focal, dense aggregates) and/or serum total tryptase level &gt;200 ng/mL",
"         </li>",
"         <li>",
"          Signs of dysplasia or myeloproliferation, in non-mast cell lineage(s), but insufficient criteria for definitive diagnosis of a haematopoietic neoplasm (AHNMD), with normal or only slightly abnormal blood counts",
"         </li>",
"         <li>",
"          Hepatomegaly without impairment of liver function, and/or palpable splenomegaly without hypersplenism, and/or lymphadenopathy on palpation or imaging",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        \"C\" findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <ol>",
"         <li>",
"          Bone marrow dysfunction manifested by one or more cytopenia (ANC &lt;1.0 x 10",
"          <sup>",
"           9",
"          </sup>",
"          /L, Hb &lt;10 g/dL, or platelets &lt;100 x 10",
"          <sup>",
"           9",
"          </sup>",
"          /L), but no obvious non-mast cell haematopoietic malignancy",
"         </li>",
"         <li>",
"          Palpable hepatomegaly with impairment of liver function, ascites and/or portal hypertension",
"         </li>",
"         <li>",
"          Skeletal involvement with large osteolytic lesions and/or pathological fractures",
"         </li>",
"         <li>",
"          Palpable splenomegaly with hypersplenism",
"         </li>",
"         <li>",
"          Malabsorption with weight loss due to GI mast cell infiltrates",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Horny HP, Metcalfe DD, Bennet JM, et al. Mastocytosis. In: WHO classification of tumours of haematopoietic and lymphoid tissues, 4th ed, Swerdlow SH, Campo E, Harris NL, et al (Eds), IARC: Lyon, 2008. Copyright &copy; 2008.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12973=[""].join("\n");
var outline_f12_42_12973=null;
var title_f12_42_12974="FEC for MBC";
var content_f12_42_12974=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F86828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F86828&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Fluorouracil, epirubicin, and cyclophosphamide (FEC) for metastatic breast cancer",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td colspan=\"4\">",
"        Cycle length: 21 days.",
"        <br/>",
"        Duration of therapy: 6 to 8 cycles*.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Fluorouracil",
"        </strong>",
"       </td>",
"       <td>",
"        500 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Drug is available in 50 mg/mL solution that needs no further dilution prior to administration as IV push.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Epirubicin",
"        </strong>",
"       </td>",
"       <td>",
"        100 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        Administer into a free flowing IV solution with normal saline (NS), generally over 3 to 20 minutes.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cyclophosphamide",
"        </strong>",
"       </td>",
"       <td>",
"        500 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        Dilute with 250 NS or 5 percent dextrose in water (D5W) and administer over 30 to 60 minutes.",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Hydration:",
"        </strong>",
"        Patients should maintain adequate oral hydration (2 to 3 L/day) and void frequently to reduce risk of hemorrhagic cystitis",
"        <sup>",
"         [2]",
"        </sup>",
"        . Refer to UpToDate topic on \"Cystitis in patients with cancer\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        HIGH (&gt;90 percent frequency of emesis). Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Vesicant/irritant properties:",
"        </strong>",
"        Epirubicin is a vesicant, fluorouracil and cyclophosphamide are irritants; avoid extravasation. Refer to UpToDate topic on \"Chemotherapy extravasation injury\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Infection prophylaxis:",
"        </strong>",
"        Primary prophylaxis with G-CSF is not indicated",
"        <sup>",
"         [1]",
"        </sup>",
"        . Refer to UpToDate topic on \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dose adjustment for baseline liver or renal dysfunction:",
"        </strong>",
"        A lower starting dose of fluorouracil may be needed for patients with liver impairment. A lower starting dose of cyclophosphamide may be needed in patients with renal impairment. A lower starting dose of epirubicin may be needed in patients with renal or hepatic impairment. Refer to UpToDate topics on \"Chemotherapy-related nephrotoxicity and dose modification in patients with renal insufficiency\" and \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Cardiac issues:",
"        </strong>",
"        Epirubicin is associated with dose-dependent cardiomyopathy, the incidence of which is related to cumulative dose. Assess baseline left ventricular ejection fraction (LVEF) prior to initiating therapy. Epirubicin is contraindicated for patients with recent myocardial infarction, severe myocardial dysfunction (LVEF &lt;50 percent), severe arrhythmias, or prior treatment with maximum cumulative doses of anthracyclines. Refer to UpToDate topic on \"Cardiotoxicity of anthracycline-like chemotherapy agents\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess liver and renal function tests prior to each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess CBC with differential prior to and during each treatment cycle.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor for diarrhea and cutaneous toxicity (palmar-plantar erythrodysesthesias).",
"       </td>",
"      </tr>",
"      <tr>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor cumulative epirubicin dose. Reassess LVEF periodically during FEC therapy as clinically indicated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose modifications for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Myelotoxicity:",
"        </strong>",
"        If the ANC &lt;1500 cells/mm",
"        <sup>",
"         3",
"        </sup>",
"        and platelets &lt;100,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        on day 1 of each cycle, therapy should be delayed until counts recover. For mid-cycle platelet count &lt;50,000/mm",
"        <sup>",
"         3",
"        </sup>",
"        , ANC &lt;250 cells/mm",
"        <sup>",
"         3",
"        </sup>",
"        , or neutropenic fever, reduce epirubicin to 75 percent of day 1 dose.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Gastrointestinal toxicity:",
"        </strong>",
"        For &ge;grade 3 mucositis (or other non-hematologic toxicity), reduce epirubicin by 10 mg/m",
"        <sup>",
"         2[1]",
"        </sup>",
"        . Withhold fluorouracil for grade 2 or worse diarrhea and restart at a lower dose after complete resolution",
"        <sup>",
"         [3]",
"        </sup>",
"        .",
"        <strong>",
"         NOTE:",
"        </strong>",
"        Severe diarrhea and mucositis after fluorouracil should prompt evaluation for dihydropyrimidine dehydrogenase deficiency. Refer to UpToDate topic on \"Enterotoxicity of chemotherapeutic agents\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Cardiac toxicity:",
"        </strong>",
"        If cardiac symptoms develop or if during treatment the LVEF decreases by &ge;10 percent in absolute value below the lowest normal limit, or &ge;15 percent below the patient's own baseline, discontinue treatment",
"        <sup>",
"         [1]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Palmar-plantar erythrodysesthesia:",
"        </strong>",
"        Hold fluorouracil for grade 2 or greater palmar plantar erythrodysesthesia, and reduce subsequent dose by 20 percent",
"        <sup>",
"         [3]",
"        </sup>",
"        . Refer to UpToDate topic on \"Cutaneous complications of conventional chemotherapy agents\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, doses should be recalculated.",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     ANC: absolute neutrophil count; CBC: complete blood count; IV: intravenous; G-CSF: granulocyte-colony stimulating factor.",
"     <br>",
"      * Anticipated treatment duration is six cycles. If a complete response is reached, two additional cycles may be given for a total of eight cycles.",
"      <br>",
"       &Delta; Epirubicin may be increased in successive cycles by 10 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       until a maximal dose per cycle of 120 mg/m",
"       <sup>",
"        2",
"       </sup>",
"       if appropriate hematological toxicity parameters are met. Refer to section above on \"Suggested dose modifications for toxicity\".",
"       <br/>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Brufman G, et al. Ann Oncol 1997; 8:155.",
"      </li>",
"      <li>",
"       Cytoxan (cyclophosphamide) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at: dailymed.nlm.nih.gov, accessed on February 24, 2012).",
"      </li>",
"      <li>",
"       Fluorouracil injection FDA-approved package insert US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on February 24, 2012).",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12974=[""].join("\n");
var outline_f12_42_12974=null;
var title_f12_42_12975="Smoking trajectories";
var content_f12_42_12975=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56174&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56174&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Trajectories for smoking continuation or cessation among adolescent smokers",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 444px; height: 302px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Predicted smoking quantity-frequency for each smoking trajectory group in a sample of adolescents and young adults in the United States.",
"    <div class=\"footnotes\">",
"     %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Costello, DM, Dierker, LC, Jones, BL, Rose, JS. Trajectories of smoking from adolescence to early adulthood and their psychosocial risk factors. Health Psychol 2008; 27:811. Copyright &copy; 2008 American Psychological Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_42_12975=[""].join("\n");
var outline_f12_42_12975=null;
